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Introduction and outline of this thesis
Cardiac arrest, restoration of spontaneous circulation  
and post-cardiac arrest syndrome
In 1972 Negovsky described for the first time a constellation of pathophysiological 
processes occurring after successful cardiopulmonary resuscitation (CPR). This state 
was named ‘postresuscitation disease’ [1]. In 2008, the International Liaison 
Committee on Resuscitation (ILCOR) proposed to introduce a new term: ‘post-cardiac 
arrest syndrome (PCAS)’, this because of the expanded use of the term ‘resuscitation’, 
including the treatment of all sorts of shock states in which blood flow has not ceased 
[2]. Moreover ‘post-resuscitation’ suggests that the act of resuscitation has ended, 
whereas with the return of spontaneous circulation (ROSC) a more complex and 
challenging phase of resuscitation begins.
 Patients resuscitated from an in-hospital and out-of-hospital cardiac arrest (IHCA 
and OHCA) have a high (in-hospital) mortality rate ranging from 50% to 90% [3-7]. 
Despite major changes in the (pre)hospital treatment after OHCA, the overall 
prognosis after cardiac arrest has not substantially improved in the past decades 
[8-14]. New developments have mainly focused on improving the rate of ROSC by 
optimizing bystander cardiopulmonary resuscitation and by optimizing the quality of 
cardiopulmonary resuscitation [2, 9]. Training and equipping volunteers to attempt 
early defibrillation (by using an automatic external defibrillator (AED)) within a 
structured response system increased the number of survivors to hospital discharge 
after out-of-hospital cardiac arrest in public locations [15]. 
 More recently the post-cardiac arrest care has increasingly been recognized as a 
weak link in the Chain of Survival. Improvement of the post-cardiac arrest care is 
supposed to considerably attribute to the improvement of outcome [12, 16]. For 
example, the great majority of cardiac arrest patients have evidence of coronary 
heart disease, and immediate primary PCI in cardiac arrest survivors with ECG changes 
other than STEMI is associated with better survival after OHCA [17, 18]. Also important, 
the pathologies that result from cardiac arrest should be a major concern in the ICU. 
Only a minority of the cardiac arrest patients survive with a favorable neurological 
recovery [19]. Therefore growing understanding of the pathophysiology of the PCAS 
is essential for the development of new therapeutic strategies improving survival. For 
example, targeted temperature management benefits the postcardiac arrest 
myocardium and brain, and proves to be effective in improving the neurological 
outcome after cardiac arrest [20-24].
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(aiming at normocapnia, avoiding hypocapnia) in establishing an optimal environment 
for cerebral recovery [28-31].
(2) Post-cardiac arrest myocardial dysfunction. This is an important component of the 
PCAS and it is essential to recognize this shortly after ROSC because it may decrease 
cerebral blood flow and may contribute to injury of other vital organs, such as liver 
and kidneys, as well. Even in the absence of acute ST elevation, early coronary 
angiography and PCI improve postresuscitation myocardial function and outcome in 
synergy with mild therapeutic hypothermia (MTH) [17]. Cardiac dysfunction after 
successful resuscitation can be severe and even lethal; however, as stated by Zia et 
al., generally it is also transient and full recovery in days is common, emphasizing the 
importance of early supportive therapies [18]. The transient feature of the cardiac 
dysfunction suggests ‘myocardial stunning’ rather than ischemic heart disease. In 
animal studies, stunning is diffuse and global, involving compromise of both systolic 
and diastolic function of both left and right ventricular function [32, 33]. In humans 
reversible myocardial dysfunction consisting of systolic myocardial dysfunction and 
disturbances of segmental contractility  was demonstrated after successful CPR [34]. 
Myocardial dysfunction can be treated by administration of vasoactive medication 
and/or inotropes and occasionally with hemodynamic support using intra-aortic 
balloon pump (IABP), left or right ventricular assist devices (LVAD/RVAD) or extra- 
corporeal membrane oxygenation (ECMO). As mentioned before, the global myocardial 
dysfunction generally is transient and full recovery in days is common [35, 36]. 
Nevertheless, the prearrest state of the left ventricle is a crucial determining factor in 
long-term outcome from postresuscitation myocardial dysfunction [37].
(3) Systemic ischemia/reperfusion response. During CPR oxygen delivery and removal of 
metabolites is insufficient. Accumulated oxygen debt induces endothelial activation and 
systemic inflammation [38]. The whole body ischemia/reperfusion with associated oxygen 
debt also leads to activation of  blood coagulation and various immunologic pathways, 
which may result in MOF [39, 40]. During CPR and early after restoration of spontaneous 
circulation, blood levels of various cytokines and soluble receptors increase, mimicking 
the inflammatory state in septic patients [39-42]. Coagulation/anticoagulation and 
fibrinolysis/antifibrinolysis systems are in disbalance during and after CPR, contributing 
to disturbed microcirculatory reperfusion [43]. Clinical manifestations of the ischemia- 
reperfusion response include intravascular volume depletion, impaired vasoregulation, 
impaired oxygen delivery and utilization, and increased susceptibility to infection [2]. 
(4) Persistent precipitating pathology. The PCAS occurs simultaneously with the 
expression of the clinical characteristics of the underlying disease which led to cardiac 
arrest, for instance acute coronary syndrome (ACS), pulmonary embolism, sepsis or 
hemorrhage. Specific treatment of the underlying cause is necessary and preferably 
happens in concordance with the treatment of the PCAS, directed to hemodynamic 
optimization and neurological preservation.
Post-cardiac arrest syndrome
Phases of PCAS
The post-cardiac arrest period is divided in 4 phases: (1) immediate post arrest phase 
(first 20 minutes after ROSC), (2) early post arrest phase (period between 20 minutes 
and 6 to 12 hours after ROSC) when early interventions might be most effective, (3) 
intermediate post arrest phase (period between 6-12 hours to 72 hours after ROSC) 
when injury pathways are still active and finally (4) the recovery phase (> 72 hours 
after ROSC to > 3 days) [2].
Pathophysiological processes after ROSC
Instead of denominating the different phases of the PCAS it seems more useful to 
focus on the different pathophysiological processes after ROSC to understand clinical 
manifestations and develop potential new treatments. These processes are 
superimposed on the injury responsible for the cardiac arrest and on comorbidities, 
and mainly arise after admission of the patient to the ICU. The PCAS is a unique and 
complex combination of different processes, which include (1) post-cardiac arrest 
brain injury, (2) post-cardiac arrest myocardial dysfunction, (3) systemic ischemia/
reperfusion, and (4) persistent precipitating pathology such as acute myocardial 
infarction, pulmonary disease, thromboembolic disease, CNS disease, hypovolemia, 
infection (sepsis) or toxicological factors [2]. The four major elements of the PCAS are 
discussed below.
(1) Post-cardiac arrest brain injury. Cardiac arrest is a state of global ischemia, but the 
brain is especially vulnerable. Of all the different body tissues, the brain is the most 
vulnerable for ischemia, resulting in irreversible tissue damage within minutes. In 
patients admitted to the ICU, brain injury was the cause of in-hospital death in 68% of 
patients after OHCR and in 23% after in-hospital cardiac arrest [25]. The prognosis 
after cardiac arrest and resuscitation is mainly determined by the (primary) 
neurological injury which has occurred as a result of the cerebral ischemia [25]. The 
mechanisms leading to secondary neurological damage are complex and are the 
result of cerebral perfusion failure due to impaired cerebrovascular autoregulation, 
cerebral edema and due to postischemic neurodegeneration. In animal experiments 
cerebral blood flow (CBF) after cardiac arrest is characterized by 4 phases: (1) 
no-reflow, (2) global hyperemia, (3) delayed hypoperfusion and (4) normal, increased 
or decreased CBF [26]. Different cell death pathways (neuronal necrosis and apoptosis) 
are caused by diverse injury cascades over time [27]. This protracted course could 
imply a broad neuroprotective therapeutic window [2]. Although reperfusion during 
CPR/ROSC prevents further neuronal degeneration, to a certain degree it does not 
necessarily completely restore function. More recently there is a growing interest for 
the role of controlled re-oxygenation (avoiding hypoxia and hyperoxia) and ventilation 
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leakage, cerebral thermopooling, brain edema and intracranial hypertension [60]. 
Hypothermia inhibits or mitigates many of these mechanisms and possibly promotes 
protective early gene activation [60]. Side effects such as shivering, increased 
systemic vascular resistance, electrolyte shifts, hypovolemia caused by cold diuresis, 
arrhythmias, decreased insulin sensitivity and production, impaired coagulation, 
impairment of the immune system, hyperamylasaemia, and decreased drug clearance 
are in general easy to control in the modern ICU-setting. Currently the optimal 
induction/maintenance method, duration of hypothermia, degree of hypothermia, 
and rewarming rate remain important issues to be resolved.
Postresuscitation care
Secondary injury after cardiac arrest results from multiple pathways and injuries and 
will require a multimodality therapeutic approach. The use of hypothermia is one of 
the key components of post-cardiac arrest care. Haemodynamic management is 
another crucial component of the post-cardiac arrest care, but little clinical data are 
available to guide clinical treatment in hypothermic patients [61]. Therapy should be 
balanced between adequate cerebral perfusion pressure and exposing the 
myocardium to an excessive afterload.
 After ischemia the brain is highly susceptible to disturbances in general homeostasis 
[29, 62-64]. Neuronal injury is an important factor in determining the final prognosis, 
so even before admission of a cardiac arrest patient to the ICU, therapeutic measures 
should be directed to the establishment of an optimal environment for cerebral 
recovery. It has been proposed to protocolize this postresuscitation care into a 
‘post-cardiac arrest care bundle’, as for other critically ill patients [14, 65]. Essential 
components of this bundle include early coronary reperfusion and hemodynamic 
optimization, a strict control of blood glucose, targeted oxygen saturation (preventing 
hypoxia and hyperoxia) and ventilation (preventing hypo-, and hypercapnia), strict 
temperature control with subsequent prevention of pyrexia and aggressive treatment 
of seizures.
Outline of this thesis
The aim of the current thesis is to better understand the underlying mechanisms 
through which hypothermia exerts its beneficial effects. Understanding these 
mechanisms can be helpful in guiding clinical decisions regarding the moment and 
rate of rewarming after MTH.
 This thesis has been divided into two sections, discussing cerebral blood flow in 
cardiac arrest patients during MTH and rewarming in Section I, and inflammation 
during MTH and rewarming after cardiac arrest in Section II.
Targeted temperature management
Although the first scientific reports about the clinical application of hypothermia for 
various indications are dated from the 1940s and 1950s, the first clinical trials with 
induced moderate and deep hypothermia were performed in the 1960s [44-48]. 
However, interest in therapeutic hypothermia decreased due to side effects, 
uncertain benefits, and a lack of technical support in inducing and maintaining MTH. 
The evolution of ICU care over the past three decades with increasing technical 
abilities to prevent and treat potential side-effects and the recognition that higher 
temperatures (32-35 °C) could also be beneficial, refueled the interest in induced 
hypothermia. Supported by the consistently positive results of improved outcome in 
animal studies, two randomized clinical trials in humans were published in 2002 [20, 
21, 49-53]. A multicenter trial from Europe included 273 patients after out-of-hospital 
cardiac arrest, and despite the fact that the target temperature of 32-34 °C was only 
reached after an average time period of 8 hours, it demonstrated a beneficial effect 
of MTH on mortality and neurological outcome [20]. The second study from Australia, 
in which MTH (33 °C) was maintained for 12 hours, included 77 patients with an 
out-of-hospital cardiac arrest and showed a significant improvement in good 
neurological outcome without a significant decrease in mortality [21]. Further 
supporting evidence came from seven randomized controlled trials from the field of 
neonatology [54] . Since 2002 implementation of MTH has revolutionized the 
management of comatose PCAS patients in the ICU. Induced mild hypothermia is 
widely practiced, although due to the strict inclusion criteria for the original studies it 
remains debatable whether MTH is also applicable for other rhythms than ventricular 
fibrillation and in-hospital cardiac arrest [24, 55, 56]. Generalization of MTH to 
comatose non VF-VT based cardiac arrest patients received a Class IIb recommendation 
in the 2010 AHA guidelines [57].
 However, more recently this evidence has been challenged. For example, the 
largest randomized controlled trial (RCT) until 2013 had no strict temperature 
management in the control group (average temperature of 37.8 ˚ C), and was criticized 
for a lack of prior power calculation and a low enrollment rate [20]. In 2013 the 
TTM-trial, a RCT enrolling 939 witnessed cardiac arrest patients regardless of initial 
rhythm, cooled patients to either 33 ˚C or 36 ˚C. Hypothermia at a targeted 
temperature of 33 ˚C did not confer a survival benefit as compared with a targeted 
temperature of 36˚C [58], challenging the results of the aforementioned 2 RCT’s and 
more than 40 non-randomized studies and meta-analysis [19, 24, 54, 59]. Because of 
the extensive body of evidence favoring MTH, up to now MTH has remained the 
standard of care in cardiac arrest patients in many ICU’s.
 As described, a destructive cascade of several pathophysiological processes 
unfolds during the PCAS including excitotoxicity, neuroinflammation, apoptosis, free 
radical production, seizure activity, blood-brain barrier disruption, blood vessel 
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 Section I starts with an introduction on cerebral blood flow after cardiac arrest 
(chapter 2). The subsequent two studies evaluate the effect of controlled hypothermia 
on cerebral blood flow during 24 hours of cooling and subsequent rewarming (chapter 
3). This chapter also elucidates the effect of hypothermia on the cerebrovascular CO2 
reactivity. An observational study in patients treated with MTH for 72 hours 
differentiates the effects of hypothermia on the cerebral blood flow described in 
chapter 3 from a more temporal pattern of cerebral blood flow after cardiac arrest 
(chapter 4). Finally blood viscosity is measured and the relation between blood 
viscosity, cerebral blood flow and cerebral oxygen extraction is assessed in 
hypothermic cardiac arrest patients (chapter 5).
 Section II begins with an introduction of ischemia/reperfusion injury and 
subsequent inflammation during the post-cardiac arrest syndrome (chapter 6). The 
differentiation between a time relation or a direct effect of MTH and rewarming on 
the course of inflammatory parameters and complement activation is the topic of the 
following two studies (chapter 7 and chapter 8).
 A general discussion and summaries in English and Dutch are provided in the last 
two chapters (chapter 9 and 10).
section I
Cerebral blood flow after  
cardiac arrest
L.L.A. Bisschops, C.W.E. Hoedemaekers, J.G. van der Hoeven
Adapted from
Annual Update in Intensive Care and Emergency Medicine 2012 (J.-L. Vincent, ed.),
Section XIII Cardiac Arrest, p. 545-55.
Springer-Verlag Berlin Heidelberg 2012, ISBN 978-3-642-25715-5
2
23
Cerebral blood flow after cardiac arrest
2
Introduction
Patients resuscitated from a cardiac arrest have a high (in-hospital) mortality rate 
between 50 – 90% [3-7]. Despite major changes in (pre)hospital treatment after out 
of hospital cardiac arrest (OHCA), overall prognosis has not substantially improved in 
the past decades. Although ROSC rate has substantially improved to 20-50% [66, 67], 
improving long term survival has been less successful [2]. Only a minority of patients 
survive with a favorable neurological recovery [19]. In 1972 Negovsky described the 
‘post-resuscitation syndrome’, a constellation of pathophysiological processes occurring 
after restoration of spontaneous circulation (ROSC) [1]. In 2008 the International 
Liaison Committee on Resuscitation (ILCOR) proposed a new term: the ‘post-cardiac 
arrest syndrome’ (PCAS) [2]. Growing understanding of the PCAS has contributed to 
the development of new therapeutic strategies. For example, mild therapeutic 
hypothermia was effective in improving neurological outcome after cardiac arrest in 
two randomized controlled trials [20, 21]. In 2011 these results were confirmed in a 
retrospective, multicenter observational study showing that the implementation of 
mild therapeutic hypothermia (MTH) in Dutch intensive care units (ICU) is associated 
with a 20% relative reduction in hospital mortality [24].
Post-cardiac arrest syndrome
The PCAS is usually divided into 4 phases: (1) immediate post-arrest phase (first 20 
minutes after ROSC); (2) early post-arrest phase (period between 20 minutes and 6 to 
12 hours after ROSC) when early interventions are probably most effective; (3) 
intermediate post-arrest phase (period between 6-12 hours to 72 hours after ROSC) 
when injury pathways are still active; and finally (4) the recovery phase (> 72 hours 
after ROSC) [2]. The underlying pathophysiological processes occurring in the PCAS 
were described in the introduction of this thesis.
Cerebral blood flow
Although the brain is only about 2% of the total body weight, it receives 15-20% of the 
cardiac output. Under normal circumstances, the regulation of the CBF is under direction 
of the brain itself, and is controlled through three different mechanisms changing 
cerebrovascular resistance: (1) metabolic activity; (2) pressure autoregulation; and (3) 
cerebrovascular reactivity. Although perivascular adrenergic nerves richly supply the 
cerebral circulation, the importance of neural regulation of the cerebral circulation 
remains controversial [68, 69].
Cerebral blood flow after cardiac arrest
The amount of brain damage after cardiac arrest strongly depends on the recovery of 
the cerebral circulation. Understanding the pathophysiology and temporal pattern of 
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2. Transient global hyperemia (vasoparalysis)
This next phase (15-30 minutes) is characterized by transient global vasoparalysis and 
‘reactive’ hyperemia, which can co-exist with the no-reflow phase [26, 86-88]. Since 
the no-reflow is heterogenous, post-ischemic reactive hyperemia is heterogenous as 
well [72, 89]. Measurement of global CBF after ischemia may therefore reveal normal 
or even increased flow rates, although focal areas of no-reflow are still present [75]. 
The vasoparalysis is attributed to reduction of vascular tone due to tissue acidosis 
[90], and does not respond to changes in blood pressure or CO2 [91]. After ROSC, the 
viscosity of streaming blood declines. As a result of brain swelling, which already 
starts to develop in the no-reflow phase, and the following hyperemia, intracranial 
pressure may increase sharply after the beginning of recirculation but usually 
normalizes before the next hypoperfusion phase starts [75].
3. Delayed (protracted) global hypoperfusion phase
In contrast to the no-reflow phenomenon the severity of the protracted global 
hypoperfusion is independent of the duration of ischemia [92], it develops after a 
delay and is due to an impairment of the metabolic/hemodynamic coupling 
mechanisms. The timing of the hypoperfusion phase correlates with the duration of 
ischemia: the longer the ischemia, the later the onset of hypoperfusion [75]. Based on 
various lines of evidence, the underlying pathophysiology of hypoperfusion appears 
to indicate a functional disturbance because of an increased arterio-arteriolar 
vascular tone [75]. Autoregulation recovery usually occurs earlier (during the 
hyperemic phase) than recovery of reactivity to CO2. The reason for this is unknown, 
but is also found in experimental subarachnoid hemorrhage [93]. Despite the delay in 
recovery of cerebrovascular reactivity to changes in CO2 in comparison with recovery 
of autoregulation, Buunk et al. demonstrated that intact cerebrovascular reactivity in 
normothermic cardiac arrest survivors occurs in the hypoperfusion phase [29]. 
 During the delayed hypoperfusion phase CBF is characterized by an (inhomo-
geneous) decrease to about 50% or less [72, 94]. In cardiac arrest patients treated 
with normothermia, cerebrovascular resistance was initially high and gradually 
decreased during the first 24 hours [95]. This may be explained by an imbalance 
between local production of vasoconstrictors and vasodilators such as endothelin-1 
and nitric oxide (NO) [95].
 Another possible factor contributing to hypoperfusion is platelet and leukocyte 
adhesion triggered by morphological changes of the vascular lumen or by increased 
expression of adhesion molecules [96-98].
 An abnormal coupling between CBF and brain metabolism is controversial. 
Several studies conclude that the ratio of CBF and cerebral metabolic rate of oxygen 
(CMRO2) is normal [99-101]. Other studies indicate uncoupling (increase in CMRO2 
while CBF decreases) aggravating ischemia [102-104]. 
cerebral perfusion is essential. Unfortunately, human studies are rare and the bulk of 
our present knowledge is obtained from animal studies, with a lack of reproducible 
and controllable resuscitation models [70].
 ROSC does not automatically restore normal cerebral circulation. Animal experiments 
demonstrate that the course of CBF after cardiac arrest is abnormal for several days. 
CBF with normotensive reperfusion after ROSC apparently progresses through 4 
different stages, which are described in the following paragraphs [26].
1. Multifocal no-reflow
When blood flow to the brain is interrupted for more than a few minutes, vascular 
changes occur which interfere with the re-establishment of normal CBF. This has 
been referred to as the ‘no-reflow phenomenon’. First described by Ames et al. post 
ischemic perfusion defects increased in number and size after increasing the duration 
of global ischemia in rabbits [71]. In a study performed in rats by Kågström et al. areas 
of no-reflow appeared after 10 minutes of ischemia, were more extensive after 15 
minutes, and occupied a major part of the brain after 30 minutes [72]. Carbon black 
perfusion studies in dogs arrested for more than than 5 minutes showed multiple 
focal areas of small patchy and diffuse coarse reperfusion defects at the arterio-
lar-capillary levels [73]. Hossmann clearly demonstrated unstained no-reflow areas 
after infusion of carbon black after 60 minutes of global cerebral ischemia in cats [74]. 
The threshold duration of ischemia for the manifestation of no-reflow is approximately 
7 minutes of complete ischemia and is close to the ischemic threshold of irreversible 
brain damage [71, 75].
 Different mechanisms may contribute to the multifocal no-reflow: (1) red blood 
cell aggregation due to stasis of blood, resulting in increased viscosity. However, the 
role of blood viscosity in the no-reflow phenomenon  remains disputed, because 
hypothermia attenuates multifocal no-reflow, while increasing blood viscosity [75-77]; 
(2) narrowing and occlusion of vascular lumina due to ischemia-induced swelling of 
perivascular glia and endothelial cells. A proposed fall in ATP consequent to ischemia 
is thought to lead to failure of active transport processes, resulting in movement of 
salts and water from plasma into perivascular cells [78, 79]; (3) cerebrovascular 
resistance increases during ischemia because of an increase in extracellular potassium 
concentration which depolarizes vascular smooth muscle cell membrane, causing 
 vasoconstriction [79]; (4) leukocyte adhesion [80]; (5) intravascular coagulation, 
although controversial because no morphological evidence of thrombi has been 
found and heparin is unable to prevent the no-reflow phenomenon [43, 81-83]. (6) 
post-cardiac arrest hypotension, occurring in a high proportion of cardiac arrest 
survivors on admission to the ICU [84, 85]. If autoregulation is disturbed, severe 
hypotension leads to decreased and insufficient perfusion pressure of the brain.
26 27
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 It is debated whether sympathetic activity also influences CBF and cerebral 
oxygenation. If sympathetic influence on CBF exists, this could be important in the 
management of hypotensive patients. Without α-adrenergic influence on CBF, a low 
MAP can be increased to the cerebral autoregulation range by α-adrenergic receptor 
agonists to secure CBF and cerebral oxygenation. If CBF is influenced by cerebral 
α-adrenergic stimulation, CBF and cerebral oxygenation may decline while MAP 
increases in response to administration of the α-adrenergic agonist [68, 69]. The 
direct effects of norepinephrine on CBF in cardiac arrest survivors are unknown and 
probably depend on the metabolic activity of the brain, the integrity of the blood 
brain barrier and the level of autoregulation [120].
Hemodynamic optimization: cardiac output
Impaired autoregulation is thought to play an important role in the relationship 
between cardiac output and CBF. However no human study investigated this 
relationship. In severely head injured patients no correlation existed between 
changes in cardiac output and changes in CBF, regardless of the status of autoregulation 
[121]. According to Poiseuille’s law, flow is the quotient of perfusion pressure and 
vascular resistance, without cardiac output fitting in this equation. 
 At controlled levels of PaCO2 moderate hypovolemia that did not change MAP, 
significantly decreased cardiac output and CBF in normal cats [122]. The effect of 
cardiac output on CBF in cardiac arrest patients need further studies. Central venous 
oxygen saturation (ScvO2) is frequently used as a substitute for an adequate cardiac 
output. Although post-cardiac arrest care guidelines suggest an ideal target for ScvO2 
≥ 70%, there are no human data available to support this [57].
Hemodynamic optimization: volume expansion. As a result of the reperfusion injury, 
volume expansion is indicated in most cardiac arrest patients. Prospective clinical 
trials to assess the effects of early goal-directed therapy as studied in sepsis or 
postoperative patients are not available for post-cardiac arrest patients. Gaieski et al. 
examined the feasibility of establishing an integrated post-cardiac arrest resuscitation 
algorithm combining MTH and early goal-directed hemodynamic optimization 
(EGDHO) within 6 hours of emergency department presentation. They found that 13 
of 18 (78%) of patients required interventions based upon the treatment algorithm 
and that 72% of patients were able to achieve EGDHO goals within 6 h of ROSC. A 28% 
absolute reduction in mortality when compared with historic controls was achieved, 
though the study was underpowered for the results to reach statistical significance 
[123].
 Animal data indicate that volume expansion by hypertonic solutions may have a 
beneficial effects on CBF when given during CPR by preventing post-ischemic hemo-
concentration. Cerebral no-reflow after 15 minutes of cardiac arrest was significantly 
4. Normal, low or increased cerebral blood flow
Finally, after 20-24 hours, CBF either returns to normal values, remains low (with low 
global O2 uptake/coma) or increases [105, 106]. Secondary hyperemia could be 
associated with reduced O2 uptake and normal O2 supply as a sign of severe postanoxic 
cerebral impairment or brain death [100, 101, 107].
Treatment strategies in the ICU
Treatment in the ICU is directed towards limiting the pathophysiological changes and 
creating an optimal environment for cerebral recovery. Prevention of secondary 
neurological damage is a major concern. International guidelines on CPR recommend 
maintaining normotension, normoglycemia and normocapnia. However, so far it has 
been insufficiently clarified if ‘normal’ is also ideal for the injured brain and if supra-
physiological parameters should be pursued [62].
Hemodynamic optimization: arterial blood pressure
Many cardiac arrest patients face hypotension, dysrhythmias, and low cardiac output 
[35, 57, 84]. Nevertheless the effect of inotropes and vasopressors on survival has not 
been studied in clinical trials. No data are available from prospective clinical studies 
to determine the optimal blood pressure after ROSC. Normally, CBF is relatively 
constant when cerebral perfusion pressure (CPP = Mean Arterial Pressure (MAP) – 
ICP) varies between 50-150 mm Hg [108-111]. Most (normothermic) cardiac arrest 
survivors show abnormal or lost cerebral pressure autoregulation [63, 112]. Animal 
studies suggest that increasing MAP is important to improve outcome by mitigating 
both no-reflow and delayed hypoperfusion [87, 88, 94, 113-115]. Due to the abnormal 
pressure autoregulation, CBF may benefit from a higher perfusion pressure. On the 
other hand, a lower blood pressure may benefit the compromised heart as long as 
cerebral oxygen delivery remains sufficient. A good outcome after cardiac arrest has 
been reported in studies in which the target MAP was as low as 65 - 75 mm Hg or as 
high as 90 - 100 mm Hg [21, 116]. Hypertension (MAP > 100 mm Hg) in the first 5 
minutes after ROSC did not improve neurological recovery, but a higher MAP in the 
first 2 hours after ROSC showed a positive correlation with neurological outcome in a 
retrospective evaluation of 136 patients [117]. Sasser et al. examined the data from 
1,234 cardiac arrest patients who survived at least 12 hours. After controlling for age, 
sex, arrest time, CPR time and pre-existing diseases, a higher systolic arterial pressure 
at 1-2 min, 5 min, 10 min, 20 min, and 60 min were associated with CPC 1 or 2 (good 
outcome) [118]. Although the optimal blood pressure in humans is still unknown, a 
MAP ≥ 65 mm Hg is considered a reasonable goal by most [57]. In a prospective 
observational study Kilgannon et al. recently found that time-weighted average mean 
arterial pressure was associated with good neurologic outcome at a threshold of 
mean arterial pressure greater than 70 mm Hg [119].
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 Hypocapnia-induced brain ischemia may occur as a result of cerebral vaso-
constriction, reduced oxygen release from hemoglobin due to a leftward shift of the 
oxyhemoglobin dissociation curve, and increased neuronal excitability in cardiac 
arrest survivors. Increased neuronal excitability may worsen brain injury by an 
augmented cerebral oxygen demand and raised production of cytotoxic excitatory 
amino acids associated with seizures. Although hypocapnia induced cerebral vaso-
constriction has a beneficial effect on ICP it is generally outweighed by the effects of 
a reduced oxygen supply [139, 140]. 
 One form of hypocapnic alkalosis is rarely discussed. During cardiopulmonary 
resuscitation a critical reduction in pulmonary blood flow results in dissociation 
between central venous blood (high PcvCO2 and low pH) and arterial blood (low 
PaCO2 and high pH). This condition is referred to as pseudorespiratory alkalosis [134, 
141] and potentially results in severe cerebral vasoconstriction, resulting in brain 
ischemia in poorly perfused areas.
 After ROSC, cardiac arrest patients generally are treated with MTH. Under 
normothermic conditions, cerebrovascular reactivity to changes in arterial PaCO2 is 
preserved [29, 142]. We demonstrated intact CO2 reactivity during a 24-hr period of 
mild hypothermia in comatose patients after cardiac arrest. Hypocapnia and 
hypercapnia were induced by adjusting mechanical ventilator settings. The mean 
change in mean flow velocity in the middle cerebral artery (MFVMCA) as a parameter 
of CBF was 3.6 ± 2.9%/mm Hg. Hypoventilation resulted in a 4.4 ± 3.5%/mm Hg 
increase of MFVMCA and hyperventilation resulted in a 2.8 ± 2.2%/mm Hg decrease of 
MFVMCA [143]. Falkenbach et al. observed a high incidence of unintentional, iatrogenic 
hypo- and hypercapnia with marked delays in correction in cardiac arrest patients 
treated with MTH. These studies emphasize the importance of strict control of 
mechanical ventilation in cardiac arrest survivors [30].
Hypoxia/hyperoxia
In contrast to CO2, CBF is relatively insensitive to changes in PaO2. A measurable 
increase in CBF is only found with a decrease in PaO2 to < 55 mm Hg [144]. In normal 
rabbits, hypoxic hypoxia and hemodilution resulted in a similar increase in CBF as 
arterial oxygen content fell. In ischemic rabbits, hemodilution resulted in a progressive 
increase in CBF in both ischemic and nonischemic brain regions. With hypoxic hypoxia, 
however, CBF in the ischemic region showed no increase or even a slight decrease. 
Therefore, the blood flow augmentation by hemodilution in ischemic brain is probably 
related to a direct hemorheologic effect rather than the resulting hypoxemia [132]. 
During ischemia the cerebral vessels probably are maximally dilated, and only 
perfusion pressure and viscosity influence CBF.
 According to the current ILCOR consensus statement, unnecessary arterial hyperoxia 
should be avoided, especially during the initial post-cardiac arrest period. This advice 
reduced by small volume hypertonic solutions in cats [115]. Krep et al. demonstrated 
that infusion of hypertonic solutions during CPR preserved total and regional CBF and 
prevented post-cardiac arrest delayed cerebral hypoperfusion [124]. Improvement 
may be due to the rapid volume expansion or to osmotic dehydration reversing 
endothelial swelling and augmenting reoxygenation of the brain tissue. Cell shrinkage 
also reduces ICP and, therefore, improves CPP. Finally, hypertonic solutions reduce 
leukocyte adherence, which is another potential contributing factor to the delayed 
hypoperfusion phase [96, 125].
Hematocrit/viscosity
The relationship between perfusion pressure and blood flow is parlty determined by 
blood viscosity. The blood flow is indirectly proportional related to blood viscosity at 
a fixed driving pressure. Viscosity decreases as the shear rate, determined the blood 
flow velocity and vessel diameter, increases [126, 127]. The rheological properties of 
blood depend on hematocrit and plasma constituents [128]. Blood cells increase 
viscosity, whereas (colloidal) plasma expanders decrease blood viscosity by 
hemodilution. Viscosity also increases as temperature decreases. Hemodilution 
increases CBF in both normal and ischemic brain [129-131]. It is debated whether CBF 
improves after hemodilution because of a diminished O2 content with ensuing 
vasodilation or due to a decrease in blood viscosity. However, in the ischemic brain 
local coupling of CBF to oxygen demand is disrupted and the importance of blood 
viscosity probably increases [132]. Changes in blood viscosity in vivo are associated 
with changes in flow velocity in middle cerebral artery [133]. High viscosity early after 
cardiac arrest may reduce cerebral blood flow and may contribute to secondary brain 
injury. The optimal hematocrit during the different stages of the post-cardiac arrest 
syndrome is still unknown.
Carbondioxide
Hypocapnic alkalosis shifts the oxyhemoglobin dissociation curve leftwards and 
reduces cerebral oxygen supply [134]. Furthermore, cerebral vessels are very sensitive 
to changes in CO2. Decreases in CO2 result in marked cerebral vasoconstriction with a 
subsequent decrease of CBF [135]. Hypercapnia preferentially dilates the smaller 
arterioles more than the larger ones, but the vasoconstrictor effect of hypocapnia is 
size-independent [136]. Changes in hydrogen ion concentration of the extracellular 
fluid in the vicinity of the cerebral blood vessels exert their effect directly on cerebral 
vascular smooth muscle cells [137, 138]. Molecular CO2 and the bicarbonate ion do not 
have inherent vasoactivity unless a change in pH is allowed to occur. The effect of 
changes in CO2 depends on the prevailing bicarbonate ion concentration in the 
cerebrospinal fluid and extracellular fluid, since the blood brain barrier is freely 
permeable to CO2 but impermeable to bicarbonate ions [135].
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during mild hypothermia [143]. Despite low CBF, the cerebral oxygen extraction 
remained normal. This suggests decreased metabolic activity with preserved 
metabolic coupling [143]. Temperature by itself seems not to be a major determinant 
in the regulation of cerebral blood flow after cardiac arrest [154]. Royl et al. measured 
preserved neurovascular coupling in rats without a temperature threshold below 
which neurovascular coupling was impaired or lost [155].
 Blood viscosity increases when blood temperature decreases. However, the 
increase in viscosity is observed mostly at a temperature below 15°C [156]. This is 
congruent with the finding that hypothermia reduces the development of no-reflow 
in dogs, despite a potential increase in viscosity. In a model with fixed vessel diameter 
with laminar flow the linear relationship between flow velocity and blood flow was 
not affected by hypothermia, underlining that measuring CBF transcranial Doppler 
(TCD) is appropriate [157]. The influence of MTH on viscosity-induced changes in CBF 
appears to be negligible.
Monitoring cerebral blood flow in the ICU
Translation of experimental ischemia-related research to the clinical practice is 
complicated [158]. The complex imaging methods used for research are of limited 
value in observing and improving CBF in cardiac arrest patients admitted to an ICU. 
Positron-emission tomography (PET) and magnetic resonance imaging (MRI) are 
widely used for imaging cerebral ischemia and blood flow [159-161]. However, for 
obvious practical reasons these methods suffer from limited relevance in monitoring 
the ICU patient. In accordance with experimental data which demonstrate that raised 
ICP in humans is limited to the short hyperemic phase, monitoring ICP in humans 
demonstrated no sustained increase in ICP during the first 24 hours [75, 162]. 
Microdialysis is able to show ischemia-induced neurochemical changes after cardiac 
arrest and during rewarming and potentially could play a role in the guidance of 
rewarming in those patients not receiving anticoagulant therapy [162].
 Near-infrared spectroscopy (NIRS) is a non-invasive optical technique that 
calculates oxygen saturation in the arteriovenous capillary beds. NIRS of the brain 
reflects mostly cerebral venous saturation. The critical level of NIRS at which 
neurological complication occurs has not been established. So far the utilization of 
NIRS has not been studied in cardiac arrest patients treated with MTH. In patients 
undergoing deep hypothermic circulatory arrest NIRS does not closely correlate with 
jugular venous bulb saturation (SjbO2) [163]. 
 SjbO2 sampling is an invasive technique that allows measurement of the mixed 
venous saturation of the brain. It provides useful information on the global balance of 
the cerebral oxygen demand and supply. A decrease in SjbO2 points towards a 
mismatch between oxygen demand and supply that me be amendable to several 
therapeutic measures. For example, hypocapnia leads to a decrease in SjbO2 and should 
is based on the growing preclinical evidence suggesting that hyperoxia in the early 
stages of reperfusion causes excessive oxidative stress [2]. Balan et al. concluded 
that, in dogs, graded reoxygenation with oximetry guidance in order to reduce 
 postresuscitative hyperoxia resulted in less neurological injury [28]. In a multicenter 
cohort study Kilgannon et al. showed that among patients admitted to the ICU after 
resuscitation from cardiac arrest, arterial hyperoxia was independently associated 
with increased in-hospital mortality compared with either hypoxia or normoxia 
[145, 146]. However, a recent study by Bellomo et al. found no evidence for an increase 
in cerebral damage with higher PaO2 levels in humans [147]. A high PaO2 level 
may possibly reflect a high fractional inspiratory O2 (FIO2) level, which in turn could 
reflect a clinical attempt to compensate for greater physiological instability, 
suggesting that a high PaO2 is rather a  marker of illness severity than a mediator of 
injury [148]. 
 The effects of hyperoxia on CBF in humans after cardiac arrest have not been 
studied in prospective RCT’s. Although most evidence up to now suggests a detrimental 
effect of post-cardiac arrest hyperoxia, fear of hyperoxia should not lead to an 
indiscriminate decrease in inspired oxygen levels. Hypoxemia is certainly harmful for 
the damaged brain. Moreover, in daily practice the extremely supranormal oxygen 
tension of > 300 mmHg associated with increased mortality in the study of Kilgannon 
should be easy to prevent [145].
Pharmacological treatment of hypoperfusion
Theoretically, post-ischemic hypoperfusion can be improved by reducing vascular 
tone or ameliorating the microcirculation. Animal data show that the administration 
of vasodilators, antiserotonergic agents and α-adrenergic blockers resulted in a decrease 
in cerebral vascular tone. However, peripheral vasodilation decreases systemic blood 
pressure, reducing cerebral perfusion pressure, with a resultant unchanged effect on 
CBF. Administration of calcium antagonists and endothelin antagonists also led to 
controversial results [90, 149, 150].
 Pre- and post-arrest anti-thrombotic therapy with plasminogen activator and heparin 
to diminish coagulation disorders that are involved in the no-reflow phenomenon 
demonstrated a strong reduction in cerebral no-reflow in animal studies [151, 152]. 
Clinical trials have been disappointing thus far.
Hypothermia
Despite the aforementioned recent negative findings concerning a potential benefit 
of MTH versus controlled normothermia of the TTM-trial, in many ICU’s MTH is still 
considered the standard of care in most cardiac arrest patients [58]. However, MTH 
reduces cardiac output and blood pressure and may reduce CBF [153]. We measured 
low mean flow velocities in the middle cerebral artery, in 10 cardiac arrest patients 
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result in a change in mechanical ventilator settings [143]. Finally, serial transcranial 
Doppler examinations may suggest complications and guide therapy [164, 165]. 
Conclusion
The severity of brain damage after cardiac arrest strongly depends on the recovery of 
the cerebral circulation. ROSC does not automatically restore normal CBF. Under -
standing of the pathophysiology of cerebral perfusion is essential. The protracted 
abnormal level of CBF implies a neuroprotective therapeutic window. Treatment in 
the ICU is directed towards limiting these pathophysiological changes and creating an 
optimal environment for cerebral recovery. International guidelines on CPR recommend 
maintaining normotension, normoglycemia and normocapnia. Unfortunately, optimal 
blood pressure, amount of CBF, hematocrit level, PaO2 and PaCO2 are still unknown.
Preserved metabolic coupling  
and cerebrovascular reactivity 
during mild hypothermia after  
cardiac arrest
L.L.A. Bisschops, C.W.E. Hoedemaekers, K. S. Simons, J.G. van der Hoeven
Critical Care Medicine (2010) 38 (7): 1542-1547
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Introduction
Under physiologic circumstances, cerebral blood flow (CBF) is regulated by metabolic 
activity, autoregulation and cerebrovascular reactivity induced by changes in arterial 
carbon dioxide tension [166-168]. Preserved coupling between cerebral metabolism 
and blood flow is crucial, because a disturbed relation may aggravate secondary brain 
damage, especially during states of hypoperfusion. In comatose patients treated with 
normothermia, the coupling of metabolism and CBF after cardiac arrest is preserved 
[95]. CBF was low initially and gradually increased during the first 24 hours. This was 
accompanied by a normal cerebral oxygen extraction ratio, indicating a normal 
coupling between CBF and metabolism.
 The effects of mild therapeutic hypothermia on CBF in patients after cardiac 
arrest are largely unknown. In 2008, Lemiale et al. showed reduced CBF and oxygen 
extraction in survivors after cardiac arrest during the first 24 hours of hypothermia, 
with a subsequent increase of CBF during rewarming [169]. In this study, an increase 
in CBF in the first 24 hours after cardiac arrest was possibly masked by a prolonged 
decrease in PaCO2 [170]. Mild hypothermia is cardiodepressive, which may potentiate 
the initial decrease in CBF. The cardiodepressive effect of mild hypothermia results in 
a decrease of the mean arterial pressure (MAP) as a result of a combination of several 
factors, including impaired vasoregulation and myocardial dysfunction as a result of 
the cardiac arrest. There is an additional effect induced by the mild hypothermia, 
which is associated with bradycardia and cold-induced dieresis, which possibly results 
in hypovolemia. In the study by Bernard et al, patients treated with mild hypothermia 
more frequently needed a continuous infusion of epinephrine during the first 24 
hours and had a lower cardiac index [21].
 Changes in PaCO2 have a profound effect on CBF. Arterial hypocapnia results in 
cerebrospinal fluid alkalosis, which decreases CBF, cerebral oxygen delivery, and to a 
lesser extent, cerebral blood volume [134]. Under normothermic conditions, cerebro-
vascular reactivity to changes in arterial PaCO2 is preserved in patients resuscitated 
from cardiac arrest [142]. Hyperventilation was accompanied by an increase in the 
arterial-jugular lactate difference, possibly indicating cerebral ischemia in these patients. 
Preserved cerebrovascular reactivity has been demonstrated in mild hypothermic 
patients after traumatic brain injury [171]. The effects of mild therapeutic hypothermia 
on cerebrovascular reactivity to changes in PaCO2 in patients after cardiac arrest is 
unknown. Because CBF is already reduced in patients after cardiac arrest, hypocapnia 
may potentially aggravate cerebral ischemia and secondary brain damage.
 We hypothesized that the hemodynamic effects seen after induction of mild 
hypothermia and the post-cardiac arrest state as was shown by Bernard et al. may 
result in a potential mismatch between cerebral oxygen demand and oxygen supply 
[21]. In the present study, we focused on the consequences of these known 
Abstract
Objective Although mild hypothermia improves outcome in patients after out-of-hos-
pital cardiac arrest, the cardiodepressive effects of hypothermia may lead to 
secondary brain damage. This study was performed to assess the cerebral blood flow, 
cerebral oxygen extraction, and cerebrovascular reactivity to changes in partial 
pressure of carbon dioxide in the arterial blood in comatose patients after out-of-hos-
pital cardiac arrest treated with mild hypothermia.
Design Observational study.
Setting: Tertiary care university hospital.
Patients Ten comatose patients after out-of-hospital cardiac arrest.
Interventions All patients were cooled to 32-34°C for 24 hours. Cerebrovascular 
reactivity to changes in PaCO2 was measured after increasing or decreasing the 
minute ventilation by 20%.
Measurements and main results Mean flow velocity in the middle cerebral artery 
and pulsatility index were measured by transcranial Doppler at 0, 3, 6, 9, 12, 18, 24 
and 48 hours after admission. Jugular bulb oxygenation was measured at the same 
intervals. Cerebrovascular reactivity to changes in PaCO2 was studied on admission to 
the intensive care unit and at 6, 12, 18 and 24 hours by measurement of mean flow 
velocity in the middle cerebral artery and jugular bulb oxygenation. The mean flow 
velocity in the middle cerebral artery was low (30.3 ± 9.5 cm/sec) on admission, and 
remained relatively stable for the first 24 hours. After rewarming, it increased to 67.5 
± 33.0 cm/sec at 48 hours after admission from 30.3 ± 9.5 at admission (p = 0.009). 
The jugular bulb oxygenation at the start of the study was 66.2 ± 8.5% and gradually 
increased to 82.9 ± 4.9% at 48 hours (p < 0.001). Regression analysis showed a 
significant correlation between changes in PaCO2, mean flow velocity in the middle 
cerebral artery (p < 0.001) and jugular bulb oxygenation (p < 0.001). The mean 
percentage change in mean flow velocity in the middle cerebral artery was 3.6 ± 2.9% 
per 1 mm Hg change of PaCO2.
Conclusions The mean flow velocity in the middle cerebral artery, as a parameter of 
cerebral blood flow, was low during mild hypothermia, while cerebral oxygen 
extraction remained normal, suggesting decreased cerebral metabolic activity. We 
demonstrated that CO2 reactivity is preserved during hypothermia in these patients.
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The radial or femoral artery was cannulated for monitoring of blood pressure and 
sampling of arterial blood. A central venous catheter was inserted in the subclavian 
or jugular vein for administration of drugs and monitoring of central venous pressure. 
According to our local protocol, MAP was maintained between 80-100 mm Hg with a 
diuresis > 0.5 mL/kg/hr. If necessary, patients were treated with volume infusion and 
dobutamine or norepinephrine. A 7-Fr single lumen catheter was introduced into the 
left or right jugular bulb as described by Goetting and Preston [173]. Jugular bulb 
oxygenation (SjbO2) was measured by repeated sampling of blood from the jugular 
bulb catheter.
 Serum concentrations of sodium, potassium and magnesium were maintained 
within the normal range. All patients were treated with continuous insulin infusion 
therapy aiming at blood glucose levels between 4.4 and 6.1 mmol/L [174, 175]. 
Hemoglobin concentration was kept ≥ 6.0 mmol/L.
Data collection
Demographic and prehospital data were collected on admission. Hemodynamic 
parameters, temperature and SaO2 were measured continuously. On admission and 
at 3, 6, 9, 12, 18, 24, and 48 hours arterial PaO2 and PaCO2, lactate, arterial and mixed 
venous oxygen saturation, and SjbO2 were measured.
 Mean flow velocity in the middle cerebral artery (MFVMCA) and pulsatility index 
(PI) were measured by transcranial Doppler (TCD) through the temporal window with 
a 2-Mhz probe (Sonosite M-Turbo, Sonoview Nederland BV, Rijswijk, The Netherlands), 
according to the method developed by Aaslid et al. [176]. Normal mean middle 
cerebral artery velocities vary from 41 ± 7 to 94 ± 10 cm/sec [177]. PI was calculated as 
(VMCAsystolic-VMCAdiastolic)/VMCAmean. Normal PI in the middle cerebral artery 
varies between 0.69 ± 0.10 at an insonation depth of 55 mm and 0.71 ± 0.13 at an 
insonation depth of 30mm [177]. MFVMCA and PI were measured on admission to the 
ICU and at 3, 6, 9, 12, 18, 24, and 48 hours. The middle cerebral artery was chosen for 
examination because this vessel perfuses approximately 80% of the cerebral 
hemisphere and because of its easy and reproducible accessibility for TCD. The 
temporal acoustic window and Doppler depth giving the highest velocities were 
determined on admission and used for all measurements. All measurements were 
performed by two investigators (L.B. and C.H.). Although there is a wide variation in 
the normal range of mean flow velocity, a linear relationship between CBF and 
MFVMCA is present if the diameter of the insonated vessel and the angle of insonation 
remain the same. Mean flow velocity is not equivalent to volume flow, but changes in 
CBF can be deduced from changes in blood flow velocity. Changes in MFVMCA are well 
correlated with changes in CBF during changes in PaCO2 and its validity in testing 
cerebral autoregulation was previously demonstrated [178-180].
hemodynamic alterations on the perfusion of the hypothermic, postanoxic brain. The 
aim of the present study was to assess CBF and cerebral oxygen extraction in 
comatose patients after out-of-hospital cardiac arrest treated with mild hypothermia. 
In addition, we determined the cerebrovascular reactivity to changes in PaCO2.
Materials and methods
Study population
We performed a prospective observational study in 10 comatose patients successfully 
resuscitated from an out-of-hospital cardiac arrest treated with mild hypothermia. 
Because therapeutic mild hypothermia is an essential part of standard care, a 
normothermic control group was considered unethical [172]. The local Institutional 
Review Board approved the protocol and written informed consent was obtained 
from the nearest relative. All patients ≥ 18 years were eligible for the study if they met 
the following criteria: 1) comatose (Glasgow Coma Scale ≤ 6) after return of 
spontaneous circulation (ROSC) and 2) primary cardiac rhythm of ventricular 
fibrillation. Patients were excluded if they were pregnant, received thrombolytic 
therapy, in case of refractory cardiogenic shock, or if they had a life expectancy of < 
24 hours. Patients were also excluded if written informed consent could not be 
obtained within 4 hours after admission to the ICU. Time between collapse and ROSC, 
start of cooling and first study measurement was determined based on data provided 
by the paramedic team.
Patient management
All patients were admitted to the ICU of a tertiary care university hospital in Nijmegen, 
The Netherlands. If necessary, a coronary angiogram followed by percutaneous 
coronary intervention was performed before admission to the ICU. In agreement 
with our local protocol, all patients were cooled to 32-34°C by rapid infusion of 30 
mL/kg bodyweight of cold Ringer’s lactate at 4°C followed by external cooling using 
two water-circulating blankets (Blanketroll II, Cincinnati Subzero, The Surgical 
Company, Amersfoort, The Netherlands). Temperature was measured continuously 
with a rectal temperature probe (YSI Incorporated 401, vd Putte Medical, Nieuwegein, 
The Netherlands) and maintained at 32-34°C for 24 hours, followed by passive 
rewarming to normothermia (defined as 37°C). All patients were sedated with 
midazolam and/or propofol and morphine. Sedation was stopped as soon as the body 
temperature was ≥ 36.5°C. In case of shivering, patients were paralysed using 
intravenous bolus injections of rocuronium.
 All patients were intubated and mechanically ventilated to obtain a PaO2 > 75 mm Hg 
and a PaCO2 between 34 and 41 mm Hg. Alpha-stat was used for pH maintenance. 
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In all patients, (ischemic) cardiomyopathy was considered the underlying cause of 
ventricular fibrillation. None of the patients required a coronary angiogram or 
percutaneous coronary intervention. All patients were treated with mild hypothermia 
according to our local protocol; in one patient the temperature was increased to 35°C 
after 18 hours because of recurring arrhythmias. Five patients died in the ICU, all as a 
result of severe postanoxic brain damage; one patient died of pneumosepsis in the 
hospital 8 days after discharge from the ICU. There were no statistical differences in 
delay between time of collapse and return of spontaneous circulation (p = 0.47), 
collapse and start of cooling (p = 0.95), and collapse and start study (p = 0.83) between 
survivors and non-survivors.
Clinical data
Mean temperature at the start of the study and at 24 hours was 33.7 ± 0.9°C and 34.5 
± 1.5°C, respectively (p = 0.19). Passive rewarming resulted in a significant rise in 
temperature (p = 0.03) to 37.8 ± 0.5°C at 48 hours (Figure 1).
MAP decreased from 88.3 ± 15.0 mm Hg at the start of the study to 78.1 ± 10.6 mm Hg 
at 24 hours (p = 0.2), and thereafter increased to 83.1 ± 16.3 mm Hg at 48 hours 
(p = 0.5) (Figure 2).
Mixed venous oxygen saturation (SvO2) gradually increased during admission from 
68.1 ± 9.3% at the start of the study to 83.3 ± 4.5% at 48 hours (p < 0.001). Three of 10 
patients received norepinephrine in maximal doses 0.01, 0.04, and 0.19 µg/kg/min 
norepinephrine, respectively, during hypothermia. One patient was treated with 
Cerebrovascular reactivity
Cerebrovascular reactivity to changes in PaCO2 was studied on admission to the ICU 
and at 6, 12, 18 and 24 hours by measurement of TCD and SjbO2. After obtaining 
baseline measurements, ventilator settings were changed and hypocapnia was 
achieved by increasing the minute ventilation by 20% over 20 minutes. After obtaining 
the hypocapnic measurements, the minute ventilation was returned to baseline 
settings over 20 minutes and decreased by 20% over 20 minutes to obtain hypercapnia.
Statistical analysis
Statistical analysis was performed using SPSS version 14.0.1 (SPSS, Chicago, Illinois). 
Data are presented as mean with standard deviation (SD) or median with interquartile 
ranges, unless otherwise indicated. Changes over time were analyzed with repeated 
measures analysis of variance. Effects of hyperventilation and hypoventilation on 
MFVMCA and SjbO2 were analyzed with the Student’s t test for paired samples. The 
relation between changes in PaCO2 and middle cerebral artery velocity were 
determined by linear regression analysis with calculation of the Pearson correlation 
coefficient. A p value < 0.05 was considered to indicate statistical significance.
Results
Population
We studied 10 comatose patients successfully resuscitated from out-of-hospital 
cardiac arrest. Demographic data are shown in Table 1. 
Table 1  Demographic data
Male n (%)
Age (years)
BMI (kg/m2)
Time between collapse and ROSC (min)
Time between collapse and start cooling (min)
Time between collapse and start experiment (min)
SAPS 2
APACHE II
Patients died n (%)
8 (80%)
65.7 ± 7.6
25.9 ± 3.0
18.3 ± 12.7
139.7 ± 34.6
232.2 ± 79.0
65.8 ± 18.0
26.7 ± 7.3
6 (60%)
Demographic data of 10 hypothermic patients after cardiac arrest
Data are expressed as mean values ± SD. BMI: Body mass index, ROSC: Return of spontaneous 
circulation; SAPS: Simplified Acute Physiology Score, APACHE II: Acute Physiology and Chronic Health 
Evaluation II
Figure 1  Temperature changes over time
Values represent mean ± SD, * p < 0.03
30 
31  
32  
33  
34 
35  
36 
37  
38 
39 
40 
0 3 6 9 12 18 24 48
Te
m
pe
ra
tu
re
 (°
C)
 
Time after admission to the ICU (hrs)
* 
42 43
Chapter 3 Preserved metabolic coupling and CO2-reactivity during hypothermia after cardiac arrest
3
epinephrine in a dosage of 0.13-0.25 µg/kg/min. Eight of 10 patients received 
dobutamine in maximal doses ranging from 0.9 to 9.5 µg/kg/min dobutamine. 
Median PaO2 was > 75 mm Hg throughout the study period and also during hypo- and 
hyperventilation. Patients were ventilated to normocapnia with median arterial 
PaCO2 values between 34 and 41 mm Hg (Table 2). Median arterial pH varied between 
7.33 (7.28-7.37) on admission and 7.39 (7.34-7.41) at 48 hours. Median arterial lactate 
concentrations were elevated at the start of the study 3.2 (2.3-4.4) mmol/L) and 
decreased rapidly during admission to normal values.
Mean flow velocity, pulsatility index and SjbO2
MFVMCA was low (30.3 ± 9.5 cm/sec) on admission and remained relatively constant 
for the first 18 hours (Figure 3A). At 24 hours, MFVMCA increased to 53.4 ± 25.5 cm/
sec. In comparison with the MFVMCA on admission (30.3 ± 9.5 cm/sec), we found a 
significant increase to 67.5 ± 33.0 cm/sec at 48 hours (p = 0.009). The PI was 1.18 ± 
0.46 at the start of the study and remained relatively stable in the first 24 hours 
(Figure 3B). We noted a significant decrease in PI from 1.05 ± 0.33 at 24 hours to 0.77 
± 0.32 at 48 hours after start of the study (p = 0.04). SjbO2 at the start of the study 
was 66.2 ± 8.5% and gradually increased to 80.1 ± 7.6% and 82.9 ± 4.9% at 24 and at 
48 hours (p < 0.001 at 48 hours) respectively (Figure 3C). There were no differences in 
MFVMCA, PI, and SjbO2 between survivors and non-survivors. There was no significant 
correlation (R = 0.02) between MAP and MFVMCA (Figure 3D).
Figure 2  Mean arterial pressure changes over time
Values represent mean ± SD, * p = 0.194, ‡ p = 0.49
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increase in SjbO2 from 70.2 ± 12.2 to 77.4 ± 9.5% (p < 0.001). A 20% increase in minute 
ventilation resulted in an absolute decrease in PaCO2 from 38.6 ± 7.3 to 31.4 ± 5.6 mm 
Hg (p < 0.001), accompanied by an absolute decrease in MFVMCA from 38.6 ± 15.5 to 
33.7 ± 16.6 cm/sec (p = 0.003) and decrease in SjbO2 from 70.2 ± 12.2 to 58.8 ± 14.5% 
(p < 0.001). Regression analysis showed a significant correlation between the change 
Cerebrovascular reactivity to changes in PaCO2
No significant changes occurred in MAP, heart rate or oxygen saturation during hypo-
ventilation and hyperventilation. A 20% decrease in minute ventilation resulted in an 
absolute increase in PaCO2 from 38.6 ± 7.3 to 46.5 ± 7.2 mm Hg (p < 0.001) with an 
absolute increase in MFVMCA from 38.6 ± 16.9 to 49.2 ± 22.8 cm/sec (p < 0.001) and 
Figure 3A   Mean flow velocity in the middle cerebral artery as measured  
by transcranial Doppler
Values expressed as mean ± SD. MFVMCA: mean flow velocity in the middle cerebral artery, * p = 0.009
Figure 3C   Jugular bulb oxygen saturation
Values are expressed as mean ± SD. SjbO2: jugular bulb oxygen saturation. * p < 0.001.
Figure 3D   Correlation between MAP and MFVMCA
MAP: mean arterial pressure, MFVMCA: mean flow velocity in the middle cerebral artery
Figure 3B   Pulsatility index in the middle cerebral artery as measured  
by transcranial Doppler
Values are expressed as mean ± SD,  * p =0.04. PI: pulsatility index.
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Hg decrease of MFVMCA (p = 0.03). The effects of hypoventilation and hyperventila-
tion on SjbO2 and PI were comparable (delta SjbO2 7.2 ± 8.9 vs. 10.2 ± 8.7%; p = 0.3 and 
delta PI 0.22 ± 0.37 vs. -0.26 ± 0.31; p = 0.9.
Discussion
MFVMCA was lower in patients treated with mild hypothermia after cardiac arrest 
compared with normal physiological values, reflecting lower CBF. This lower CBF 
during mild hypothermia was accompanied by a normal SjbO2. Rewarming to 
normothermia after 24 hours increased flow velocities to normal values. Normal 
SjbO2 during mild hypothermia together with lower middle cerebral artery flow 
velocities strongly suggests a decrease in cerebral metabolism in these patients. A 
second important finding in this study is the preserved cerebrovascular reactivity to 
changes in PaCO2 during hypothermia.
 Flow velocities in the middle cerebral artery were lower compared with normal 
flow velocities in healthy volunteers [177]. The first measurements of MFVMCA and 
SjbO2 were taken at a mean of 4 hours after cardiac arrest, a moment in the 
post-cardiac arrest syndrome usually characterized by cerebral hypoperfusion. In 
cardiac arrest patients treated with normothermia, this hypoperfusion phase results 
among others from an increase in cerebrovascular resistance that may be explained 
by an imbalance between the levels of endothelin and nitric oxide [95]. In our patients, 
treated with hypothermia, PI was also high during the first 24 hours and decreased 
after rewarming at 48 hours. This also suggests an increase in cerebrovascular 
resistance in patients treated with mild hypothermia during the first 24 hours after 
cardiac arrest.
 We compared the data from our study with those obtained by Buunk et al. in 
normothermic patients [95]. Mild therapeutic hypothermia resulted in an additional 
and prolonged reduction of middle cerebral artery flow velocities compared with 
normothermia. This lower MFVMCA during hypothermia is most likely the result of a 
further reduction in metabolism, reflected by reduced oxygen consumption, glucose 
use, ATP breakdown, and lactate formation during hypoxia-ischemia [142]. In addition, 
hypothermia also improves recovery of energetic parameters (ATP, phosphocreatine) 
during the reperfusion phase [181]. Rapid volume infusion used for initial rapid cooling 
of our patients possibly resulted in a decrease in hematocrit concentration. Because 
hemodilution theoretically results in an increase of mean flow velocity, the effects of 
hypothermia on MFVMCA may have been underestimated in our study.
 SjbO2  in our study was normal at the start and remained normal in the next 24 
hours. Although we measured a lowered MFVMCA, an increased oxygen extraction 
rate was not seen, indicating lower cerebral metabolic activity with preserved metabolic 
in PaCO2 and both MFVMCA (p < 0.001) and SjbO2  (p < 0.001) (Figure 4A and B). The 
mean change in MFVMCA was 3.6 ± 2.9%/mm Hg. Hypoventilation resulted in a 4.4 ± 
3.5%/mm Hg increase of MFVMCA and hyperventilation resulted in a 2.8 ± 2.2%/mm 
Figure 4A   Correlation between the change in PaCO2 and mean flow velocity in  
the middle cerebral artery
MFVMCA: mean flow velocity in the middle cerebral artery
Figure 4B   Correlation between the change in PaCO2 and jugular bulb oxygen 
saturation (SjbO2)
SjbO2: jugular bulb oxygen saturation
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coupling. This reduction in cerebral metabolic activity may contribute to the neuro-
protective effect in patients after cardiac arrest in the delayed hypoperfusion phase. 
The reduced MFVMCA may partly be explained by the use of anesthetic drugs during 
hypothermia. Sedation is well known to reduce the metabolic demands of the brain 
and to decrease CBF. However, rewarming resulted in an increase in MFVMCA although 
sedation remained unchanged until a temperature of 36.5°C was reached, strongly 
suggesting a differential effect of hypothermia by itself. Furthermore, the increase in 
MFVMCA is not the result of a rise in PaCO2; the median PaCO2 remained constant 
during rewarming from T = 24 hours to T = 48 hours. This indicates that the increase 
of MFVMCA is a temperature effect and not a result of a change in PaCO2.
 These observations are in concordance with animal studies indicating a direct 
protective effect of hypothermia after brain injury. Human data from a recent study 
in four patients treated with hypothermia after cardiac arrest show a biphasic pattern 
of ischemia and excitoxicity with peak values immediately after return of spontaneous 
circulation and during the rewarming phase, suggesting a direct protective effect of 
hypothermia [162].
 Only one other study describes CBF and oxygen extraction in patients after 
cardiac arrest during mild therapeutic hypothermia [169]. In this study, the authors 
also observed low CBF velocities during the first 24 hours of hypothermia, with an 
increase during subsequent re-warming. However, the results of this study are difficult 
to interpret since the arterial PaCO2 decreased from 45 ± 6mm Hg on admission to 
36 ± 6 and 37 ± 7 mm Hg at 12 and 24 hours, increasing again after 36h [170]. As we 
demonstrate in our study, changes in arterial PaCO2 correlate significantly with 
changes in MFVMCA and the prolonged decrease in PaCO2 may have reduced CBF. A 
reduction in PaCO2 may also explain the decrease in SjbO2 after 3 hours in our study. 
The reduction in PaCO2 at T = 3 hours possibly results in a mismatch between cerebral 
oxygen demand and supply as reflected by the decrease in SjbO2.
 Hypercapnia induces an increase in arterial blood pressure as a result of increased 
sympathetic nerve activity. This increased arterial blood pressure may have influenced 
the flow velocities measured in the middle cerebral artery [182]. However, the effect 
of blood pressure on MFVMCA is not linear and simple mathematical methods are not 
available to correct for these changes. In our patients no relation between MAP and 
MFVMCA was found (Figure 3D).
 Our study is the first study that shows intact CO2 reactivity during a 24 hour 
period of mild hypothermia in comatose patients after cardiac arrest. Previously, 
Lavinio et al. observed intact cerebral vasoreactivity in head-injured patients cooled 
for refractory intracranial hypertension [171]. In our study, hypocapnia induced a 
decrease in SjbO2 and MFVMCA. We measured a mean percentage change in MFVMCA 
of 3.6 ± 2.9%/mm Hg change in PaCO2 in cardiac arrest patients which is comparable 
to the mean relative CO2 reactivity of 3.7 ± 0.5%/mm Hg observed by Klingelhöfer et 
al. in healthy subjects [183]. Lee et al. reported a mean CO2 reactivity of 3.3 ± 1.6% 
ΔVMCA/mm Hg in patients after moderate or severe head injury [184]. Changes in 
PaCO2 correlated well with changes in MFVMCA and SjbO2 but not with PI. This might 
be related to the baseline constriction of the cerebral resistance vessels, reducing the 
ability to further constrict or dilate. The role of the endothelium and (endotheli-
um-derived) vasoactive substances in hypothermia and rewarming remains to be 
elucidated.
 Practically, hypocapnia decreases CBF and SjbO2 in comatose patients after 
cardiac arrest which may induce cerebral ischemia. Falkenbach et al. observed a high 
incidence of unintentional iatrogenic hypo- and hypercapnia (45% of 1627 
measurements of CO2) and marked delays until correction to normocapnia was 
reached in a retrospective cohort study in 122 survivors of OHCA, treated with mild 
hypothermia [30]. These findings, in combination with the intact CO2 reactivity that 
was demonstrated in our study, emphasize the importance of strict control of 
mechanical ventilation in cardiac arrest patients treated with mild hypothermia. We 
assume that secondary neurological injury as a result of cerebral ischemia could be 
prevented by avoiding iatrogenic hypocapnia.
Conclusions
Mild hypothermia results in lower CBF with preserved metabolic coupling. Furthermore, 
the cerebrovascular reactivity to CO2 in the first 48 hours after cardiac arrest remains 
intact. Despite this decrease in CBF,  cerebral oxygenation is probably not compromised. 
Therefore, hypothermia can be considered as a safe therapeutic strategy in the first 
24 hours after cardiac arrest. Prolonged or severe hypocapnia should be avoided 
because of the risk of ischemia induced by cerebral hypoxemia as a result of 
hypocapnia induced cerebral vasoconstriction.
Effects of prolonged mild  
hypothermia on cerebral blood flow 
after cardiac arrest
L.L.A. Bisschops, J.G. van der Hoeven, C.W.E. Hoedemaekers
Critical Care Medicine (2012) 40 (8): 2362-2367
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Introduction
Brain damage after cardiac arrest strongly depends on the recovery of the cerebral 
circulation. Return of spontaneous circulation (ROSC) does not automatically restore 
normal cerebral blood flow (CBF). A longer duration of global ischemia is associated 
with increased post ischemic perfusion defects, resulting in early microcirculatory 
reperfusion disorders despite adequate cerebral perfusion pressure in circumscribed 
areas of the brain [71, 82]. Many of the pathophysiological pathways that lead to brain 
injury occur in the hours and days after ROSC when patients are admitted to the 
intensive care unit (ICU). Mild therapeutic hypothermia (MTH) improves the 
neurologic outcome after out-of-hospital cardiac arrest [19-21]. MTH mitigates the 
destructive cascades during ischemia and reperfusion, while at the same time 
stimulates protective systems promoting cell repair [60]. The optimal duration of 
MTH is unknown. Data from some animal experiments suggest that more severe 
insults may require longer cooling. In an animal model of forebrain ischemia, longer 
duration of MTH resulted in increased survival of neurons [185, 186]. In addition, 
neonates with peripartum asphyxia are treated with MTH for 48-72 hours. This 
resulted in a highly significant and clinically important reduction in the composite 
outcome of death or major neurodevelopmental disability in survivors [187]. Compared 
with short-term mild hypothermia, long-term mild hypothermia significantly improved 
the outcome of severe traumatic brain injured adult patients with cerebral contusion 
and intracranial hypertension without significant complications [188]. In contrast, a 
shorter duration of mild hypothermia induced rapidly and early after restoration of 
spontaneous circulation improved postresuscitation microcirculation, myocardial 
and cerebral functions, and survival as well as, or better than, prolonged duration of 
hypothermia after resuscitation in a rat model of cardiopulmonary resuscitation 
[189].
 CBF is low in adult patients treated with MTH after cardiac arrest [143]. Rewarming 
to normothermia after 24 hours increases cerebral blood flow to normal values. The 
low CBF during hypothermia is accompanied by a normal cerebral oxygen extraction 
rate, strongly suggesting a decrease in cerebral metabolism. This decrease in cerebral 
metabolism may contribute to the neuroprotective effect of (prolonged) MTH. The 
aim of the present study was to assess CBF and cerebral oxygen extraction in adult 
patients after pulseless electrical activity (PEA)/asystole or resistant ventricular 
fibrillation who were treated with MTH for 72 hours.
Abstract
Objective The aim of the present study was to assess the cerebral blood flow and 
cerebral oxygen extraction in adult patients after pulseless electrical activity/asystole 
or resistant ventricular fibrillation who were treated with mild therapeutic hypothermia 
for 72 hours.
Design Observational study.
Setting Tertiary care university hospital.
Patients Ten comatose patients with return of spontaneous circulation after pulseless 
electrical activity/asystole or prolonged ventricular fibrillation.
Intervention Treatment with mild therapeutic hypothermia for 72 hours.
Measurements and main results Mean flow velocity in the middle cerebral artery 
was measured by transcranial Doppler at 12, 24, 36, 48, 60, 72, 84, 96, and 108 hours 
after admission. Jugular bulb oxygenation was measured at the same intervals. Mean 
flow velocity in the middle cerebral artery was low (26.5 (18.7-48.0) cm/sec) on 
admission, and significantly increased to 63.9 (45.6-65.6) cm/s at 72 hours (p = 0.002). 
Upon rewarming, the mean flow velocity in the middle cerebral artery remained 
relatively constant with a mean flow velocity in the middle cerebral artery of 71.5 
(56.0-78.5) at 108 hours (p = 0.381). Jugular bulb oxygenation at the start of the study 
was 57.0 (51.0-61.3)% and gradually increased to 81.0 (78.5-88.0)% at 72 hours (p = 
0.003). Upon rewarming, the jugular bulb oxygenation remained constant with a 
jugular bulb oxygenation of 84.0 (77.3-86.3)% at 108 hours (p = 0.919). There were no 
differences in mean flow velocity in the middle cerebral artery, pulsatility index, and 
jugular bulb oxygenation between survivors and non-survivors.
Conclusions Temperature by itself is probably not a major determinant in regulation 
of cerebral blood flow after cardiac arrest. The relatively low mean flow velocity in 
the middle cerebral artery in combination with normal jugular bulb oxygenation 
values suggests a reduction in cerebral metabolic activity that may contribute to the 
neuroprotective effect of (prolonged) mild therapeutic hypothermia (MTH) in the 
delayed hypoperfusion phase.
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mean arterial blood pressure (MAP) was maintained between 80 mm Hg and 100 mm 
Hg, and diuresis was aimed at > 0.5 mL/kg/hr. If necessary, patients were treated with 
volume infusion and dobutamine, and/or (nor)epinephrine. As part of the regular 
post-cardiac arrest care protocol, a 7F single lumen catheter was introduced into the 
left or right jugular bulb as described by Goetting and Preston [173].
 Serum concentrations of sodium, potassium, magnesium and phosphate were 
maintained within the normal range. All patients were treated with continuous insulin 
infusion therapy aiming at blood glucose levels between 6.0 mmol/L and 8.0 mmol/L. 
Haemoglobin concentration was kept ≥ 6.0 mmol/L.
Data collection
Demographic and pre-hospital data were collected upon admission. Hemodynamic 
parameters, temperature, and SaO2 were measured continuously. PaO2 and PaCO2, 
lactate, arterial and central venous oxygen saturation, and jugular bulb oxygenation 
(SjbO2) were measured every 6 hours until 114 hours after admission to the ICU. Mean 
flow velocity (MFV) in the middle cerebral artery (MCA) and the pulsatility index (PI) 
were measured by transcranial Doppler (TCD) with a 2-Mhz  probe (Sonosite M-Turbo, 
Sonoview Nederland BV, Rijswijk, The Netherlands), according to the method 
developed by Aaslid et al. [176]. The PI was calculated as (Vsystolic-Vdiastolic)/Vmean. 
Normal PI in the MCA varies between 0.69 ± 0.10 at 55 mm and 0.71 ± 0.13 at 30mm 
[177]. MFVMCA and PI were measured on admission to the ICU and at 12, 24, 36, 48, 
60, 72, 84, 96 and 108 hours. The MCA was chosen for examination because this 
vessel perfuses approximately 80% of the cerebral hemisphere and because of its 
easy and reproducible accessibility for transcranial Doppler. The temporal acoustic 
window and Doppler depth giving the highest velocities were determined upon 
admission and used for all measurements. All measurements were performed by two 
investigators (LB and CH). Normal mean MCA velocities vary from 41 ± 7 to 94 ± 10 
cm/sec [177]. Although there is a wide variation in the normal range of MFV, a linear 
relationship between CBF and MFVMCA is present if the diameter of the insonated 
vessel and the angle of insonation remain constant.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad 
Software. Inc. La Jolla, USA). Data are presented as median with 25th and 75th 
percentile. In the figures besides median (black lines in boxes), interquartile range 25 
and interquartile range 75 (boxes), and minimum and maximum (whiskers) are depicted. 
Changes over time were analyzed with the repeated measures test for non-parametric 
data, and the Wilcoxon rank-sum test was used to compare survivors to non-survivors. 
Correlation was tested with the Spearman test (two tailed). A p value < 0.05 was 
considered to indicate statistical significance.
Materials and methods
Study population
We performed a prospective observational study in 10 comatose patients successfully 
resuscitated from an out-of-hospital cardiac arrest. Prolonged MTH (72 hours) is a 
standard-of-care in our intensive care unit in comatose patients with ROSC after 
asystole, PEA, or resistant ventricular fibrillation. The local Institutional Review Board 
waived the need for informed consent. All patients 18 years or older were eligible for 
the study if they met the following criteria: 1. comatose (Glasgow Coma Scale ≤ 6) 
after ROSC; and 2. ROSC after asystole, PEA, or ventricular fibrillation with prolonged 
(> 30 minutes) cardiopulmonary resuscitation. Exclusion criteria were: 1. pregnancy; 
2. thrombolytic therapy; 3. contraindication to start MTH due to refractory cardiogenic 
shock despite the use of vasopressor and/or inotropic agents, based on the clinical 
judgement of the attending physician; 4. life expectancy of < 24 hours; 5. hypoxemia 
defined as arterial oxygen saturation (SaO2) < 90%, 6. chronic renal failure (creatinin 
> 200 µmol/L); 7. chronic liver failure; 8. known pre-existing neurological disease. The 
last 3 exclusion criteria were based on potential changes in baseline cerebral blood 
flow (CBF) and/or CBF regulation. Time between collapse and ROSC, start of cooling and 
start of the experiment were calculated based on data provided by the paramedic team.
Patient management
All patients were admitted to the ICU of a tertiary care university hospital in Nijmegen, 
The Netherlands. If necessary, a coronary angiogram and a percutaneous coronary 
intervention were performed before admission to the ICU. In agreement with our 
local protocol, all patients were cooled to 32-34°C by rapid infusion of 30 mL/kg 
bodyweight of cold Ringer’s lactate at 4°C followed by external cooling using two 
water-circulating blankets (Blanketroll II, Cincinatti Subzero, The Surgical Company, 
Amersfoort, The Netherlands). Temperature was measured continuously with a rectal 
temperature probe (YSI Incorporated 401, vd Putte Medical, Nieuwegein, The 
Netherlands) and maintained at 32-34°C for 72 hours, followed by passive rewarming 
to normothermia (defined as 36.5°C). All patients were sedated with midazolam and/
or propofol and sufentanil during hypothermia. Sedation and analgetics were stopped 
as soon as the body temperature was ≥ 36.5°C. In case of shivering, patients received 
an intravenous bolus injection of rocuronium.
 All patients were intubated and mechanically ventilated aiming at an arterial 
oxygen partial pressure (PaO2) > 75 mm Hg and arterial carbondioxide pressure 
(PaCO2) between 34 and 42 mm Hg. Alpha-stat was used for pH maintenance. The 
radial or femoral artery was cannulated for monitoring of blood pressure and 
sampling of arterial blood. A central venous catheter was inserted in the internal 
jugular or subclavian vein for administration of drugs. According to our local protocol, 
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Results
Population
We studied 10 comatose patients successfully resuscitated from an out-of-hospital 
cardiac arrest. Individual patient data are shown in Table 1.
The primary rhythm was asystole in four patients, ventricular fibrillation in 4 patients 
and PEA in 2 patients. Upon admission to the emergency room, the patients showed 
signs of prolonged circulatory and respiratory arrest with a median pH of 7.15 
(6.93-7.23), a median base excess (BE) of -13.4 (-17.1- -8.1) mmol/L and a median lactate 
concentration of 9.6 (5.3-11.8) mmol/L. Six patients died in the ICU: three patients 
because of circulatory failure and 2 patients because of severe postanoxic brain 
damage. One patient, admitted to the ICU after PEA, regained consciousness, but active 
treatment was withdrawn because of preexisting severe chronic respiratory failure.
Clinical data
Median temperature at the start of the study was 34.3 (33.4-35.2)°C and was 
maintained between 32 and 34°C for 72 hours (Figure 1).
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Figure 1   Temperature, mean flow velocity of the middle cerebral artery as 
measured by transcranial Doppler and jugular bulb oxygenation changes 
over time
Values (median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), and 
minimum and maximum (whiskers)) are depicted for temperature (white bars), mean flow velocity of the 
middle cerebral artery (light gray bars) and jugular bulb oxygenation (dark gray bars). # significant 
difference MFVMCA (p = 0.002); x significant difference jugular bulb oxygenation (p = 0.003); ∞ significant 
difference significant difference temperature (p < 0.001).
MFVMCA, mean flow velocity of the middle cerebral artery; SjbO2, jugular bulb oxygenation; hrs, hours.
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All patients were passively rewarmed after 72 hours from 33.7 (33.1-33.9)°C at 72 
hours to 38.0 (37.5-38.1)°C at 114 hours after admission (p < 0.001). The mean arterial 
pressure (MAP) on admission was 85.5 (81.0-90.0) mm Hg and was kept at a target of 
80 mm Hg according to the local protocol. Upon rewarming the median MAP gradually 
increased from 75.5 (73.0-81.0) mm Hg at 72 hours to 90 (84.5-98.5) mm Hg at 114 
hours (p = 0.077). Median central venous oxygen saturation gradually increased 
during admission from 73.5 (70.3-77.5) % at the start of the study to 80.0 (76.5-83.5) 
% at 72 hours (p = 0.038) and remained relatively stable until the end of the study 
(84.0 (82.5-84.5) %, p = 0.724).
 Norepinephrine was used in all patients. The median dose of norepinephrine 
significantly increased from 0.00 (0.00-0.02) µg/kg/min to 0.20 (0.07-0.33) µg/kg/
min at 72 hours (p= 0.003) (Figure 2A). Rewarming resulted in a nonsignificant 
increased requirement of norepinephrine with a peak of 0.67 (0.16-1.13) µg/kg/min at 
84 hours, gradually decreasing to 0.13 (0.00-0.31) µg/kg/min at the end of the study 
(p = 0.727). In four patients a positive correlation between norepinephrine dose and 
MFVMCA was demonstrated, whereas in the remaining six patients no correlation 
between norepinephrine dose and MFVMCA was found.
 Dobutamine was added in seven patients. The median dose of dobutamine 
increased from 0.00 (0.00-0.00) µg/kg/min on admission to 3.16 (0.00-4.17) µg/kg/
min at the end of the hypothermia period (p = 0.801) and was rapidly tapered off to 
0.00 (0.00-0.00) µg/kg/min after rewarming (p = 0.067) (Figure 2B). In six of seven 
patients receiving dobutamine no correlation with MFVMCA was found. In one of the 
7 patients receiving dobutamine, the dose (negatively) correlated with the MFVMCA 
(p = 0.0368).
 Administration of epinephrine was necessary in two patients. In one patient it 
was started at 6 hours at a maximal dose of 1.67 µg/kg/min until the patient died at 
60 hours. In this time period MFVMCA increased from 17.8 cm/sec to 63.6 cm/sec 
while SjbO2 increased from 72% to 82%. The second patient received epinephrine 
from 36 hours until 72 hours when the patient died. At that moment the patient 
received a maximal dose of 0.167 µg/kg/min. MFVMCA decreased from 70 cm/sec to 
63.9 cm/sec, SjbO2 increased from 78% to 80%. Both patients showed no correlation 
between epinephrine dose and MFVMCA (p = 0.5560 and p = 0.5948, respectively) 
(data not shown).
 Median PaCO2 was 40.5 (36.7-45.0) mm Hg upon admission and did not change 
significantly throughout the study period (p = 0.980). The median PaO2 was > 75 mm 
Hg throughout the study.
Sedation and anesthetics
Administrated doses of midazolam and sufentanil over time are shown in Figure 3. At 
0 hours median dose of midazolam was 5.0 (0-10.0) mg/hr and significantly increased 
Figure 2A   PI, MFVMCA and norepinephrine dose changes over time
Values (median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), and 
minimum and maximum (whiskers)) are depicted for PI (white bars), mean flow velocity of the middle 
cerebral artery (light gray bars) and norepinephrine dose (dark gray bars). # significant difference MFVMCA 
(p = 0.002); * significant difference norepinephrine dose (p = 0.003).
MFVMCA, mean flow velocity of the middle cerebral artery; PI, pulsatility index; jugular bulb oxygenation; 
hrs, hours.
Figure 2B   PI, MFVMCA and dobutamine dose changes over time
Values (median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), and 
minimum and maximum (whiskers)) are depicted for PI (white bars), mean flow velocity of the middle 
cerebral artery (light gray bars) and dobutamine dose (dark gray bars). # significant difference MFVMCA 
(p = 0.002). ∞ significant difference dobutamine dose (p = 0.067)
MFVMCA, mean flow velocity of the middle cerebral artery; PI, pulsatility index; jugular bulb oxygenation; 
hrs, hours.
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 Median  SjbO2 at the start of the study was 57.0 (51.0-61.3)% and gradually 
increased to 81.0 (78.5-88.0)% at 72 hours (p = 0.003). At the start of the study the 
SjbO2 was below the potential ischemic threshold (SjbO2 <55%) in four of the ten 
patients (SjbO2 51, 51, 48, and 46% respectively); at 6 hours in two patients a critical 
SjbO2 < 55% (49 and 46% respectively) was measured. Upon rewarming the SjbO2 
remained constant with a SjbO2 of 84.0 (77.3-86.3)% at 108 hours (p = 0.919) (Figure 1).
 There were no differences in MFVMCA, PI, and SjbO2 between survivors and 
non-survivors (p = 0.129, p = 0.894 and p = 0.500 respectively).
Discussion
To the best of our knowledge, this study is the first study in adult patients describing 
the effects of 3-day hypothermia treatment on the CBF after cardiac arrest. CBF was 
low after cardiac arrest, and gradually increased during the 3-day cooling period 
towards normal values. The SjbO2 was normal in the majority of patients throughout 
the study. Normal SjbO2, together with the low MFVMCA strongly suggests a decreased 
cerebral metabolism during MTH in the first 24-48 hours. CBF and the cerebral 
oxygen extraction rate did not change during rewarming to normothermia after 72 
hours.
 In the first hours after cardiac arrest CBF was low. This low flow state is a typical 
feature of the delayed hypoperfusion phase of the post-cardiac arrest syndrome and 
is partly explained by an increase in cerebrovascular resistance due to a disbalance in 
the local production of endothelin and cyclic guanosine monophosphate [2, 95]. 
During hypothermia, MFVMCA gradually increased towards normal physiological 
values and continued to increase until 96 hours after admission, simultaneously with 
rewarming. The restoration of normal CBF is congruent with the fourth phase of the 
post-cardiac arrest syndrome, starting at approximately 20 hours after ROSC in which 
normal blood flow is restored, remains low, or is hyperemic [190]. Cardiac output can 
change cerebral blood flow, independently of changes in MAP [122]. Postresuscitation 
myocardial dysfunction results in low cardiac output in the first hours after ROSC [35]. 
Recovery of myocardial function, together with progressive vasoplegia, gradually 
increases cardiac output in the course of days. The initial low cardiac output, reflected 
by low central venous oxygen saturation in our patients, may to some extend 
contribute to the relatively low MFVMCA in the first hours of the study.
 The results from this study indicate that temperature by itself is not a major 
determinant in restoration of CBF towards normal values. When comparing our data 
with those from normothermic cardiac arrest survivors, MTH seemed to delay the 
restoration of CBF towards normal values, possibly by decreasing the metabolic 
demand of the brain [95]. The prolonged treatment with hypothermia may have 
to 20.0 (13.8-25.0) mg/hr at 72 hours (p <0.0001). Midazolam dose significantly 
decreased from 20.0 (13.8-25.0) mg/hr at 72 hours to 0 (0-0) mg/hr at 108 hours 
(p = 0.02). Median sufentanil dose at 0 hours was 2.5 (0-10.0) µg/hr and significantly 
increased to 15.0 (13.8-16.3) µg/hr at 72 hours (p < 0.0001) and subsequently 
significantly decreased to 0 (0-10) µg/hr at 108 hours (p = 0.01). Propofol doses were 
omitted from the graph because propofol was used only in a minority of patients in a 
low dose for only a few hours.
Mean flow velocity, pulsatility index and SjbO2
Median MFVMCA was low (26.5 (18.7-48.0) cm/sec) on admission, and significantly 
increased to 63.9 (45.6-65.6) cm/sec at 72 hours (p = 0.002). Upon rewarming the 
MFVMCA remained relatively constant with a MFVMCA of 71.5 (56.0-78.5) at 108 hours 
(p = 0.381) (Figure 1).
 The median PI was 1.23 (0.94-1.45) at the start of the study and remained 
relatively stable throughout the study period (p = 0.919). Rewarming did not 
significantly change the PI (1.00 (0.88-1.57) at 72 hours vs. 1.27 (1.15-1.32) at 108 hours 
(p = 0.924).
Figure 3   Sedation dose, mean flow velocity of the middle cerebral artery as 
measured by transcranial Doppler, and jugular bulb oxygenation changes 
over time
Midazolam dose: mg/hr and sufentanil dose: µg/hr. Values (median (black lines in boxes), interquartile 
range 25 and interquartile range 75 (boxes), and minimum and maximum (whiskers)) are depicted for 
midazolam (white bars), sufentanil (light gray bars), mean flow velocity (dark gray bars) and jugular bulb 
oxygenation (dashed bars). # significant difference midazolam (p < 0.0001); * significant difference 
sufentanil (p < 0.0001); x significant difference MFVMCA (p = 0.002); ∞ significant difference jugular bulb 
oxygenation (p = 0.003); ± significant difference midazolam (p = 0.02); = significant difference sufentanil 
(p = 0.01).
MFVMCA, mean flow velocity of the middle cerebral artery; SjbO2, jugular bulb oxygenation; hrs, hours.
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 This study has a number of limitations. We performed an observational study in 
a limited cohort of patients after cardiac arrest. Because MTH is an essential part of 
standard care, a normothermic control group was considered unethical. The results 
of this study may be biased in several ways. We used transcranial Doppler as a 
measure of CBF because this is the most widely used non-invasive and bedside 
technique; it is, however, a measure of cerebral blood flow velocity and may be 
inaccurate as the diameter of the median cerebral artery changes. Treatment with 
MTH requires adequate levels of sedation and analgesia. Sedation is well-known to 
reduce the metabolic demands of the brain and to decrease CBF. However, MFVMCA 
increased during constant hypothermia while sedation increased in the first 12 hours 
and remained unchanged until a temperature of 36.5°C was reached. No significant 
changes in MFVMCA or SjbO2 occurred after cessation of sedation. This strongly 
suggests a minor role for sedation in influencing the CBF during MTH. All patients 
required norepinephrine infusion to ensure adequate cerebral perfusion pressures. 
The effects of norepinephrine on cerebral blood flow in patients after cardiac arrest 
are unknown and probably depend on the metabolic activity of the brain, the integrity 
of the blood-brain barrier, and the level of autoregulation [120]. Cerebral 
autoregulation is either absent or shifted to the right in the majority of patients in the 
acute phase after cardiac arrest [63]. The effects of hypothermia on autoregulation in 
patients after cardiac arrest are unknown. Studies in patients after traumatic brain 
injury suggest that hypothermia and subsequent rewarming do not change cerebro-
vascular reactivity, unless the body temperature exceeds 37 °C [171].
Concluding remarks
Temperature by itself is probably not a major determinant in regulation of CBF after 
cardiac arrest. The relatively low MFVMCA in combination with normal SjbO2 values 
suggests a reduction in cerebral metabolic activity that may contribute to the neuro-
protective effect of (prolonged) MTH in the delayed hypoperfusion phase. A 
randomized controlled trial is necessary to evaluate the optimal duration of cooling 
in patients after cardiac arrest.
further decelerated the restoration of the MFVMCA to normal values, since MFVMCA 
at 24 and 48 hours after admission in the present cohort was lower compared to our 
previous study in patients that were treated with hypothermia for 24 hours [143]. The 
relatively low MFVMCA in combination with (generally) normal SjbO2 values suggests 
a reduction in cerebral metabolic activity that may contribute to the neuroprotective 
effect of (prolonged) MTH in the delayed hypoperfusion phase. Although a reduction 
in brain metabolism is the most likely explanation for the normal SjbO2 values, 
mitochondrial dysfunction, arteriovenous shunting or impaired tissue oxygen delivery 
through maldistribution of capillary flow may also contribute to the relatively high 
SjbO2 values [191].
 SjbO2 was low at the start of the study, and gradually increased to reach a plateau 
after 24-30 hours. Although in four patients the ischemic threshold (SjbO2 < 55%) was 
exceeded at the start of the study, the SjbO2 generally was normal during the first 
phase of MTH. In combination with the relatively low MFVMCA this finding strongly 
suggests a decrease in cerebral metabolism in these patients. The SjbO2 reached a 
plateau after 24-30 hours after admission, indicating a relatively low cerebral oxygen 
extraction, while cerebral blood flow was still increasing. PET studies that measured 
cerebral metabolic activity in normothermic patients after cardiac arrest indicated 
that metabolic activity is decreased after cardiac arrest, most markedly in the gray 
matter and to a lesser extent in the white matter [192, 193]. This metabolic decrease 
is most profound in the cerebral cortex and basal ganglia and less in the pons and 
cerebellum. Several pathophysiological mechanisms may underlie this relative 
decrease in cerebral oxygen extraction. First, cerebral metabolic coupling may be 
(temporarily) lost during hypothermia and subsequent rewarming, resulting in a 
steeper increase in flow velocities compared to cerebral oxygen extraction. This loss 
of metabolic coupling would increase the risk of hyperemia with subsequent brain 
edema and elevated intracranial pressure, contributing to secondary brain damage. 
Secondly, cerebral metabolism may not recover immediately after ROSC. This 
disturbed cerebral metabolism may be related to the mitochondrial dysfunction that 
is observed after global brain ischemia [71]. The mitochondrial damage is the result of 
intracellular calcium accumulation and results in transient swelling, disaggregation of 
polyribosomes and abnormal Golgi complexes. Plasma from patients after cardiac 
arrest can induce major endothelial cell toxicity with an impairment of the 
mitochondrial chain activity (complexes II, III, and IV) in endothelial cell cultures [194]. 
We speculate that as a result of mitochondrial dysfunction, oxygen uptake by the 
brain may be diminished after cardiac arrest, resulting in relatively high SjbO2 values. 
Alternatively, the amount of ischemic brain tissue may increase over time, reducing 
the capacity of the brain to extract oxygen. As no differences in SjbO2 and MFVMCA 
values and patterns were found between survivors and non-survivors this seems 
highly unlikely.
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Introduction
After cardiac arrest, macro- and microcirculatory alterations develop that may 
contribute to secondary brain injury. After the return of spontaneous circulation 
(ROSC), cerebral blood flow (CBF) in the middle cerebral artery (MCA) is initially low 
and increases to normal values within 24 to 48 hours [143, 169]. Microcirculatory 
failure is attributed to endothelial damage by ischemia-induced swelling of perivascular 
glia and endothelial cells, red cell aggregation due to stasis of blood, inflammation, 
and activation of the coagulation system, resulting in reduced CBF, despite adequate 
cerebral perfusion pressure [2]. 
 Whole blood viscosity is a determinant of both macrovascular and microvascular 
cerebral resistance and influences cerebral blood flow [195]. The vascular cerebral 
resistance is related to blood viscosity, as described in the Hagen-Poisseuille equation: 
resistance (R) of blood flow is determined both by a vascular and a viscous component: 
R = 8ηL/π.r4, in which r is vessel radius, L is vessel length, and η is blood viscosity. 
Viscosity decreases as the shear rate (SR) (Υ) increases, which is characteristic for 
non-Newtonian fluids such as blood [126]. The SR in a blood vessel has a parabolic 
shape and is lowest in the middle and highest at the vessel wall. The SR at the wall of 
a cylindrical tube for a Newtonian fluid is determined by the blood flow velocity (vm) 
and radius (r) of the blood vessel as Υ = 4vm/r [126, 127]. The non-Newtonian rheologic 
properties of blood depend on hematocrit and plasma constituents (acute phase 
proteins) [195]. Especially at low SR, blood viscosity strongly increases when 
inflammatory proteins appear, due to their aggregating forces on blood cells. 
 The post-cardiac arrest syndrome is characterized by macro- and microvascular 
CBF impairment. At the same time, cardiac arrest and resuscitation induce a 
whole-body ischemia-reperfusion syndrome with systemic and cerebral activation of 
the innate immune system [39, 196]. As blood viscosity is an important determinant 
of blood flow and strongly influenced by inflammation, we hypothesized that it will 
play a significant role in determining the cerebral blood flow during the post 
resuscitation phase after cardiac arrest.
 The aim of this study was to determine blood viscosity in comatose adult patients 
after cardiac arrest. In addition, we aimed to assess the relation between blood viscosity, 
CBF, and cerebral oxygen extraction.
Materials and methods
Study population
We performed a prospective observational study in 10 comatose patients successfully 
resuscitated from an out-of-hospital cardiac arrest. Patients were treated with mild 
therapeutic hypothermia (MTH) for 24 hours followed by passive rewarming. The 
Abstract
Objective To determine blood viscosity in adult comatose patients treated with mild 
therapeutic hypothermia after cardiac arrest and to assess the relation between 
blood viscosity, cerebral blood flow, and cerebral oxygen extraction.
Design Observational study.
Setting Tertiary care university hospital.
Patients Ten comatose patients with return of spontaneous circulation after out-of- 
hospital cardiac arrest.
Intervention Treatment with mild therapeutic hypothermia for 24 hours followed by 
passive rewarming to normothermia.
Measurements and main results Median viscosity at shear rate 50 sec-1 was 5.27 
(4.29-5.91) mPa·s at admission; it remained relatively stable during the first 12 hours 
and decreased significantly to 3.00 (2.72-3.58) mPa·sec at 72 hours (p < 0.001). 
Median mean flow velocity of the middle cerebral artery was low (27.0 (23.8-30.5) 
cm/sec) at admission and significantly increased to 63.0 (51.0-80.0) cm/sec at 72 
hours. Median jugular bulb saturation at the start of the study was 61.5 (55.5-75.3)% 
and significantly increased to 73.0 (69.0-81.0)% at 72 hours. Median hematocrit was 
0.41 (0.36-0.44) L/L at admission and subsequently decreased significantly to 0.32 
(0.27-0.35) L/L at 72 hours. Median C-reactive protein concentration was low at 
admission (2.5 (2.5-6.5) mg/L and increased to 101 (65-113.3) mg/L in the following 
hours. Median fibrinogen concentration was increased at admission 2795 (2503-3565) 
mg/L and subsequently further increased to 6195 (5843-7368) mg/L at 72 hours. 
There was a significant negative association between blood viscosity and the mean 
flow velocity of the middle cerebral artery (p = 0.0008). 
Conclusions Changes in blood viscosity in vivo are associated with changes in mean 
flow velocity of the middle cerebral artery. High viscosity early after cardiac arrest 
may reduce cerebral blood flow and may contribute to secondary brain injury. Further 
studies are needed to determine the optimal viscosity during the different stages of 
the post-cardiac arrest syndrome.
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Data collection
Demographic and prehospital data were collected at admission. Hemodynamic 
variables, temperature, and SaO2 were measured continuously. Viscosity was 
measured at 0, 3, 6, 12, 24, 36, 48, and 72 hours after inclusion in the study. Viscosity 
measurements were performed by using the Contraves LS300 viscometer (proRheo, 
Germany). Arterially sampled blood in lithium heparin tubes was drawn at the 
previously described time points. As soon as possible, but always within 20 minutes, 
the cup of the Contraves LS300 viscometer was filled using a pipette. Viscosity 
measurements were then performed at the same temperature as the core 
temperature of the patient. Blood viscosity was measured at a SR of 50/s, because 
this SR is supposed to be present in a middle-sized artery such as the MCA. Whole 
blood viscosity in normal healthy volunteers at shear rate 50/s is 4.37 ± 0.09 mPa.s 
[197]. At the same time points, mean MCA flow velocities (MFVMCA) were measured 
by transcranial Doppler (TCD) with a 2-Mhz probe (Multi-Dop T Digital; Compumedics 
DWL, Singen, Germany), according to the method developed by Aaslid et al. [176]. The 
MCA was chosen for examination because this vessel perfuses approximately 80% of 
the cerebral hemisphere and because of its easy and reproducible accessibility for 
TCD. The temporal acoustic window and Doppler depth giving the highest velocities 
were determined at admission and used for all measurements. All measurements 
were performed by two investigators (LB and CH). Normal MFVMCA varies from 41 ± 7 
to 94 ± 10 cm/s [177]. Hematocrit, fibrinogen, C-reactive protein (CRP), jugular bulb 
saturation (SjbO2), PaO2, PaCO2, and lactate were measured at 0, 3, 6, 12, 24, 36, 48, 
and 72 hours after inclusion in the study.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad 
Software, La Jolla, USA) and SAS 9.2 (SAS Institute, Cary, NC). Data are presented as 
median with 25th and 75th percentile. Figures also show minimum and maximum 
(whiskers) values. Changes over time were analyzed with the repeated measures test 
for nonparametric data.
 For each patient, association of the blood viscosity with MFVMCA and of Ht with 
MFVMCA was assessed for linearity using scatterplots. To assess the association of 
blood viscosity with MFVMCA over all patients, a model was fitted (linear model with 
random intercept random slope). The association of blood viscosity with MFVMCA was 
tested on the mean slope over the patients as estimated from this model (i.e. the 
fixed effect MFVMCA in the model). Similarly the linear association between blood 
viscosity and SjbO2 was tested. A p-value < 0.05 was considered to indicate statistical 
significance.
local Institutional Review Board approved the protocol and informed consent was 
obtained from the nearest relative. All patients 18 years or older were eligible for the 
study if they met the following criteria: 1. comatose (Glasgow Coma Scale ≤ 8) after 
ROSC and 2. ROSC after asystole, pulseless electrical activity (PEA), or ventricular 
fibrillation. Exclusion criteria were: 1. pregnancy; 2. thrombolytic therapy; 3. contra-
indication to start MTH due to refractory cardiogenic shock despite the use of 
vasopressor and/or inotropic agents, based on the clinical judgement of the attending 
physician; 4. life expectancy of less than 24 hours; 5. hypoxemia, defined as arterial 
oxygen saturation (SaO2) less than 85% with a fraction of inspired oxygen more than 
50%; 6. chronic renal failure (creatinin > 200 µmol/L); 7. chronic liver failure; 8. known 
preexisting neurological disease/coma. The last three exclusion criteria were based 
on potential changes in baseline CBF and/or CBF regulation. 
Patient management
All patients were admitted to the intensive care unit (ICU) of a tertiary care university 
hospital in Nijmegen, The Netherlands. If necessary, coronary angiography and a 
percutaneous coronary intervention were performed before admission to the ICU. All 
patients were cooled to 32-34 °C by rapid infusion of 30 mL/kg bodyweight of cold 
Ringer’s lactate at 4°C followed by external cooling using water-circulating blankets 
(Blanketroll II, Cincinatti Subzero; The Surgical Company, Amersfoort, The 
Netherlands). All patients were sedated with midazolam and/or propofol and 
sufentanil during hypothermia. Sedation and analgetics were stopped as soon as the 
body temperature was more than or equal to 36.5°C. In case of shivering, patients 
received an intravenous bolus injection of rocuronium.
 All patients were intubated and mechanically ventilated aiming at an arterial 
oxygen partial pressure (PaO2) > 75 torr (10kPa) and arterial carbon dioxide pressure 
(PaCO2) between 34 and 42 mm Hg (4.5-5.5kPa). Alpha-stat was used for pH 
maintenance. The radial or femoral artery was cannulated for monitoring of blood 
pressure and sampling of arterial blood. A central venous catheter was inserted in the 
internal jugular vein for administration of drugs and central venous blood sampling. 
According to our local protocol, mean arterial blood pressure (MAP) was maintained 
between 80 and 100 mmHg, and diuresis was aimed at more than 0.5 mL/kg/hr. If 
necessary, patients were treated with volume infusion and dobutamine and/or 
norepinephrine. As part of the regular post-cardiac arrest care protocol a 7F single 
lumen catheter for jugular bulb blood sampling was introduced into the left or right 
jugular bulb as described by Goetting and Preston [173].
 Serum concentrations of sodium, potassium, magnesium and phosphate were 
maintained within the normal range. All patients were treated with continuous insulin 
infusion therapy aiming at blood glucose levels between 6.0 and 8.0 mmol/L. 
Hemoglobin concentration was kept at more than or equal to 9.7 g/dL.
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at 24 hours and remained relatively stable until the end of the study (75.0 (73.0-81.0)%, 
p = 0.724).
Norepinephrine was used in nine patients. The median dose of norepinephrine 
significantly increased from 0.00(0.00-0.00)µg/kg/min to 0.03(0.01-0.04)µg/kg/
min at 24 hours, gradually decreasing to 0.01(0.00-0.05)µg/kg/min at the end of the 
study at 72 hours (p = 0.727).
 Dobutamine was added in two patients. None of the patients received epinephrine. 
None of the patients received a blood transfusion.
 Median PaCO2 was 36.0 (34.0-41.3) mm Hg at admission and did not change 
significantly throughout the study period (p = 0.980). The median PaO2 was more 
than 75 mm Hg throughout the study.
Blood viscosity
Median viscosity at SR 50/s was 5.27 (4.29-5.91) mPa·s at admission; it remained 
relatively stable during the first 12 hours and decreased significantly to 3.00(2.72-
3.58) mPa·s at 72 hours (p<0.001) (Figure 2).
Hematocrit and inflammatory parameters
Median hematocrit was 0.41 (0.36-0.44) L/L at admission and subsequently 
significantly decreased to 0.32 (0.27-0.35) L/L at 72 hours (p < 0.001) (Figure 3A). 
There was a significant association between hematocrit and viscosity: blood viscosity 
= 17,056 x hematocrit - 1,8328 (p < 0.001). Median CRP concentration was low at 
admission (2.5 (2.5-6.5) mg/L and increased significantly to 145.5 (100.3-183.5) mg/L 
Results
Population
We studied ten comatose patients successfully resuscitated from an out-of-hospital 
cardiac arrest. The demographic data are shown in Table 1. A coronary angiogram and 
a percutaneous coronary intervention were performed in six patients before 
admission to the ICU. At the start of the study, patients had a median pH of 7.35 
(7.33-7.41), a median base excess of -3.7 (-6.5 - -2.3) mmol/L, and a median lactate 
concentration of 2.9 (1.8-3.5) mmol/L. Three patients (two patients with asystole and 
one patient with PEA as primary rhythm), died in the ICU because of severe postanoxic 
brain damage.
Clinical data
Median temperature at the start of the study was 33.4 (33.0-35.5)°C. All patients 
were passively rewarmed after 24 hours from 34.2 (32.8-34.9)°C at 24 hours to 37.4 
(37.2-37.7)°C at 72 hours after admission (p < 0.001) (Figure 1). The median MAP on 
admission was 91.0 (88.0-97.0) mm Hg and was kept at a target of 80 mm Hg according 
to the local protocol. Median central venous oxygen saturation gradually increased 
during admission from 76.0 (65.5-82.8)% at the start of the study to 77.0(73.0-79.5)% 
Table 1  Demographic data and patient characteristics after cardiac arrest
Male, no. (%) 8 (80%)
Age, yrs 68.0 (53.5-74.5)
Body mass index, kg/m2 25.5 (24.8-31.4)
Primary rhythm, no
         Asystole
         VF
         PEA
3
6
1
Time collapse – ROSC, min 25.0 (17.0-68.0)
Time collapse-start cooling, min 180 (150-235)
Time collapse-start study, min 415 (393-420)
SAPS 2 51.5 (36.8-58.5)
APACHE II 18.5 (17.0-23.5)
Patients died, no. (%) 3 (30%)
VF, ventricular fibrillation; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; 
SAPS 2, Simplified Acute Physiology Score 2; APACHE II, Acute Physiology and Chronic Health Evaluation 
II. Data are expressed as median values (IQR) or whole number (percentage).
Figure 1   Temperature changes over time
Values (median (black lines in boxes), IQR 25 and IQR 75 (boxes), and minimum and maximum (whiskers)) 
are depicted for the temperature. * indicates a significant increase in temperature.
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Correlation between viscosity and mean flow velocity and SjbO2 
Median MFVMCA was low (27.0 (23.8-30.5) cm/s) on admission and significantly 
increased to 63.0 (51.0-80.0) cm/s at 72 hours (p = 0.002) (Figure 4A). Median SjbO2 
at the start of the study was 61.5 (55.5-75.3)% and gradually increased to 73.0(69.0-
81.0)% at 72 hours (p=0.0154) (Figure 4B).
 We tested the association between the MFVMCA and the blood viscosity (Figure 5). 
The association of the viscosity at SR 50/s with the MFVMCA was statistically significant 
at 36 hours with a subsequent significant decrease to 101 (65-113.3) mg/L in the 
following 36 hours (p < 0.001) (figure 3B). Median fibrinogen concentration was increased 
at admission (2795(2503-3565) mg/L and further increased to 6195 (5843-7368) mg/L 
at 72 hours (p < 0.001) (figure 3C).
Figure 2   Viscosity changes over time
Values (median (black lines in boxes), interquartile ranges 25-75 (boxes), and minimum and maximum 
(whiskers)) are depicted for the viscosity at SR 50. * indicates a significant decrease in viscosity.
Figure 3B   CRP concentration changes over time
Values (median (black lines in boxes), interquartile ranges 25-75 (boxes), and minimum and maximum 
(whiskers)) are depicted for CRP concentration changes over time. * indicates significant increase in CRP; # 
indicates significant decrease in CRP concentration. CRP, C-reactive protein.
Figure 3C   Fibrinogen concentration changes over time
Values (median (black lines in boxes), interquartile ranges 25-75 (boxes), and minimum and maximum 
(whiskers)) are depicted for fibrinogen concentration changes over time. * indicates significant increase in 
fibrinogen concentration.
Figure 3A   Hematocrit changes over time
Values (median (black lines in boxes), interquartile ranges 25-75 (boxes), and minimum and maximum 
(whiskers)) are depicted for hematocrit changes over time. * indicates significant decrease in Ht. Ht, 
hematocrit.
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Discussion
The two main findings of this study are that blood viscosity is highest in the first hours 
after cardiac arrest gradually decreasing over the following days, and a significant 
negative correlation exists between blood viscosity and the MFVMCA. This negative 
relation between blood viscosity and the CBF suggests that especially in the early 
phase after cardiac arrest, CBF may be hampered by a relatively high blood viscosity.
The relationship between whole blood viscosity and CBF is complex. In vitro, in rigid 
tubes, flow and viscosity are inversely related, as described by the Hagen-Poisseuille 
equation. The influence of viscosity on CBF in vivo is influenced by a number of 
(compensatory) mechanisms. Changes in blood viscosity in vivo can induce changes 
in arteriolar diameter. These active changes in arteriolar diameter have been referred 
to as ‘viscosity autoregulation’ [198]. It is unknown if this viscosity autoregulation is 
disturbed under pathological conditions such as the post-cardiac arrest syndrome. 
We found some variation in the effect of viscosity on CBF between different subjects. 
We speculate that this variation may be related to differences in level of the viscosity 
autoregulation in those patients.
 In the normal brain, decreased viscosity results in vasoconstriction and vice versa 
[199]. This effect of viscosity on CBF is likely mediated through a change of the shear 
stress that is applied on the endothelium. Lower viscosity at similar SR will diminish 
(p = 0.0008), with an overall regression line: blood viscosity = 5.9822 - 0.03144 x 
MFVMCA, indicating that if blood viscosity decreased, MFVMCA increased. The 
association of the MFVMCA with the SjbO2 was statistically significant (p = 0.0037), 
with an overall regression line: MFVMCA = 0.9622 x SjbO2 - 20.75 (data not shown). The 
association between blood viscosity and SjbO2 was not statistically significant (p = 
0.4441) with overall regression line: blood viscosity = 5.6055 - 0.01649 x SjbO2. We 
found no association between whole blood viscosity and fluid balance, amount of 
infused volume, or vasopressor dosage (data not shown).
Figure 4A   Mean flow velocity in the middle cerebral artery as measured by 
transcranial Doppler
Values (median (black lines in boxes), interquartile ranges 25-75 (boxes), and minimum and maximum 
(whiskers)) are depicted for the mean flow velocity in the middle cerebral artery. * indicates significant 
increase in MFVMCA.MFVMCA, mean flow velocity middle cerebral artery.
Figure 4B   Jugular bulb oxygen saturation
Values (median (black lines in boxes), interquartile ranges 25-75 (boxes), and minimum and maximum 
(whiskers)) are depicted for the jugular bulb oxygen saturation. * indicates significant increase in SjbO2. 
SjbO2, jugular bulb oxygen saturation.
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Figure 5   Association between viscosity at SR 50 and the MFVMCA
MFVMCA, mean flow velocity middle cerebral artery.
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the shear stress on the vessel wall, and hence, shear stress-induced nitric oxide 
release by the endothelium will cause less vasodilation [200]. Alternatively, hemodi-
lution-induced low viscosity may also result in a decreased arterial oxygen-carrying 
capacity that induces vasodilation in an attempt to maintain adequate oxygen supply 
to the brain. The ultimate change in vascular diameter will be determined by the 
balance of several factors, including the baseline values of hematocrit, viscosity, oxy-
gen-carrying capacity, and oxidative metabolism [201].
 Under ischemic conditions such as a cardiac arrest, the coupling of CBF to tissue 
oxygen demand is disrupted and maximal vasodilation exists. Under these 
circumstances, blood viscosity probably becomes a major factor determining the CBF 
[132]. Additionally, it must be taken into account that blood is a non-Newtonian fluid, 
and its viscosity increases when shear rates decrease. During and immediately after 
cardiac arrest, shear rates of blood are zero and low, and consequently, blood 
viscosity in vivo significantly rises. In the first hours after cardiac arrest, blood viscosity 
was highest in our population. During this period, CBF is below normal levels [143, 
169] and cerebral tissue oxygen saturation is decreased [202].
 Our results are consistent with observations in patients with acute brain injury, 
such as stroke, in which hemorheologic variables play a crucial role in the development 
of ischemia and outcome [203]. Several studies have indicated elevated viscosity, 
hematocrit, fibrinogen concentration, and enhanced red blood cell aggregation in 
cerebral disorders [131, 204, 205]. Increased viscosity in patients with acute brain 
injury most likely enhances microcirculatory failure and may thus contribute to the 
extent of the cerebral ischemia [206].
 Viscosity gradually decreased in the first 3 days after cardiac arrest, despite an 
increase in inflammatory proteins. This decrease in viscosity is explained by a 
significant decrease in hematocrit. This decrease in hematocrit in our population was 
most likely due to fluid expansion, a shortened life span of erythrocytes (e.g., 
diagnostic phlebotomies) and diminished erythrocyte production as commonly found 
in critically ill patients [207]. Although temperature influences the inflammatory 
response after cardiac arrest [196], blood viscosity is not significantly influenced by 
temperature in the mild hypothermia range that was used in this study.
 This study has a number of limitations. Blood viscosity was measured at a SR of 
50/s. In vivo, the SR is lower in the center of the vessel and higher toward the artery 
wall [208]. The viscosity is higher in the center of the vessel, because red blood cells 
tend to stream in the center of the vessel, thereby reducing the shear stress gradients 
they are exposed to [209]. The velocity profiles are often also skewed due to curvature 
effects, branching, and bifurcation of arteries. Together, this results in different shear 
rates within and along the vessel. Because blood viscosity is a rheologic variable that 
depends on complex interactions and deformations of suspended cells, physical 
effects that alter the local hematocrit and radial distribution of cells across a vessel 
affect blood viscosity in a non-Newtonian manner [209]. Taken together, the ex vivo 
measurement of viscosity may differ from the in-vivo local rheologic state. The 
association between viscosity and cerebral flow was very heterogenous between 
patients, indicating that other factors influence the MFVMCA besides viscosity.
 CBF is determined by a number of factors, including blood pressure, PaCO2, level 
of sedation, and level of autoregulation. Although we actively controlled these 
factors, interference with cerebral blood flow cannot be excluded. We used TCD as a 
measure of CBF because this is a noninvasive bedside technique; it is, however, a 
measure of CBF velocity and may be inaccurate as the diameter of the cerebral artery 
changes.
Conclusions
The severity of the neurological dysfunction strongly depends on the recovery of 
cerebral circulation after cardiac arrest. Viscosity is a major determinant of CBF, 
especially in the injured brain. Our study suggests that changes in blood viscosity 
early after cardiac arrest may change the CBF and contribute to the secondary brain 
damage. Further studies are needed to determine the optimal viscosity during the 
different stages of the post-cardiac arrest syndrome.
section II
The inflammatory response after 
cardiac arrest
C.W.E. Hoedemaekers, L.L.A. Bisschops, J.G. van der Hoeven
Submitted
6
83
The inflammatory response after cardiac arrest
6
Introduction
Patients admitted to the intensive care unit (ICU) after successful resuscitation for 
cardiac arrest have a poor prognosis and a high risk of postresuscitation disease [210]. 
The post-cardiac arrest syndrome comprises post-cardiac arrest brain injury, 
post-cardiac arrest myocardial dysfunction, the systemic ischemia/reperfusion 
response, and the persistent precipitating disease [211].
 Cardiac arrest induces an ischemia/reperfusion response with activation of the 
innate and adaptive immune system, endothelial cells, complement system, programmed 
cell death pathways and coagulation cascades. Activation of this inflammatory 
response serves as a defense against cell injury, and initiation of repair mechanisms 
but may by itself contribute to secondary (brain) injury. Treatment strategies in the 
ICU are directed towards prevention of secondary injury. The ICU treatment includes 
therapies that influence this immune response, such as active cooling and rewarming 
of patients and use of vasopressors. Knowledge and awareness of the pathophysio-
logical mechanisms underlying the post-cardiac arrest syndrome may contribute to 
better treatment of these patients.
 In this review we describe the present status of research on the immune response 
after cardiac arrest and how ICU treatment influences post-cardiac arrest inflammation. 
Data for this review were identified by researches of MEDLINE, Currents Contents, 
PubMed and references from relevant articles using the search terms “cardiac arrest” 
and “inflammation”. Abstracts and reports from meetings were included only when 
they related directly to previously published work. Only articles published in English 
between 1980 and 2014 were included.
Immune response to ischemia
Immune cells and parenchymal cells constitutively express cell surface receptors that 
can recognize molecular structures derived from microorganisms (pattern recognition 
receptors). Pattern recognition receptors such as toll like receptors (TLRs) play an 
important role in pathogen-derived inflammation, but also participate in the 
inflammatory response after ischemia [212]. Cells injured by hypoxia release 
molecules, so called damage-associated molecular patterns (DAMPs), with structural 
motifs that are recognized by these pattern recognition receptors [213]. Hypoxia 
induced necrosis results in the release of the intracellular sequestered DAMPs to the 
extracellular compartment, such as high-mobility group box 1 (HMGb1), DNA 
fragments, mitochondrial contents and heat shock proteins (HSPs) [214]. We recently 
showed that plasma levels of nuclear DNA are increased in patients after cardiac 
arrest and correlate with the proinflammatory cytokine IL-6. Furthermore, plasma 
levels of nuclear DNA remain elevated in the first days after the arrest, suggesting 
ongoing cell damage during hospital admission (submitted).
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ischemia induced cytokines, chemokines or components of the complement system 
can activate T cells through an antigen independent pathway. Irrespective of the 
mode of stimulation, once activated, T cells contribute to ischemic injury. T cells can 
both mediate and mitigate the inflammatory response to ischemia and reperfusion. 
Direct blockade of T cells or blockade of T cell costimulatory molecules attenuates the 
ischemic inflammatory injury in different animal models of ischemia reperfusion [216]. 
T cell subpopulations can both positively and negatively regulate the inflammatory 
response. Production of IL-17 by activated CD4 positive lymphocytes contributes to 
the active recruitment of neutrophils to the damaged tissue [217]. At the same time, 
CD4 positive T cells may suppress activation of neutrophils [218]. The interplay 
between the different effector cells of the innate and adaptive immune response is 
complex and not fully understood.
Immune response to reperfusion 
Return of spontaneous circulation not always results in return of microvascular blood 
flow. This no-reflow phenomenon occurs in a number of organs, including the brain 
and the heart [71, 219]. Ischemia induces swelling of endothelial cells and endothelial 
“blebbing” that occludes the capillary lumen [220]. Leukocytes are activated in these 
no-reflow areas and interact with the endothelium, enhancing the inflammatory 
response. Besides leukocytes, platelets, and complement activation impair vascular 
relaxation and decrease microvascular flow [212].
 Return of spontaneous circulation after cardiac arrests results in restoration of 
blood flow and reoxygenation and is frequently associated with an exacerbation of 
tissue injury and a profound inflammatory response [221]. Reactive oxygen species, 
generated by xanthine oxidase from endothelial cells, are one of the main contributers 
to this reperfusion injury. They evoke mitochondrial damage, act as neutrophil che-
moattractants, mediate dysfunction of the sarcoplasmic reticulum and contribute to 
intracellular Ca2+ overload. These reactive oxygen species induce a cascade of events 
resulting in damage to the cell membrane by lipid peroxidation, enzyme denaturation 
and direct oxidative damage to DNA [222].
 Ischemia-damaged endothelial cells expose a number of (previously unexposed) 
neoepitopes resulting in release of reactive oxygen species after recognition by 
neutrophils [221]. IgM natural antibodies can also bind to neoepitopes on hypoxic 
endothelium. A specialized subset of B cells (termed B1 cells) produce so called natural 
antibodies that are constitutively secreted without prior immune activation [223]. 
These highly conserved antibodies may be present from birth without external 
antigenic exposure, in contrast to antibodies that arise after specific immune exposure 
or antigenic challenge. The contribution of these natural antibodies to reperfusion 
injury was demonstrated inRAG-1-/- mice, which are deficient in immunoglobulins 
[224]. These mice were protected from reperfusion injury in a hindlimb model of 
Tissue injury may also generate DAMPs from the extracellular matrix such as heparan 
sulphate and biglycan [215]. Binding of DAMPs to the pattern recognition receptors 
activates downstream signaling pathways such as the nuclear factor κb (NFκb) and 
mitogen activated protein kinase (MAPK), which result in activation of cytokines and 
chemokines that are released to recruit and activate additional inflammatory cells 
(Figure 1).
The innate immune response is followed by activation of the adaptive immune 
response. Ischemia can activate T cells through an antigen dependent and an antigen 
independent manner [216]. In the antigen dependent way, antigen presenting cells 
such as dendritic cells and macrophages, present an antigen (for example heat shock 
proteins) by their MHC molecule to the T cell receptor, together with a second signal 
provided by costimulatory molecules such as B7-1, B7-2 and CD-40. In addition, 
Figure 1   
Injured cells release DAMPs in response to ischemia. These DAMPs bind to pattern recognition receptors 
on cells of the innate immune system such as macrophages and initiate an inflammatory response with the 
production of inflammatory mediators such as cytokines, chemokines and complement. These 
inflammatory mediators can directly contribute to cell damage and also activate a large variety of cells of 
the adaptive immune system such as T cells. These T cells can further propagate the inflammatory response 
in an antigen dependent manner (requiring T cell receptor stimulation and co-stimulation) and an antigen 
independent manner.
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 Activation of complement plays a critical role in ischemia-reperfusion injury, 
leading to increased vascular permeability, activation of the coagulation cascade, 
free-radical production, and direct tissue damage. In patients after cardiac arrest, 
complement activation was initiated by the classical pathway and augmented by the 
alternative pathway, ultimately resulting in formation of the terminal complement 
complex [196]. During normothermia, the anaphylatoxin C3a and the soluble 
membrane attack complex SC5b-9 (TCC) are increased during cardiopulmonary 
resuscitation and returned to baseline values within 48 hours of return of spontaneous 
circulation [232]. In contrast to this systemic complement activation by the classical 
route, ischemic acute tubular necrosis results in complement activation by the 
alternative route [234]. Inhibition of complement activation ameliorates injury in 
several ischemia/reperfusion models [235].
Ischemia reperfusion injury in the brain
Approximately 70% of the patients dying after out-of hospital cardiac arrest die due to 
neurological injury [25]. Cardiac arrest also induces an extensive cerebral inflammatory 
response (Figure 2).
 In the central nervous system, pattern recognition receptors are constitutively 
expressed on most cells [236]. Upon stimulation by DAMPs they locally modulate the 
inflammatory response in the brain. Cytokines can have direct and indirect actions on 
the brain after cardiac arrest. Cytokines are produced in the brain mainly by microglial 
cells and astrocytes and directly contribute to the autonomic, neuroendocrine and 
metabolic homeostasis in the normal brain [237]. Under normal healthy conditions, 
cytokines that originate from peripheral immune organs can cross the blood brain 
barrier at leaky areas in the circumventricular organs. Cytokines can also be actively 
transported from the periphery into the brain by a saturable and specific carrier 
system [238].
 Under ischemic conditions, cerebral cytokine production increases and contributes 
to the inflammatory cascade after cardiac arrest. In a porcine cardiac arrest model, 
proinflammatory cytokine concentrations increased in cerebral spinal fluid and showed 
a very poor correlation with plasma cytokine concentrations, strongly suggesting 
local production [239]. Cardiac arrest induces microglial activation with upregulation 
of proinflammatory mRNA cytokine expression resulting in neuronal damage [240, 
241]. Attempts to demonstrate compartmentalized cerebral production of cytokines 
in jugular bulb venous blood of human cardiac arrest patients have failed, most likely 
due to large quantities of cytokines produced systemically [196].
 Endothelial activation resulted in cerebral upregulation of the adhesion molecule 
ICAM-1 in an animal model of cardiac arrest [240]. In postmortem human brain, 
upregulation of ICAM-1 and P-selectin was demonstrated up to 2 days after the arrest, 
with a similar intensity as compared to focal infarct brain tissue [242].
ischemia, whereas reconstitution of RAG-1-/- mice with normal mouse serum restored 
injury in this model. Natural antibodies subsequently initiate activation of the 
complement cascade through the classical pathway. Reperfusion injury thus involves 
innate recognition of ”self” and the initiation of inflammation against “self” and may 
be referred to as “innate autoimmunity”.
Inflammatory response after cardiac arrest 
Return of spontaneous circulation after cardiac arrest results in ischemia reperfusion 
injury inducing a profound inflammatory response with sepsis-like features [39]. As 
soon as 3 hours after the arrest, increased concentrations of proinflammatory and 
anti-inflammatory cytokines can be measured in plasma. The levels of sTNFRII, IL-6, 
IL-8 and IL-10 on admission were significantly higher in non-survivors than in survivors. 
In another cohort of 64 patients, plasma concentrations of C-reactive protein, TNFα, 
IL-6 but not IL-10 were higher in non-survivors compared to survivors [225]. This 
increased cytokine response in patients with a poor outcome may be considered as 
an epiphenomenon reflecting a stronger ischemia-reperfusion reaction e.g. due to 
longer time to return of spontaneous circulation. Alternatively, the post-cardiac 
arrest inflammatory response may affect the patients’ outcome by interfering with 
organ function as suggested by a number of studies.
 IL-6 concentrations correlate with the occurrence and degree of organ failure in 
patients with cardiogenic and septic shock [226]. In a swine model of cardiac arrest, 
increases in TNFα were associated with depression of left ventricular function and 
this effect was blocked by the administration of anti-TNFα antibodies [227]. TNFα, 
IL-6, and IL-2 have direct negative inotropic effects on mammalian myocardium 
mediated through myocardial nitric oxide synthase [228].
 TNFα and IL-1β regulate the development of lung ischemia-reperfusion injury 
[229]. They appear to promote injury by altering expression of proinflammatory and 
anti-inflammatory cytokines and influencing tissue neutrophil recruitment. Blockade 
of these cytokines decreased lung vascular injury in this model.
 The ischemia-reperfusion induced inflammatory response directly contributes to 
renal injury by damage of renal cells by the innate and adaptive immune system [230]. 
At the same time, tubular cells themselves contribute to the inflammatory response 
by release of cytokines and chemokines from the injured renal tubular epithelium.
 Besides cytokines, neutrophil and vascular endothelial adhesion molecules also 
play an important role in the post-cardiac arrest inflammatory response. ICAM-1, VCAM-1, 
and E-selectin are the three major adhesion molecules responsible for neutrophil 
attachment to endothelium. Increased expression of adhesion molecules is usually 
associated with increased serum concentrations of their soluble forms [231]. The levels of 
these adhesion molecules increase during the first 24 hours after cardiac arrest, 
suggesting an important role for the endothelium in post-cardiac arrest injury [232, 233].
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on neurons [245]. This suggests an important role for complement in the ischemia- 
induced cerebral inflammation.
Effect of ICU treatment on inflammation
Mild therapeutic hypothermia
The effect of mild therapeutic hypothermia on the inflammatory response after 
cardiac arrest has resulted in conflicting data. In a rat model, no differences over time 
of different cytokines and chemokines were demonstrated between hypothermic 
and normothermic animals [246]. In contrast, hypothermia attenuated upregulation 
of inflammatory cytokine and adhesion molecule expression in cerebral tissue in a 
ventricular fibrillation model in pigs [240]. Fries et al measured increasing IL-6 plasma 
concentrations in 71 cardiac arrest patients during hypothermia [247]. Rewarming 
promptly reversed IL-6 concentrations in this population. The effect of hypothermia 
and subsequent rewarming was studied in 10 patients treated with mild therapeutic 
hypothermia for 24 hours after cardiac arrest [196]. The proinflammatory IL-6 
remained low during hypothermia and increased during rewarming and returned to 
baseline at 48 hours after the arrest. The anti-inflammatory cytokines IL-10 and IL-1ra 
did not significantly change during mild therapeutic hypothermia and rewarming, 
although low values of IL-10 were observed after rewarming. Soluble ICAM-1 increased 
significantly during hypothermia and remained at this level after rewarming. 
Complement activation was increased on admission and decreased after induction of 
hypothermia, followed by a secondary increase during rewarming. Although this 
study suggested a temporal relationship between several inflammatory parameters 
and hypothermia and subsequent rewarming, as a result of the observational study 
design, a causal effect between temperature and inflammation cannot be ascertained. 
To analyze the effect of temperature on the inflammatory response after cardiac 
arrest the inflammatory response was studied over time in patients treated with 
therapeutic hypothermia for an extended period of 72 hours after cardiac arrest 
(Bisschops et al, accepted, Crit Care). Prolonged hypothermia blunted the inflammatory 
response after rewarming. Complement activation was efficiently attenuated during 
the whole hypothermia period, indicating that complement activation is highly 
temperature sensitive also in vivo. Because inflammation is a potential mediator of 
secondary brain injury, a blunted proinflammatory response after rewarming may be 
beneficial. The optimal duration of mild therapeutic hypothermia and the optimal 
rewarming rate therefore remain to be determined. 
Sedation
In the first hours after cardiac arrest, sedatives and analgetics are used to tolerate 
hypothermia and invasive mechanical ventilation. Sedatives have a profound effect on the 
immune system. Midazolam reduces the capacity of peripheral blood monocytes of 
 In the brain, complement activation results in microvascular failure and direct 
neuronal cell death. Complement receptors are constitutively expressed on neurons 
and astrocytes. After focal ischemia, de novo complement receptor expression was 
detected on endothelial cells, macrophage-like cells and astrocytes [243]. Global 
cerebral ischemia in the rat induced early and widespread upregulation of the classical 
pathway complement component C1q in brain microglial cells and secretion of 
functionally active C1q in the cerebrospinal fluid [244]. Increased concentrations of 
the terminal complement complex were also found in the cerebrospinal fluid of 
asphytic newborns and deposition of the terminal complement complex was found 
Figure 2   
Ischemia/reperfusion induced DAMPs bind to pattern recognition receptors on most cells in the central 
nervous system. Microglia are the major inflammatory cells in the CNS, and their activation results in the 
production of a number of cytokines, chemokines and complement. Astrocytes and neurons are 
increasingly recognized as key targets and effectors of cytokines and inflammatory mediators in the brain. 
In addition to the compartimentalized production  of inflammatory mediators, cytokines are actively 
transported from the periphery to the brain by a specific carrier system and also passively leak into the 
central nervous system through the circumventricular organs. Infiltration of immune cells, macrophages 
and lymphocytes is an essential step in the progression of the inflammatory response after cardiac arrest. 
Expression of adhesion molecules such as ICAM-1, P-selectin, E-selectin and integrins on endothelial cells 
promote the adhesion and transendothelial migration of these cells.
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arrest have an attenuated immune response to Gram-negative and Gram-positive 
antigens [262]. This hyporesponsiveness resembles the immune paralysis as seen in 
patients after sepsis characterized among others by a reduced intrinsic leukocyte 
function and a whole blood hyporesponsiveness caused by soluble serum factors. 
This hyporesponsiveness may serve as a protective response against overwhelming 
inflammation but at the same time induces a state of immunoparalysis [263]. Several 
mechanisms have been associated with the development of the sepsis-induced 
 immunoparalysis [264]. Leukocytes isolated from patients with sepsis have a number 
of functional defects, such as impaired chemotaxis, diminished expression of cell 
surface antigens such as HLA-DR on monocytes, and enhanced apoptosis. A number 
of T cell subpopulations may interfere with the activation of the adaptive immune 
response. During immunoparalysis, the cytokine production is shifted from a 
predominantly proinflammatory to a more anti-inflammatory response. In sepsis, 
 immunoparalysis is an important cause of the poor outcome of patients in the 
postacute phase, even when the primary infection has been overcome. Treatment of 
septic patients with agents such as granulocyte-macrophage colony–stimulating 
factor (GM-CSF) or IFN-γ have successfully restored leukocyte function and enhanced 
proinflammatory cytokine production [265, 266]. The effects on outcome of these 
agents remain to be established. The effect of intervention to restore immunoparal-
ysis in patients after ischemia-reperfusion is unclear.
Conclusions
The inflammatory response after cardiac arrest is complex. It is initiated by isch-
emia-reperfusion and participates in the development of (secondary) organ damage 
and initiation of repair. Standard ICU treatment has an important effect on the 
immune response following cardiac arrest. Due to the different roles of various 
elements of the immune system at different times and sites in the body, interference 
with this complex and compartmentalized response will be challenging. However, recent 
experience with functional blockade of Toll like receptor-2 resulting in increased 
survival and improved neurofunctional outcome underscore the importance of the 
inflammatory response after cardiac arrest and warrant further studies [267].
anesthetized patients to produce IL-1β, TNF-α and IL-6 in response to lipopolysaccha-
ride [248]. Propofol attenuates IL-6 production and enhances IL-10 secretion in 
patients with impaired myocardial function undergoing cardiac surgery [249].
 Immune cells such as macrophages, neutrophils and T lymphocytes express 
different types of opioid receptors and may regulate the immune response. Opioids 
decrease the effectiveness of several functions of both natural and adaptive immunity, 
and significantly reduce both cellular and humoral immunity [250]. The effects of 
different opioids on the immune system varies. For instance, morphine suppressed 
IL-6 production and neutrophil adhesion molecule expression more than fentanyl in 
patients after cardiac surgery [251].
Vasopression
Vasopressors are frequently used in patients after cardiac arrest to improve the 
(cerebral) perfusion pressure and avoid secondary ischemic injury. Norepinephrine is 
the main neurotransmitter of the central nervous system and can alter lymphoid 
functions. β-adrenergic receptors are present on lymphoid cells, and the stimulation 
of these receptors can affect the immune response [252]. Norepinephrine increases 
the production of both pro- and anti-inflammatory cytokines, and may shift the 
cytokine balance towards a more anti-inflammatory profile [252, 253].
 Vasopressin is a peptide secreted by the hypothalamus whose major systemic 
effects are mediated via the specific receptors V1R, V2R, and oxytocin receptor. 
Vasopressin decreases the immune response in both kidney and lung models of 
inflammation [254, 255]. This effect was partly mediated trough the V2R receptor. 
Vasopressin compared with norepinephrine was associated with significantly greater 
decreases of plasma concentrations of a large number of cytokines [256]. The 
underlying mechanism may be related to the fact that vasopressin stimulates the V1b 
receptor in the anterior pituitary to secrete adrenocorticotropic hormone, increasing 
serum cortisol, thereby inducing a diffuse anti-inflammatory effect.
 Dobutamine is a β1-adrenoreceptor agonist, with weak β2-adrenoreceptor activity 
and α1-adrenoreceptor-selective activity. Dobutamine increased circulating TNF-α levels 
in patients with septic shock, whereas dopamine increased Il-6 levels, independently 
of disease severity, hemodynamics and outcome [257]. The calcium-sensitizer 
levosimendan did not have effects on systemic or cerebral inflammation in animal 
model of cardiac arrest [258].
Immune paralysis after cardiac arrest
Infections are common in patients after cardiac arrest, occurring in 46-67% of all 
patients [259-261]. Pneumonia was the most frequently reported infection site and 
Staphylococcus aureus the main causative agent. Hypothermia is identified as an 
independent risk factor for the development of infections [261]. Patients after cardiac 
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Introduction
The mechanisms leading to brain injury as a result of whole-body ischemia and 
reperfusion (I/R) after cardiac arrest are complex. Hypoperfusion of the brain initiates 
a complex series of events, including excitotoxicity, oxidative stress, microvascular 
injury, blood-brain barrier dysfunction, and postischemic inflammation, ultimately 
leading to cell death of neurons, glia, and endothelial cells. Free oxygen radicals 
induce the production of proinflammatory cytokines by astrocytes and microglial 
cells, resulting in expression of adhesion molecules on the endothelial cell surface 
[268]. This leads to chemotaxis of activated leukocytes across the blood-spinal cord 
barrier and blood-brain barrier. Activation of the complement system further 
promotes the passage of neutrophils and monocytes to the brain tissue. So far, mild 
therapeutic hypothermia (MTH) is the only therapy applied that has been shown to 
be effective in increasing survival and decreasing morbidity in cardiac arrest patients 
[20, 21]. Several studies have demonstrated that hypothermia suppresses isch-
emia-induced proinflammation in traumatic brain injury [269-271]. The effect of MTH 
on the inflammatory response in patients after cardiac arrest has poorly been 
investigated and has resulted in conflicting data [240, 247, 272].
 Cardiac arrest and resuscitation represent a whole-body I/R syndrome with 
systemic activation of the innate immune system. This systemic inflammatory 
response may further contribute to the brain injury. At the same time, the postischemic 
brain inflammation can be transmitted to the peripheral immune system, thus 
contributing to the systemic inflammatory response [273]. Whereas early events are 
generally characterized by a proinflammatory response that contributes to the tissue 
damage, later events seem to be involved in cell repair and clearance of necrosis and 
apoptotic cell bodies. The cross-talk between the cerebral and peripheral immune 
system in humans after whole-body I/R injury and the changes over time in the 
inflammatory response are largely unknown. The aim of this study was to describe 
the inflammatory response over time in patients treated with MTH after cardiac 
arrest.
Materials and methods
Study population
We performed a prospective observational study of ten comatose patients successfully 
resuscitated from an out-of-hospital cardiac arrest treated with MTH. Because 
therapeutic MTH is an essential part of standard care, a normothermic control group 
was considered unethical. The local Institutional Review Board approved the protocol 
and written informed consent was obtained from the nearest relative. All patients of 
Abstract
Objective The aim of this study was to simultaneously analyze the key components of 
the cerebral and systemic inflammatory response over time in cardiac arrest patients 
during mild therapeutic hypothermia (MTH) and rewarming.
Design and setting Clinical observational study in a tertiary care university hospital.
Patients Ten comatose patients after out-of-hospital cardiac arrest.
Interventions All patients were cooled to 32-34°C for 24 hours. After 24 hours 
patients were passively rewarmed to normothermia.
Measurements and Main Results On admission and at 3, 6, 12, 24, and 48 hours 
blood samples were taken from the arterial and jugular bulb catheter. Proinflammatory 
and anti-inflammatory cytokines and chemokines (interleukin-1ra, interleukin-1β, 
interleukin-6, interleukin-8, interleukin-10, interleukin-18, monocyte chemotactic 
protein-1, high-mobility group box-1 and tumor necrosis factor-α), complement 
activation products (C4d, Bb, C3a and terminal complement complex), and the 
adhesion molecule soluble intercellular adhesion molecule were measured. Mean 
temperatures at the start of the study and at 12 and 24 hours were 33.7 ± 0.9°C, 32.7 
± 0.92°C and 34.5 ± 1.5°C, respectively. Passive rewarming resulted in a temperature 
of 37.8 ± 0.5°C at 48 hours. The proinflammatory cytokine interleukin-6 increased 
from 12 to 24 hours and returned to baseline levels after 48 hours. In contrast, the 
chemokines interleukin-8 and monocyte chemotactic protein-1 stayed relatively high 
from the start and during the hypothermia period, decreasing to baseline levels after 
48 hours. The anti-inflammatory cytokines interleukin-10 and interleukin-1ra did not 
significantly change during mild therapeutic hypothermia and rewarming, although 
low values of interleukin-10 were observed after rewarming. A significant increase 
after rewarming was demonstrated on high-mobility group box-1 concentrations in the 
jugular bulb, whereas soluble intercellular adhesion molecule increased significantly 
during hypothermia and remained at this level after rewarming. Complement 
activation was increased on admission and decreased after induction of hypothermia, 
followed by a secondary increase during rewarming. No significant differences between 
any of the biomarkers were found between samples from the arterial and jugular 
bulb catheter.
Conclusions Complement activation occurs during rewarming from mild therapeutic 
hypothermia after cardiac arrest. Interleukin-6 increased already from 12 to 24 hours, 
concomitantly with a significant increase in the temperature seen during this period 
of mild therapeutic hypothermia. The optimal rate of rewarming is unknown. 
Additional clinical studies are needed to determine the optimal rewarming rate and 
strategy.
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Data collection and blood sampling
Demographic and prehospital data were collected on admission. Hemodynamic 
parameters, temperature, and SaO2 were measured continuously. On admission and 
at 3, 6, 12, 24, and 48 hours, blood samples were taken from the arterial and jugular 
bulb catheter. Blood samples were immediately centrifuged for 15 minutes at 2000 g 
at 4°C, and plasma was stored at -80°C until batch-wise analysis.
Measurements of cytokines, chemokines and adhesion molecules
IL-1 receptor antagonist (IL-1ra), IL-10, IL-18, monocyte chemotactic protein-1 (MCP-1) 
and, soluble intracellular adhesion molecule (s-ICAM) were determined using a 
simultaneous Luminex Assay according to the manufacturer’s instructions (Bio-plex 
cytokine assay, BioRad, Hercules, CA, USA). IL-1β, IL-6, IL-8, and tumor necrosis 
factor-α (TNF-α) were determined using commercial enzyme-linked immunosorbent 
assays (BioRad, Hercules, CA, USA) according to the manufacturer’s instructions. High 
mobility group box 1 (HMGB1) was determined using the HMGB1 enzyme-linked 
immunosorbent assay kit II (Shino-test, Shanghai, China).
Measurements of complement activation products.
The complement activation products C4d (classical and lectin pathway), Bb 
(alternative pathway), and C3a (common pathway) were measured using commercial 
enzyme-linked immunosorbent assay kits based on monoclonal antibodies directed 
against neoepitopes of the products and performed according to the manufacturer’s 
instructions (Quidel, San Diego, CA). Soluble terminal complement complex (TCC) 
(terminal pathway) was measured as described previously by Mollnes et al. [274], 
using an enzyme-linked immunosorbent assay. Briefly, the coating monoclonal 
antibody was an E11 (specific for a neo-epitope exposed when C9 is incorporated into 
the TCC) and a biotinylated monoclonal anti-C6 antibody was used as detecting 
antibody. All samples were measured in duplicate. Values are expressed as arbitrary 
units (AU) per milliliter, related to a standard of human serum activated with zymosan, 
defined to contain 1000 AU/mL.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad 
Software. Inc. La Jolla, USA). Data are presented as mean with standard deviation (SD) 
or median with 25th and 75th percentile in the box-and-whisker plots. The whiskers 
are drawn down to the minimum and up to the maximum. Changes over time were 
analyzed with repeated-measures test and the Wilcoxon matched pairs test. 
Differences between arterial and jugular bulb samples were analyzed using a two-way 
analysis of variance. A p value < 0.05 was considered to indicate statistical significance.
18 years or older were eligible for the study if they met the following criteria: comatose 
(Glasgow Coma Scale score ≤ 6) after return of spontaneous circulation (ROSC) and 
primary cardiac rhythm, as documented by the paramedic team, was ventricular 
fibrillation. Patients were excluded if they were pregnant, received thrombolytic 
therapy, if there was a case of refractory cardiogenic shock, or if they had a life 
expectancy of < 24 hours. Patients were also excluded if written informed consent 
could not be obtained within 4 hours after admission to the intensive care unit (ICU). 
Time between collapse and ROSC, start of cooling and start of the experiment were 
calculated based on data provided by the paramedic team.
Patient management
All patients were admitted to the intensive care unit of a tertiary care university 
hospital in Nijmegen, The Netherlands. If necessary, a coronary angiogram and a 
percutaneous coronary intervention was performed before admission to the ICU. In 
agreement with our local protocol, all patients were cooled to 32-34°C by rapid 
infusion of 30 mL/kg bodyweight of cold Ringer lactate at 4°C, followed by external 
cooling using two water-circulating blankets (Blanketroll II, Cincinatti Subzero, The Surgical 
Company, Amersfoort, The Netherlands). Temperature was measured continuously with 
a rectal temperature probe (YSI Incorporated 401, vd Putte Medical, Nieuwegein, 
The Netherlands) and maintained at 32-34°C for 24 hours, followed by passive 
rewarming to normothermia (defined as 37°C). All patients were sedated with 
midazolam or propofol or both and morphine during hypothermia. Sedation and 
analgesics were stopped as soon as the body temperature was ≥ 36.5°C. In case of 
shivering, patients were paralysed using intravenous bolus injections of rocuronium.
 All patients were intubated and mechanically ventilated aiming at a PaO2 > 75 
mm Hg and PaCO2 between 34 and 41 mm Hg. The radial or femoral artery was 
cannulated for monitoring of blood pressure and sampling of arterial blood. A central 
venous catheter was inserted in the subclavian or jugular vein for administration of 
drugs and monitoring of central venous pressure. According to our local protocol, 
mean arterial blood pressure was maintained between 80 and 100 mm Hg, and 
diuresis was aimed at > 0.5 mL/kg/hr. If necessary, patients were treated with volume 
infusion and dobutamine or (nor)epinephrine intravenously. According to our local 
protocol for postcardiac arrest patients a 7F single-lumen catheter was introduced 
into the left or right jugular bulb as described by Goetting and Preston for monitoring 
of the cerebral oxygen extraction rate [173].
 Serum concentrations of sodium, potassium, and magnesium were maintained 
within the normal range. All patients were treated with continuous insulin infusion 
therapy aiming at blood glucose levels between 4.4-6.1 mmol/L according to the 
protocol by Van den Berghe et al [174, 175]. Haemoglobin concentration was kept ≥ 
6.0 mmol/L. None of the patients were treated with anti-inflammatory drugs.
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Measurements of cytokines, chemokines, adhesion molecules  
and complement activation products
The measured concentrations of IL-6, IL-8, MCP-1, IL-10, IL-1ra, s-ICAM, HMGB1, C4d, 
Bb, C3a and TCC are demonstrated in Table 2 and Figures 1-4. TNF-α and IL-1β were 
below detection levels throughout the study period (< 15.0 pg/L and < 8.0 pg/L, 
respectively). No differences in cytokine, chemokine, and adhesion molecule 
concentrations were found between arterial and jugular bulb samples at any time 
point during the study period. Although the complement activation products were 
consistently higher in jugular bulb samples, the difference between C4d, Bb, C3a and 
TCC concentrations in arterial and jugular bulb samples was not statistically different.
Results
Population
We studied ten comatose patients successfully resuscitated from an out-of hospital 
cardiac arrest. Demographic data are shown in Table 1. In all patients ischemic 
cardiomyopathy was considered the underlying cause of the ventricular fibrillation. 
None of the patients required a coronary angiogram or percutaneous coronary 
intervention for myocardial infarction. At inclusion, none of the patients were in 
cardiogenic shock. All patients were treated with mild hypothermia according to our 
local protocol; in one patient the temperature was increased to 35°C after 18 hours 
because of recurring arrhythmias. Five patients died in the intensive care unit 
respectively 2, 3, 3, 7, and 8 days after admission as a result of severe postanoxic brain 
damage. All five patients had a normal temperature at the time of death. One patient 
died of pneumosepsis in the hospital 8 days after discharge from the intensive care 
unit. There were no differences in delay between time collapse and ROSC, collapse 
and start of cooling, and collapse and start of experiment between survivors and 
non-survivors.
Clinical data
Clinical data of the patients are shown in Table 1. Between 12 hours and 24 hours, 
mean temperature increased significantly from 32.7°C to 34.5°C (p = 0.01) (Table 2). 
Three of ten patients received norepinephrine in maximal doses of 0.01, 0.04, and 
0.19 µg/kg/min norepinephrine, respectively, during hypothermia. One patient was 
treated with epinephrine in a dosage of 0.13-0.25 µg/kg/min. Eight of 10 patients 
received dobutamine in maximal doses ranging from 0.9-9.5 µg/kg/min dobutamine.
Table 1  Demographic data of 10 hypothermic patients after cardiac arrest
Male, no. (%) 8 (80%)
Age, yrs 65.7 ± 7.6
Body mass index, kg/m2 25.9 ± 3.0
SAPS 2 65.8 ± 18.0
APACHE II 26.7 ± 7.3
Patients died, no. (%) 6 (60%)
Data are expressed as mean values ± SD. BMI, body mass index; SAPS, Simplified Acute Physiology 
Score; APACHE II, Acute Physiology and Chronic Health Evaluation II.
Figure 1   The proinflammatory cytokine IL-6 and the chemokines IL-8 and MCP-1 
during hypothermia (0-24 hrs) and after rewarming (48 hrs) in 10 patients 
after cardiac arrest
Values (median (black lines in boxes), IQR 25 and IQR 75 (boxes), and minimum and maximum (whiskers) 
are depicted for arterial (light grey bars) and and jugular bulb samples
(dark grey bars). # significant difference arterial samples, p < 0.05. * significant difference jugular bulb
samples, p < 0.05. IL, interleukin; MCP-1, monocyte chemotactic protein-1
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Discussion
In cardiac arrest survivors treated with MTH for 24 hours, we observed an increase in 
IL-6 during the period of hypothermia, which could be explained by an intrinsic 
pyrogen response to body temperature below the hypothalamic setpoint. Serum 
complement levels were increased on presentation, suggesting endothelial activation, 
declined during the period of hypothermia, and rose again during rewarming. We also 
noted an increase in HMBG-1, a marker of I/R injury, during rewarming. Systemic and 
jugular bulb cytokine levels and complement activation were not significantly 
different. This is the first study to our knowledge investigating the systemic and 
cerebral inflammatory response in cardiac arrest patients treated with MTH. These 
Figure 2   The anti-inflammatory cytokines IL-10 and IL-1ra during hypothermia (0-24 
hrs) and after rewarming (48 hrs) in 10 patients after cardiac arrest
Values (median (black lines in boxes), IQR 25 and IQR 75 (boxes), and minimum and maximum (whiskers) 
are depicted for arterial (light grey bars) and and jugular bulb samples (dark grey bars).
IL, interleukin; IL-1ra, interleukin-1 receptor antagonist
Figure 3   s-ICAM and HMGB-1 during hypothermia (0-24 hrs) and after rewarming 
(48 hrs) in 10 patients arrest after cardiac arrest
Values (median (black lines in boxes), IQR 25 and IQR 75 (boxes), and minimum and maximum (whiskers) 
are depicted for arterial (light grey bars) and and jugular bulb samples (dark grey bars).
# significant difference arterial samples, p < 0.05. * significant difference jugular bulb samples, p < 0.05.
s-ICAM, soluble intracellular adhesion molecule; HMGB-1, high mobility group box 1
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Figure 4   Complement activation products C4d (classical and lectin pathway),  
Bb (alternative pathway, C3a (final common pathway) and TCC (terminal 
pathway) during hypothermia (0-24 hrs) and after rewarming (48 hrs)  
in 10 patients after cardiac arrest
Values (median (black lines in boxes), IQR 25 and IQR 75 (boxes), and minimum and maximum (whiskers) 
are depicted for arterial (light grey bars) and and jugular bulb samples (dark grey bars).
# significant difference arterial samples, p < 0.05. * significant difference jugular bulb samples, p < 0.05.
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 HMGB-1 is a nuclear factor released by necrotic cells and by activated immune 
cells, signaling via toll-like receptors and the receptors for advanced glycation end 
products (RAGE). HMGB-1 acts as a potent “danger signal” initiating host defense or 
tissue repair and plays an important role in the pathogenesis of inflammatory diseases 
[286]. It has been proven to play an important role in the early event of I/R injury of 
the heart and in acute lung injury, resulting in the activation of proinflammatory 
pathways and additional cell injury [287, 288]. In our study, a significant increase after 
rewarming was demonstrated on HMGB-1 concentrations in the jugular bulb samples.
Activation of complement plays a critical role in I/R injury, leading to increased 
vascular permeability, activation of the coagulation cascade, free-radical production, 
and direct tissue damage [280]. Complement activation was initiated by the classical 
pathway and augmented by the alternative pathway, ultimately resulting in formation 
of the terminal complement complex. During normothermia, the anaphylatoxin C3a 
and the soluble membrane attack complex SC5b-9 (TCC) are increased during cardio-
pulmonary resuscitation and returned to baseline values within 48 hours of ROSC 
[280]. Our study suggests that complement is activated at admission, consistent with 
the systemic I/R state of these patients. Notably, complement activation was 
relatively low during mild hypothermia. In fact, this is not surprising, because 
complement activation is largely temperature-dependent. Changes in Bb were the 
most pronounced, pointing to the alternative pathway amplification loop being 
quantitatively responsible for most of the activation. It should be noted, however, 
that C4d also was increased at admission, reflecting a certain degree of classic or 
lectin pathway activation during ischemia/reperfusion. Both these pathways have 
been shown to be candidates for such activation. Rewarming was followed by a 
secondary increase in complement components, significantly detected by the increase in 
TCC, which is known to be a very sensitive indicator for complement activation [289]. 
These findings underscore that complement might be more susceptible to rewarming 
than the cytokine network.
 Studies investigating the effect of MTH on the inflammatory response in patients 
after cardiac arrest have resulted in conflicting data. In a rat model, no differences 
over time of different cytokines and chemokines were demonstrated between 
hypothermic and normothermic rats, suggesting no specific role of systemic cytokines 
after cardiac arrest [272]. Upregulation of inflammatory cytokine and adhesion 
molecule expression in cerebral tissue was shown in pigs after cardiac arrest [240]. 
Hypothermia attenuated upregulation of messenger RNA expression compared with 
normothermic controls. Remarkably, in our study TNF-α and IL-1β remained below 
detection limits. Adrie et al, who studied cardiac arrest survivors treated without 
MTH, found detectable levels of TNF-α in 33 of 61 (53%) patients; the presence of 
TNF-α was significantly associated with a higher mortality rate [39]. These and our 
data conflict with the findings of Fries et al. who measured significantly elevated 
data may be of importance because cerebral inflammation may partly explain the 
subsequent cerebral damage.
 Our data conflict with the growing evidence for an isolated cerebral inflammatory 
response after cardiac arrest. Youngquist et al. recently demonstrated increased TNF-α 
and IL-6 concentrations in the cerebrospinal fluid in patients after cardiac arrest [239]. 
Meybohm et al. found a significant upregulation of messenger RNA expression of 
several cytokines (IL-1β, IL-6, IL-10, TNF-α, and s-ICAM-1) and a significant rise in IL-1β 
concentration in the cerebral cortex tissue of pigs that were subjected to cardiac 
arrest. Assuming intact blood-brain barriers after cardiac arrest, the rise in IL-1β may 
be the result of local cerebral synthesis rather than transport across the blood 
brain-barrier [240, 275]. In contrast, Sharma et al. recently demonstrated that leakage 
of serum proteins into the brain microfluid environment occurs after induced cardiac 
arrest in a porcine model, which leads to brain edema formation, suggesting a breakdown 
of the blood-brain barriers [276]. We believe that compartmentalized production of 
cytokines in the brain tissue may occur but could be masked by the large amount of 
cytokines produced systemically, potentially explaining the discrepancy between our 
findings and those discussed.
 Ischemia and reperfusion trigger inflammation via direct effects on leukocytes, 
endothelium, and other tissues; so far it has been associated with the acute release 
of cytokines, chemokines, and complement activation [39, 41, 277-280]. A modest 
increase in temperature at the end of the hypothermia period was accompanied by a 
significant increase in IL-6, whereas IL-8 and MCP-1 barely changed. The increase in IL-6 
concentration may be the result of the increase in body temperature or alternatively 
may cause the increase in body temperature. From the nature of this study, these 
effects are indistinguishable. Our results suggest that hypothermia as such does not 
prevent systemic proinflammatory cytokine, and chemokine responses. This, however, 
may depend on the degree of hypothermia, consistent with our finding of an increase 
in IL-6 concomitantly with a modest increase in temperature. After passive rewarming, 
both IL-6, IL-8, and MCP-1 declined to baseline levels at 48 hours. The anti-inflamma-
tory cytokines IL-10 and IL-1ra did not significantly change during hypothermia and 
rewarming, suggesting a stable anti-inflammatory response during the whole study period. 
s-ICAM, mediating neutrophil adhesion to the endothelium and tissue translocation, 
like IL-6 increased from 12 to 24 hours; however, in contrast to IL-6, s-ICAM levels 
remained stable after rewarming, suggesting a sustained endothelial cell activation after 
the I/R induced acute cytokine release and reactivation during rewarming. Altogether 
our data suggest a temporarily proinflammatory effect of rewarming in cardiac arrest 
patients treated with MTH. The effects of rewarming on the inflammatory response 
have already been observed in a number of clinical and experimental studies. 
Depending on the model and setting that was used, rewarming resulted in both 
increased and decreased proinflammatory cytokine production [281-285].
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TNF-α levels in the early phase after cardiopulmonary resuscitation in 71 patients 
during MTH [247]. However, TNF-α levels were lowest in the MTH group with a good 
neurologic outcome and hypothermia did not influence the course of elevated TNF-α 
plasma levels. In contrast with our study, IL-6 plasma levels increased during MTH and 
were promptly reversed when patients were rewarmed.
 The results of our study also may have been influenced by the use of catecholamines 
necessary to preserve a supramaximal blood pressure. The use of catecholamines is 
associated with decreased expression of TNF-α and IL-6 and may have suppressed 
the inflammatory response and possibly resulted in an underestimation of the pro-
inflammatory effect of rewarming in our patients [290]. Our study detected a 
transient proinflammatory effect during rewarming, particularly seen as increased 
complement activation, in cardiac arrest patients treated with MTH. Nevertheless, 
because of the absence of a normothermic control group (considered unethical), we 
cannot exclude a time effect in the regular course of the inflammatory response after 
cardiac arrest.
Concluding remarks
This is the first study to demonstrate changes in cytokines, complement activity and 
markers of I/R injury during hypothermia and rewarming in patients after cardiac 
arrest. A modest increase in temperature during the late phase of MTH was associated 
with an increase in IL-6, whereas subsequent rewarming was accompanied by 
increased complement activation. The clinical importance of these changes in 
inflammatory parameters is still largely unknown and requires additional studies in 
order to determine the optimal duration of hypothermia and rewarming.
Seventy-two hours of  
mild hypothermia after cardiac arrest 
lowers the inflammatory response 
during rewarming in  
a prospective observational study
L.L.A. Bisschops, T.E. Mollnes, J.G. van der Hoeven, C.W.E. Hoedemaekers
Critical Care, (2014) 18 (5): 546
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Introduction
Induced hypothermia confers a neuroprotective effect in comatose cardiac arrest 
patients after ROSC [19, 21, 133]. Clinical and experimental studies demonstrate a 
multifactorial neuroprotective effect of hypothermia during and after an ischemic 
insult by simultaneous suppression of multiple damaging pathways [60, 291].
 The post-cardiac arrest phase is characterized by high levels of circulating cytokines 
and adhesion molecules, the presence of plasma endotoxins, and dysregulated leukocyte 
production of cytokines and complement activation. The mechanisms underlying this 
postresuscitation disease involve a whole-body ischemia and reperfusion syndrome 
that triggers a systemic inflammatory response, mimicking the immunologic and 
coagulation disorders observed in severe sepsis [40]. Although reperfusion is essential 
for ultimate tissue survival, it may exacerbate cerebral injury and thus presents a 
treatment paradox [292]. Mild hypothermia inhibits inflammation after experimental 
stroke and brain inflammation [293, 294]. Mild hypothermia for 12 -24 hours is advised 
by the ILCOR in comatose patients after cardiac arrest [295]. In a previous study we 
demonstrated that complement activation and a proinflammatory response occur 
during rewarming after 24 hours induction of mild hypothermia after cardiac arrest [196]. 
Although this study suggested a strong temporal relationship between inflammatory 
parameters and hypothermia and subsequent rewarming, as a result of the observational 
study design (normothermic control group considered unethical) it was not possible 
to establish a causal effect between temperature and inflammation. The aim of the 
present study was to analyze the effect of temperature on the inflammatory response 
after cardiac arrest. We describe the inflammatory response over time in patients 
treated with therapeutic hypothermia for an extended period of 72 hrs after cardiac 
arrest.
Materials and methods
Study population
We performed a prospective observational study in 10 comatose patients successfully 
resuscitated from an out-of-hospital cardiac arrest. Prolonged mild therapeutic 
hypothermia (MTH) (72 hrs) is a standard-of-care in our intensive care unit in 
comatose patients with ROSC after asystole, PEA or resistant ventricular fibrillation. 
The study has been carried out in the RadboudUMC, a tertiary care hospital in the 
Netherlands, after approval of the local Institutional Review Board (Commissie 
Mensgebonden Onderzoek (CMO) RadboudUMC). The CMO RadboudUMC waived 
the need for informed consent for the withdrawal of small amounts of blood for 
research purposes, because this small amount of blood withdrawn from an arterial 
catheter does not cause any discomfort or harm to the patient. All legal representa-
Abstract
Introduction Whole-body ischemia and reperfusion trigger a systemic inflammatory 
response. This study analyzed the effect of temperature on the inflammatory 
response in patients treated with prolonged mild hypothermia after cardiac arrest.
Methods Ten comatose patients with return of spontaneous circulation (ROSC) after 
PEA/asystole or prolonged ventricular fibrillation were treated with mild therapeutic 
hypothermia for 72 hours after admission to a tertiary care university hospital. On 
admission and at 12, 24, 36, 48, 72, 96 and 114 hrs  temperature was measured and 
blood samples were taken from the arterial catheter. Proinflammatory (IL-6) and anti- 
inflammatory (IL-10) cytokines and chemokines (IL-8 and monocyte chemotactic 
protein1 (MCP-1), the intercellular adhesion molecule 1 (ICAM-1), and complement 
activation products (C1rs-C1-INH, C4bc, C3bPBb, C3bc and TCC) were measured. 
Changes over time were analyzed with the repeated measures test for non-parametric 
data. The Dunn’s Multiple Comparison Test was used for comparison of individual 
time points.
Results Median temperature at the start of the study was 34.3°C (33.4-35.2) and was 
maintained between 32-34°C for 72 hrs. All patients were passively rewarmed after 
72 hrs from 33.7°C (33.1-33.9) at 72 hrs to 38.0 °C (37.5-38.1) at 114 hrs after admission 
(p<0.001). In general, the cytokines and chemokines remained stable during hypothermia 
and decreased during rewarming, whereas complement activation was suppressed 
during the whole hypothermia period and increased modestly during rewarming.
Conclusions Prolonged hypothermia possibly blunts the inflammatory response after 
rewarming in patients after cardiac arrest. Complement activation was low during the 
whole hypothermia period, indicating that complement activation is highly temperature 
sensitive also in vivo. Since inflammation is a strong mediator of secondary brain 
injury, a blunted pro-inflammatory response after rewarming may be beneficial.
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infusion therapy aiming at blood glucose levels between 6.0-8.0 mmol/l. Haemoglobin 
concentration was kept ≥ 6.0 mmol/l.
Data collection and blood sampling
Demographic and pre-hospital data were collected upon admission. Hemodynamic 
parameters, temperature and SaO2 were measured continuously. On admission and 
at every 12 hours until 114 hours after admission EDTA-anticoagulated blood samples 
were taken from the arterial catheter. Blood samples were immediately centrifuged 
for 15 min at 2000g at 4°C, and plasma was stored at -80°C until batchwise analysis. 
Measurement of cytokines, chemokines, adhesion molecules  
and complement 
Concentrations of IL-6, IL-10, IL-8, and MCP-1 were measured using a simultaneous 
Luminex Assay according to the manufacturer’s instructions (Milliplex, Millipore, 
Billerica, MA, USA). Concentrations of ICAM-1 and VCAM-1 were measured using a 
simultaneous Luminex Assay according to the manufacturer’s instructions (Bio-Rad, 
Hercules, CA, USA). The complement activation products C1rs-C1-INH complexes 
(classical pathway), C4bc (classic and lectin pathway), C3bPBb (alternative pathway), 
C3bc (common pathway) and the soluble terminal complement complex TCC) were 
measured using enzyme-linked immunosorbent assays based on monoclonal 
antibodies directed against neoepitopes of the products and performed according to 
the protocol described in detail in [296]. Values are expressed as arbitrary units per 
milliliter, related to a standard of human serum activated with zymosan, defined to 
contain 1000 arbitrary units/mL.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.0 (GraphPad 
Software. Inc. La Jolla, USA) and Microsoft Office Excel 2007. Data are presented as 
median with 25th and 75th percentile. In the figures besides median (black lines in 
boxes), interquartile range 25 and interquartile range 75 (boxes), and minimum and 
maximum (whiskers) are depicted. Changes over time were analyzed with the repeated 
measures test for non-parametric data. The Dunn’s Multiple Comparison Test was used 
for comparison of individual time points. A p value < 0.05 was considered to indicate 
statistical significance.
tives of the patients were informed about the study details. The study was performed 
under the guidelines of The National Institutes of Health and in accordance with the 
declaration of Helsinki and its later amendments. All patients 18 years or older were 
eligible for the study if they met the following criteria: 1. comatose (Glasgow Coma 
Scale ≤ 6) after ROSC; 2. ROSC after asystole, pulseless electrical activity (PEA) or 
ventricular fibrillation (VF) with prolonged (> 30 minutes) cardiopulmonary resuscitation. 
Exclusion criteria were: 1. pregnancy; 2. thrombolytic therapy; 3. Refractory cardiogenic 
shock, despite the use of vasopressor and/or inotropic agents, compromising cerebral 
blood flow, which was one of the study objectives during prolonged hypothermia 
[154]; 4. life expectancy of < 24 hrs; 5. hypoxemia defined as arterial oxygen saturation 
(SaO2) < 90%, 6. chronic renal failure (creatinin > 200 µmol/l); 7. chronic liver failure; 
8. known pre-existing neurological disease. Time between collapse and ROSC, start of 
cooling and start of the experiment was calculated based on data provided by the 
paramedic team.
Patient management
All patients were admitted to the ICU of a tertiary care university hospital in Nijmegen, 
The Netherlands. If necessary, a coronary angiogram and a percutaneous coronary 
intervention were performed before admission to the ICU. In agreement with our 
local protocol, all patients were cooled to 32-34°C by rapid infusion of 30 ml/kg 
bodyweight of cold Ringer’s lactate at 4°C followed by external cooling using two 
water-circulating blankets (Blanketroll II, Cincinatti Subzero, The Surgical Company, 
Amersfoort, The Netherlands). Temperature was measured continuously with a rectal 
temperature probe (YSI Incorporated 401, vd Putte Medical, Nieuwegein, The 
Netherlands) and maintained at 32-34°C for 72 hrs, followed by passive rewarming to 
normothermia (defined as 36.5°C). All patients were sedated with midazolam and/or 
propofol and sufentanil during hypothermia. Sedation and analgetics were stopped 
as soon as the body temperature was ≥ 36.5°C. In case of shivering, patients received 
an intravenous bolus injection of rocuronium.
 All patients were intubated and mechanically ventilated aiming at an arterial 
oxygen partial pressure (PaO2) > 75 mm Hg and arterial carbondioxide pressure 
(PaCO2) between 34 and 42 mm Hg. Alpha-stat was used for pH maintenance. The 
radial or femoral artery was cannulated for monitoring of blood pressure and 
sampling of arterial blood. A central venous catheter was inserted in the internal 
jugular vein for administration of drugs. According to our local protocol, mean arterial 
blood pressure (MAP) was maintained between 80-100 mmHg, and diuresis was 
aimed at > 0.5 ml/kg/hr. If necessary, patients were treated with volume infusion and 
dobutamine and/or (nor)epinephrine.
 Serum concentrations of sodium, potassium, magnesium and phosphate were 
maintained within the normal range. All patients were treated with continuous insulin 
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Clinical data
Median temperature at the start of the study was 34.3 (33.4-35.2)°C and was 
maintained between 32-34°C for 72 hrs. All patients were passively rewarmed after 
72 hrs from 33.7 (33.1-33.9)°C at 72 hrs to 38.0 (37.5-38.1)°C at 114 hrs after admission 
(p<0.001) (Figure 1). The median rewarming rate was 0.27 ± 0.03 (SEM) °C/hr. 
Norepinephrine was used in all patients, dobutamine was added in 7 patients. 
Administration of epinephrine was necessary in 2 patients. Median PaCO2 was 40.5 
(36.7-45.0) mm Hg upon admission and did not change significantly throughout the 
study period (p = 0.980). The median PaO2 was > 75 mm Hg throughout the study.
Cytokines and chemokines
Median IL-6 concentration at the start of the study was 118 (55-359) pg/ml, decreased 
significantly to 19.5 (8.8-83.7) pg/ml at t = 96 hrs and to 6.7 (1.7-51) pg/ml at t = 114 hrs 
(p = 0.0018) (Figure 2A). Median IL-8 concentration at the start of the study was 184 
(61-446) pg/ml, and decreased significantly to 15 (1.24-32) pg/ml at 114 hrs (p =0.0102) 
(Figure 2B). Median MCP-1 concentration at the start of the study was 2158 (724-10493) 
pg/ml, decreased significantly to 503 (310-881) at 96 hrs and to 240 (45-1166) at 114 
hrs (p = 0.0006) (Figure 2C). Median IL-10 concentration at the start of the study was 
517 (269-1796) pg/ml, decreased significantly to 8.3 (3.6-394) pg/ml at t = 72 hrs and 
to 3.7 (2.6-5.1) pg/ml at 114 hrs (p<0.001). (Figure 3). There were no differences in 
cytokine and chemokine concentrations between survivors and non-survivors (data 
not shown).
Results
Population
We studied 10 comatose patients successfully resuscitated from an out-of hospital 
cardiac arrest. Data on cerebral blood flow and cerebral oxygen extraction in this 
cohort of patients have been published previously [11]. Demographic data and patient 
characteristics are shown in Table 1. The primary rhythm was asystole in 4 patients, 
ventricular fibrillation in 4 patients and PEA in 2 patients. Six patients died in the ICU: 
3 patients because of circulatory failure during rewarming and 2 patients because of 
severe postanoxic brain damage. One patient, admitted to the ICU after PEA, regained 
consciousness, but active treatment was withdrawn because of pre-existing severe 
chronic respiratory failure. None of the patients died during the 72 hr period of cooling.
Table 1  Demographic data
Male, no. (%) 9 (90%)
Age yrs 66.0 (62.3-72.8)
Body mass index, kg/m2 26.0 (25.0-26.0)
Time between collapse and ROSC, mins 30.0 (25.0-33.8)
Time between collapse and start cooling, mins 120 (120-155)
Time between collapse and start study, mins 180 (150-200)
SAPS 2 72.5 (68.5-77.8)
APACHE II 30.0 (27.5-33.8)
pH upon arrival at the ED 7.15 (6.93-7.23)
BE upon arrival at the ED, mmol/l -13.4 (-17.1- -8.1)
Lactate upon arrival at the ED, mmol/l 9.8 (5.6-13.0)
PaCO2 upon arrival at the ED, mm Hg 40.5 (36.71-45.0)
Patients died, no (%) 6 (60%)
ROSC, return of spontaneous circulation; SAPS, Simplified Acute Physiology Score; APACHE II, Acute 
Physiology and Chronic Health Evaluation II; ED, emergency department. 
Data are expressed as median values (IQR)
Figure 1   Temperature changes over time
Values represent median (black lines in boxes), IQR 25 and IQR 75 (boxes), and minimum and maximum 
(whiskers). ICU, intensive care unit.
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Adhesion molecules
Median ICAM-1 concentration increased significantly from 130 (108-162) ng/ml at t = 
0 hrs to 237 (167-370) ng/ml at t = 72 hrs and 175 (137-265) at 114 hrs (p < 0.0166) 
(Figure 4). Median VCAM-1 concentration was 170 (156-196) ng/ml at admission and 
decreased significantly from 228 (174-262) ng/ml at 48 hrs to 147 (130-177) ng/ml at 72 
hrs and remained stable during the rest of the observation period (p = 0.001) (data 
not shown). There were no differences in adhesion molecule concentrations ICAM-1 
and VCAM-1 between survivors and non-survivors (data not shown).
Figure 2   The proinflammatory cytokine interleukin IL-6 (A) and the chemokines IL-8 
(B) and MCP-1 (C) during hypothermia (0-72 hrs) and after rewarming 
(72-114 hrs) in 10 patients after cardiac arrest
Figure 2A
Figure 2B
Figure 2C
Values represent median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), 
and minimum and maximum (whiskers).* indicates statistical significance compared to t=0.
ICU, intensive care unit, hrs, hours, MCP-1 monocyte chemotactic protein-1.
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Figure 3   The anti-inflammatory cytokine interleukin IL-10 during hypothermia  
(0-72 hrs) and after rewarming (72-114 hrs) in 10 patients after cardiac 
arrest
Values represent median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), 
and minimum and maximum (whiskers). * indicates statistical significance compared to t=0.
ICU, intensive care unit, hrs, hours
Figure 4   The intercellular adhesion molecule ICAM-1 during hypothermia (0-72 hrs) 
and after rewarming (72-114 hrs) in 10 patients after cardiac arrest
Values represent median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), 
and minimum and maximum (whiskers). * indicates statistical significance compared to t=0.
ICU, intensive care unit, hrs, hours.
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treatment with MTH complement activation was low during the whole MTH period. 
These results indicate that hypothermia may have a significant impact on important 
markers of ischemia/reperfusion injury in patients after cardiac arrest.
 The proinflammatory cytokine IL-6 remained stable during 72 hrs of MTH and 
decreased after rewarming. This finding is in contrast to the rise of IL-6 during 
rewarming after 24 hrs of hypothermia [196]. The proinflammatory chemokines IL-8 
and MCP-1, and the anti-inflammatory cytokine IL-10, also decreased during 72 hrs of 
MTH and rewarming. These data suggest that a proinflammatory effect of rewarming 
is mitigated after prolonged hypothermia. Currently only a small number of studies 
measuring inflammatory mediators during hypothermia and rewarming exist with 
conflicting results and in different types of acute brain injury, possibly with similar 
pathophysiogical basis [297].
 Mild therapeutic hypothermia resulted in decreased mRNA expression of typical 
cerebral inflammatory mediators (IL-1β, IL-6, IL-10, TNFα, and ICAM-1) after 
experimental ventricular fibrillation in pigs [240]. However, in a clinical study Fries et 
al. demonstrated significantly increased systemic IL-6 levels [247]. Altogether, these 
studies focus on the inflammatory response during hypothermia, not during 
rewarming. The proinflammatory response of rewarming has been described in a 
number of animal models and in patients with traumatic brain injury Hypothermia 
and subsequent rewarming was studied in a murine model of trauma, hemorrhage 
and subsequent fracture fixation [281]. Rewarming before fracture stabilization was 
associated with a more pronounced IL-6 and MCP-1 increase without affecting the 
anti-inflammatory response. In a rat model of mild hypothermia and haemorrhagic 
shock rewarming resulted in higher synthesis of reactive oxygen species from 
peritoneal phagocytes, and increased circulating levels of nitric oxide, with no effects 
on the pro- or anti-inflammatory cytokine production [282]. Hypothermia decreased 
IL-6 concentrations in patients after severe traumatic brain injury, similar to the 
results found in our study [271]. Rewarming brain injured patients after 4-9 days of 
hypothermia resulted in a further decrease in IL-6 in patients whose clinical course 
improved. In contrast, rewarming increased IL-6 concentrations in patients with a 
poor outcome. This differential response of IL-6 to rewarming in patients with a poor 
or favorable outcome could not be determined in our cohort of patients, probably 
due to the small number of patients or the different underlying pathophysiology 
(brain death versus heart arrest). 
 A number of mechanisms may explain the blunted pro-inflammatory response 
on rewarming after prolonged hypothermia. Hypothermia has been reported to 
decrease both the leukocyte count and function, and prolonged hypothermia has 
been linked to a sustained impairment of the neutrophil function. In vitro, neutrophil 
and monocyte chemotaxis, migration, phagocytosis, and oxidative metabolism were 
markedly reduced at 29°C versus 37°C. In vivo, neutrophil oxidative function is 
Complement activation products
Median C1rs-C1-INH concentration was 9.8 (7.0-11) AU/ml on admission, decreased to 
7.2 (5.0-12) AU/ml at t = 72 hrs followed by a significant increase during rewarming to 
9.4 (7.4-17) AU/ml at 114 hrs (p =0.0283). Median C4bc concentration decreased from 
14 (9.3-66) AU/ml at the start of the study to 8.5 (7.1-19) AU/ml at t = 72 hrs, followed 
by a non-significant increase to 11 (8.4-20) (p =0.6361). Median C3bPBb concentration 
decreased significantly from 97 (32-136) AU/ml on admission to 23 (15-94) and 17 
(15-39) AU/ml at 72 and 114 hrs (p = 0.0179). C3bc decreased by a trend from 36 (11-89) 
AU/ml on admission to 9.1 (5.0-51) AU/ml and 8.3 (6.3-15) AU/ml at 72 and 114 hrs (p = 
0.0619). The end product TCC was 1.3 (0.9-5.1) AU/ml at admission, decreased 
significantly during hypothermia to 0.5 (0.4-0.7) AU/ml at 72 hrs and increased 
significantly during rewarming to 1.1 (0.7-1.6) AU/ml at 114 hrs (p <0.001) (Figure 5). 
There were no differences in concentrations of the complement products between 
survivors and non-survivors (data not shown). 
 Comparison with the results of our previous study describing complement 
activation and the proinflammatory response during rewarming after 24 hours of 
MTH was not possible as a result of different patient characteristics [196].
Discussion
This study demonstrates that hypothermia may affect the inflammatory response 
after cardiac arrest in 2 ways. Firstly, after prolonged hypothermia the pro-inflamma-
tory cytokine activation during rewarming was absent. Secondly, during prolonged 
Figure 5   Terminal complement complex (TCC, terminal pathway) during 
hypothermia (0-72 hrs) and after rewarming (72-114 hrs) in 10 patients 
after cardiac arrest
Values represent median (black lines in boxes), interquartile range 25 and interquartile range 75 (boxes), 
and minimum and maximum (whiskers). * indicates statistical significance compared to t=0. # indicates 
statistical significance compared to t = 72 hrs. ICU, intensive care unit, hrs, hours.
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cytokines, chemokines and other proteins. It also suggests a variable inflammatory 
profile among the 10 included patients. This could be related to heterogeneity in 
genetic factors of the immune system and/or the variation in duration until ROSC. A 
longer duration of the resuscitation leads to more ischemia-reperfusion damage with 
subsequent stronger immunological response. The different pathophysiological 
mechanisms leading to the arrest of circulation (PEA,VF/VT, asystole) could also play 
a confounding role, affecting the inflammatory response. However, we found no 
differences in the immune response between different primary rhythms.
 We describe several strong temporal relationships between activation of the 
innate immune system and hypothermia and rewarming. The study design (a 
longitudinal observational study without control group) prohibits definite conclusions 
about the causal relationship between temperature and activation of the innate 
immune response after cardiac arrest. We included patients with a non-shockable 
primary rhythm or prolonged cardiac arrest. These patients had a stronger ischemia/
reperfusion response compared to our previous study that included only patients 
after out-of-hospital ventricular fibrillation, reflected by higher SAPS-2, APACHE-II 
score, and lactate levels on admission [143]. This more severe ischemia/reperfusion 
reaction induced a stronger inflammatory reaction. This difference in patient charac-
teristics complicates a (quantitative) comparison between 24 and 72 hours of MTH. 
Vasopressors are frequently used in patients after cardiac arrest to improve the 
(cerebral) perfusion pressure and avoid secondary ischemic injury. Norepinephrine is 
the main neurotransmitter of the central nervous system and can alter lymphoid 
functions. β-adrenergic receptors are present on lymphoid cells, and the stimulation 
of these receptors can affect the immune response. Norepinephrine increases the 
production of both pro- and anti-inflammatory cytokines, and may shift the cytokines 
towards a more anti-inflammatory profile [252, 253]. The use of catecholamines may 
have influenced the results of our study by suppressing the inflammatory response 
resulting in an underestimation of the inflammatory response during rewarming. 
Conclusion
Prolonged hypothermia may blunt the inflammatory response after rewarming in 
patients after cardiac arrest. Complement activation was low during the whole 
hypothermia period, indicating that complement activation is highly temperature 
sensitive also in vivo. As inflammation is a strong mediator of secondary brain injury, 
a blunted pro-inflammatory response after rewarming may be beneficial. Further 
research is required to explore the benefits of MTH with regard to the optimal 
duration of MTH and the optimal timing and rate of rewarming.
impaired at 33°C [298]. Alternatively, we hypothesize that simultaneous with the 
proinflammatory response, an anti-inflammatory response is mounted, presumably 
to curtail inflammation and prevent collateral tissue damage. This anti-inflammatory 
response may be comparable to the immunoparalysis effect seen in septic patients 
[263]. Reduced monocyte and leukocyte activity may thus result in failure to induce a 
pro-inflammatory reaction at day 3 after cardiac arrest.
 ICAM-1 is an endothelial adhesion molecule of the immunoglobulin gene 
superfamily and is involved in the cascade of leukocyte rolling on the activated 
endothelial blood vessel walls, neutrophil activation, adherence to endothelial cells, 
and transmigration into the interstitium. Our present study confirms that ischemia/
reperfusion such as found in cardiac arrest survivors induces ICAM-1 concentrations 
in both humans and laboratory animals [41, 196, 242, 272, 280, 299]. We previously 
measured a significant increase in plasma ICAM-1 during a modest increase in 
temperature during rewarming after 24 hrs of MTH [196]. However, after 72 hrs of 
MTH no subsequent increase of ICAM-1 was measured during rewarming, suggesting 
a blunted inflammatory response during prolonged hypothermia. This suppressed 
ICAM-1 production is most likely the result of hypothermia mediated decreased 
ICAM-1 production at the transcriptional level [293, 294, 300]. As ICAM-1 expression 
is enhanced by pro-inflammatory cytokines, the production of ICAM-1 will be further 
reduced in the patients by the fact that proinflammatory stimulation of ICAM-1 is 
diminished during hypothermia.
 Complement is an important component of the innate immune system and a key 
player in ischemia/reperfusion injury [292, 301]. Böttiger et al. demonstrated 
significant systemic increase in the complement activation products C3a and SC5b-9 
(TCC) during resuscitation and early reperfusion in human adults, returning to 
baseline levels within 48 hrs after return of spontaneous circulation [280]. 
Complement activation is largely temperature dependent in vitro. The slow ongoing 
spontaneous hydrolysis of the alternative pathway is efficiently inhibited by lowering 
the temperature. This would also be the case in vivo. Thus, during hypothermia the 
concentration of activation products was reduced, including TCC, the terminal 
component of complement activation. Rewarming after 72 hours resulted in a 
reactivation of the complement system with increased TCC concentrations and 
certain other activation products. Based on our results, prolonged hypothermia 
seemed to suppress complement activation during the whole hypothermia period. 
The increased complement activity seen during rewarming is most likely caused by 
the increase in temperature per se. A possible additional effect induced by circulatory 
molecules activating the system cannot be excluded, but this activation was not 
accompanied by an inflammatory response as discussed above for the cytokines.
 The present study has several limitations. The number of studied patients is 
small. This possibly contributes to the wide range in concentration of various 
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General discussion, conclusions, and future perspectives
Patients resuscitated from a cardiac arrest have a high in-hospital mortality rate [5, 
302]. Two clinical trials published in 2002 showed beneficial effects of 12-24 hours of 
mild therapeutic hypothermia (MTH) in patients with a cardiac arrest due to 
ventricular tachycardia/ventricular fibrillation (VT/VF). Hypothermia compared to no 
temperature control resulted in improved neurological outcome and better survival 
[20, 21]. Since then, mild therapeutic hypothermia (MTH) has been adopted as an 
important part of the standard of care in many countries [24]. Recently, a multicenter 
clinical trial including 939 cardiac arrest survivors, showed that hypothermia at a 
targeted temperature of 33°C did not confer a benefit as compared with a targeted 
temperature of 36°C [58]. 
 Since 2002 a notorious increase in the number of scientific publications regarding 
hypothermia related to cardiac arrest can be observed (Figure 1). 
Although targeted temperature management is widely recognized as a useful 
therapeutic strategy, many fundamental questions including the mechanisms of 
action and the most appropriate method to induce hypothermia and rewarming 
remain to be solved. The traditional idea that the protective effect of hypothermia is 
merely based on lowering of the (cerebral) metabolism with subsequent decreased 
need of glucose and oxygen has been abandoned in the last decade. Instead, hypo- 
thermia may mitigate brain damage through a multitude of protective mechanisms 
[60].
 In this thesis we studied the effects of hypothermia (and subsequent rewarming) 
on the cerebral metabolism and blood flow (section I) and on the inflammatory 
response (section II) in patients treated after a cardiac arrest.
Figure 1   Number of publications in PubMed: 'hypothermia' AND 'cardiac arrest'
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studies measured jugular bulb oxygenation generally was normal/above the ischemic 
threshold of 55%. Therefore, assuming CMRO2 was normal, this suggests a preserved 
metabolic coupling under both normothermic and hypothermic conditions. Because 
CMRO2 was normal under all conditions, these results suggest that hypothermia 
induces a strong reduction in brain metabolic activity compared to normothermia. 
Induction of hypothermia for 72 hours resulted in a gradual increase of CBF during 
cooling towards normal values, with no significant further increase after rewarming. 
Temperature by itself is probably not a major determinant in restoration of CBF 
towards normal values. When comparing our data with those from normothermic 
cardiac arrest survivors, MTH seemed to delay the restoration of CBF towards normal 
values, possibly by decreasing the metabolic demand of the brain. The prolonged 
treatment with hypothermia may have further decelerated the restoration of the 
MFVMCA to normal values, since CBF at 24 and 48 hours after admission in the 72 
hours cooling cohort was lower compared to the study in patients that were cooled 
for 24 hours. However, when comparing these studies it is important to realize that 
the two study groups were not homogeneous.
 The optimal duration of the application of MTH is unknown. Animal experiments 
resulted in conflicting data with regard to the optimal duration of cooling. Longer 
duration of MTH led to increased survival of neurons in an animal model of forebrain 
ischemia [185, 186]. However, survival, post-resuscitation microcirculation, myocardial 
and cerebral functions were better in a rat model of cardiopulmonary resuscitation 
with rapidly induced hypothermia early after ROSC in comparison with prolonged 
MTH [189]. Most studies and case series of patients have reported 24-48 hours of 
hypothermia [20, 59]. The TTM-trial commenced gradual rewarming after 28 hours of 
MTH [58]. The effect of prolonged MTH has only been studied in newborns, reporting 
a clinically important reduction in the composite outcome of death and neurodevel-
opmental disability in survivors of peripartum asphyxia without any safety concerns 
regarding the duration of the MTH [187]. A prolonged decrease in cerebral metabolism 
as seen during prolonged hypothermia might contribute to an augmented neuro-
protective effect of MTH. We demonstrated that hypothermia for a longer period 
than 24 hours is safe. New prospective randomized controlled trials are needed to 
assess the optimal duration of mild therapeutic hypothermia or controlled 
normothermia in cardiac arrest survivors. 
CO2 is a very potent cerebral vasodilator. Hypocapnia possibly aggravates neurological 
damage by inducing cerebral vasoconstriction and decreasing CBF. Hypercapnia and 
hypocapnia cause a 3-5% increase and a 2-3% decrease respectively of CBF per mm 
Hg change in CO2 [304, 305]. Previously Buunk et al. described that in normothermic 
comatose patients after cardiac arrest CO2 reactivity is preserved [29]. In chapter 3 
we demonstrated that the cerebrovascular reactivity to changes in CO2 remains 
Section I: cerebral metabolism and blood flow
Chapter 2 reviews the current literature regarding cerebral blood flow after cardiac 
arrest. Crucial in the ICU treatment is creating an optimal environment for cerebral 
recovery and limiting the secondary brain damage occurring during the post-cardiac 
arrest syndrome. The brain has a high metabolic demand (approximately 20% of total 
body oxygen consumption). The severity of neurologic dysfunction after cardiac 
arrest strongly depends on the recovery of cerebral blood flow (CBF), providing 
oxygen and glucose to the brain. Under normal circumstances the vascular bed of the 
brain maintains the cerebral perfusion at a constant level. Brain perfusion is tightly 
coupled to neuronal activity. The CBF is dependent on cardiac output and intracranial 
pressure (jugular venous pressure), but is mainly controlled by the brain itself through 
metabolic activity, pressure autoregulation, and cerebrovascular reactivity to CO2. 
Unfortunately, ROSC does not automatically restore normal cerebral circulation. 
From the clinical perspective the multifocal no-reflow phase and the delayed 
hypoperfusion phase are the most relevant because CBF is disturbed in both phases, 
and possibly open for therapeutic interventions. The multifocal no-reflow phase and 
the delayed hypoperfusion phase occur in the first 24 hours, when controlled 
hypothermia is applied (at least in the delayed hypoperfusion phase).
In chapters 3 and 4 we described the effect of 24 hours and 72 hours of hypothermia 
on the cerebral blood flow and metabolic coupling after cardiac arrest. Previously, 
under normothermic conditions, cerebral blood flow was initially low and gradually 
increased during the first 24 hours. This was accompanied by a normal cerebral 
oxygen extraction ratio, indicating a normal coupling between CBF and metabolism 
[95]. In the studies by Buunk and both our studies cerebral blood flow velocity in the 
middle cerebral artery was comparable on admission (Buunk 29 ± 10 cm/sec, 24 
hours hypothermia group 25 (19-37) cm/sec and 72 hours hypothermia group 30 
(25-35) cm/sec). This low flow state early after the arrest is a typical feature of the 
delayed global hypoperfusion phase of the post-cardiac arrest syndrome and is partly 
explained by an increase in cerebrovascular resistance due to a disbalance in the local 
production of endothelin and cyclic guanosine monophosphate. Other pathological 
processes that contribute to this reduced blood flow include a reduction in neuronal 
activity, vasospasm, edema, platelet and leukocyte adhesion, and changes in viscosity 
[26, 94, 95, 101, 303]. 
 Normal mean middle cerebral artery flow velocities vary from 41 ± 7 to 94 ± 10 
cm/sec [177]. In normothermic patients the CBF reached the lower limit of normal 
MFVMCA at T = 6 hrs (42 ± 6,8 cm/sec), whereas under hypothermic conditions 
MFVMCA was reached at T = 24 hrs (53 (50-78) cm/sec), suggesting that hypothermia 
delays the restoration of normal blood flow velocities after cardiac arrest. In all 3 
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the currently recommended target MAP of ≥ 65 mm Hg or SBP > 90 mm Hg to sustain 
an adequate cerebral perfusion pressure [2, 57].The optimal blood pressure for the 
post-cardiac arrest period remains to be determined in (hypothermic) patients, but 
presumably is different for each individual, depending on the level of cerebral 
damage, level of autoregulation and pre-existing blood pressure. 
 Transcranial Doppler ultrasonography is a noninvasive and easy to use method to 
measure cerebral blood flow velocities in one of the supplying arteries of the brain 
[176]. The most commonly used artery is the middle cerebral artery (MCA). The flow 
in the MCA is determined by both the velocity (cm s-1) in the MCA and by its diameter. 
Under the condition that the diameter of the insonated cerebral blood vessel remains 
constant, changes in flow velocity correspond with changes in CBF in the same vessel. 
In healthy subjects and in (neuro)surgical patients the diameter of the MCA did not 
change during alterations in blood pressure [179, 310]. However, especially in the 
post-cardiac arrest brain TCD data remain difficult to interpret since measurements 
of blood flow velocity bear no direct relationship to those of blood flow. Pulsatility is a 
measure of waveform shape and is diminished by a decrease in downstream resistance 
[311]. In chapter 3 we demonstrated that the pulsatility index was stable during hypo- 
thermia (delayed hypoperfusion phase) and decreased during rewarming respectively. 
Overestimation of CBF by changes in vascular diameter therefore seems unlikely.
Whole blood viscosity is a determinant of both macrovascular and microvascular 
cerebral resistance and influences CBF. The relationship between perfusion pressure 
and blood flow is partly determined by blood viscosity. Viscosity decreases as the 
shear rate (SR), determined by blood flow velocity and vessel diameter, increases. 
This phenomenon is characteristic for non-Newtonian fluids, such as blood [126, 127]. 
The rheological properties of blood depend on hematocrit and plasma constituents 
[195]. In chapter 5 we described the course of the viscosity and CBF in hypothermic 
cardiac arrest patients. In cardiac arrest patients we measured the highest viscosity 
in the first hours after cardiac arrest. Viscosity gradually decreased over the following 
days. A negative correlation between blood viscosity and the CBF was demonstrated, 
suggesting that CBF in the early phase after cardiac arrest may be hampered by a 
relatively high blood viscosity.
 The influence of viscosity on CBF in vivo is influenced by a number of (compensatory) 
mechanisms. Changes in blood viscosity in vivo can induce changes in arteriolar 
diameter. These active changes in arteriolar diameter have been referred to as 
“viscosity autoregulation”. It is unknown if this viscosity autoregulation is disturbed 
under pathologic conditions, such as the postcardiac arrest syndrome. We found 
some variation in the effect of viscosity on CBF between different subjects. We 
speculate that this variation may be related to differences in the level of the viscosity 
autoregulation.
preserved under induced mild hypothermic conditions. We measured a mean 
percentage change in MFV of 3.6% per mm Hg. This percentage corresponds with the 
observed changes in healthy subjects and in (normothermic) patients with moderate 
or severe head injury [183, 184, 304, 305].
 Because cerebrovascular reactivity to changes in PaCO2 is preserved in 
(hypothermic) cardiac arrest survivors, hypocapnia aggravates cerebral ischemia due to 
vasoconstriction [29, 143]. Despite existing (post-) resuscitation guidelines Falkenbach et al. 
observed that unintentional dyscarbia is a common finding in post-cardiac arrest 
ICU-patients (incidence 55%), although normocapnia was considered to be the target 
of ventilatory management [2, 30, 31]. Compared with normocapnia, hypocapnia was 
independently associated with worse clinical outcomes and hypercapnia had a 
greater likelihood of discharge home among survivors [31]. In our study we 
demonstrated that hyperventilation decreased jugular bulb oxygen saturation, 
suggestive of cerebral ischemia. Similar results were found by Pynnönen et al [306]. 
Despite jugular bulb oxygen saturation < 55%, indicative of cerebral ischemia, this 
decreased jugular bulb oxygen saturation was not associated with low cerebral 
oxygen saturation measured using NIRS. Concomitantly, no systematic change in 
local cerebral tissue partial tension of oxygen occurred and no signs of cerebral 
metabolic stress were detected by cerebral microdialysis. This discrepancy between 
jugular bulb oxygen saturation and other measures of cerebral ischemia may be 
related to the fact that the intervention was limited to 60 min for safety reasons. 
Alternatively, reduced cerebral perfusion may be more pronounced in deeper cerebral 
structures such as hippocampus, corpus striatum and thalamus, and therefore 
undetectable for the techniques used.
 Mild hypothermia results in a decrease in systemic oxygen consumption, reducing 
the resting energy expenditure and thereby the CO2 production [307, 308]. In 
addition, the solubility of the CO2 increases, additionally lowering the PaCO2. It is 
questionable if this additional effect is clinically relevant at a temperature of 32-34 °C 
[309]. Taken together, these results strongly indicate that excessive mechanical 
ventilation should be avoided in postresuscitation patients. 
Of the three main regulating mechanisms of CBF we described the metabolic coupling 
and cerebrovascular reactivity to carbondioxide in hypothermic patients in chapters 
3 and 4. With regard to the third mechanism, the pressure autoregulation, Sundgreen 
et al. investigated CBF autoregulation during the delayed hypoperfusion phase with 
transcranial Doppler during a norepinephrine induced rise of the MAP [63]. An 
important conclusion was that in a majority of patients CBF autoregulation was 
abnormal or absent. The conclusion that autoregulation is lost in a majority of cardiac 
arrest patients emphasizes the significance of the otherwise preserved mechanisms 
regulating CBF. In our study we pursued a MAP of 80-100 mm Hg, which is higher than 
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local cerebral inflammatory response. Cytokines can have direct and indirect actions 
on the brain after cardiac arrest. Cytokines can be produced in the brain mainly by 
microglial cells and astrocytes and directly contribute to the normal autonomic, 
neuroendocrine and metabolic homeostasis in the normal brain [237]. Under ischemic 
conditions, cerebral cytokine production increases and contributes to the 
inflammatory cascade after cardiac arrest.
 So far, the effect of MTH on the inflammatory response after cardiac arrest has 
resulted in conflicting data [240, 247, 272]. In chapter 7 we described the inflammatory 
balance in cardiac arrest patients during 24 hours of MTH and rewarming. Mild 
hypothermia inhibits inflammation after experimental stroke and brain inflammation 
[318]. In our study a modest increase in temperature during the late phase of MTH 
was associated with an increase in IL-6, and subsequent rewarming was accompanied 
by increased complement activation. Remarkably, although a growing evidence for 
an compartimentalized cerebral inflammatory response exists, we did not find a 
significant difference between samples taken from the arterial and jugular bulb 
catheter of any (inflammatory) biomarker. A possible explanation for this finding is 
the strong systemic inflammatory response, overwhelming the isolated cerebral 
response.
 In patients treated with MTH for 24 hours we showed complement activation 
and a proinflammatory upsurge during rewarming. The complex inflammatory 
response after cardiac arrest is initiated by the ischemia-reperfusion response and 
participates in development of (secondary) organ damage and initiation of repair. The 
exact course in time of these processes is unknown, but the duration probably 
exceeds the 24 hour period of MTH. This upsurge of complement activation and 
inflammation raises new questions about the duration of MTH and could be helpful in 
titrating the rate and mode (active vs. passive) of rewarming. Because of the absence 
of a normothermic control group it is not possible to differentiate between a possible 
time effect or an effect directly related to the (change in) temperature. To compare 
the course of inflammatory parameters after 24 hours of MTH, Chapter 8 describes 
the effect of prolonged hypothermia and rewarming on the inflammatory response 
after cardiac arrest. In this study cardiac arrest patients were treated with MTH for an 
extended period of 72 hours, instead of 24 hours. During this prolonged hypothermia 
period complement activation was suppressed. Furthermore, the proinflammatory 
cytokine IL-6 decreased during 72 hours of MTH and remained low during rewarming. 
The anti-inflammatory cytokine IL-10 also decreased during prolonged hypothermia 
and rewarming. These data suggest that a proinflammatory effect of rewarming is 
mitigated after 72 hours of MTH. A number of mechanisms may explain the blunted 
proinflammatory response on rewarming after prolonged hypothermia, including 
decreased leukocyte count and function. ICAM-1 is an endothelial adhesion molecule 
of the immunoglobulin gene superfamily and is involved in the cascade of leukocyte 
 Under ischemic conditions with already maximal cerebral vasodilation, blood 
viscosity probably is an important factor determining CBF [132]. From this point of 
view it is important to determine the optimal viscosity, or hematocrit, to optimize 
cerebral blood flow after cardiac arrest.  In the complex post-cardiac arrest ICU-setting 
the hematocrit is a parameter which is relatively easy to control by hemodilution or 
blood transfusion. The hematocrit level is an essential determinant of both viscosity 
and oxygen delivery. A higher hemoglobin (Hb) level at the time of hospital arrival was 
associated with a favorable short-term neurologic outcome among post-cardiac 
arrest patients with a presumed cardiac etiology [312]. Reduced Hb-levels result in 
the up-regulation of nitric-oxide production and subsequent cerebral vasodilatation, 
possibly improving CBF [313]. It is important to determine the optimal viscosity, or 
hematocrit, to optimize cerebral blood flow and to support cerebral recovery after 
cardiac arrest in relation to the optimal oxygen delivery and dissociation to the brain, 
the compromised myocardium and other vital organs.
Conclusion
Cerebral blood flow is reduced after cardiac arrest, most likely due to a decrease in 
cerebral metabolism. Hypothermia further decreases CBF, but is not a major 
determinant of CBF in the therapeutic range after cardiac arrest. Both PaCO2 and 
viscosity are important regulators and must be considered when treating these 
patients in the ICU during the post-cardiac arrest syndrome.
Section II: the inflammatory response after cardiac arrest
Chapter 6 reviews the current literature regarding the systemic inflammatory 
response during the post-cardiac arrest phase. Cardiac arrest results in ischemia/
reperfusion injury activating a strong inflammatory cascade with activation of the 
innate and adaptive immune system, endothelial cells, complement system, cell 
death mechanisms and coagulation cascades. Activation of this inflammatory 
response serves as a defense against cell injury, and initiates repair mechanisms but 
may by itself also contribute to secondary (brain) injury. The systemic inflammation 
after cardiac arrest is associated with increased morbidity and mortality [38, 314] and 
increases the risk of multiple organ failure and infection [315-317]. The whole body 
ischemia and reperfusion syndrome with systemic activation of the innate immune 
system after cardiac arrest was referred to as a ‘sepsis-like’ syndrome by Adrie et al 
[39, 40]. Treatment strategies in the ICU are directed towards prevention of secondary 
injury in post-cardiac arrest patients. The ICU treatment includes therapies that 
influence this immune response, such as temperature management and use of 
vasopressors. Besides a systemic inflammatory reaction, cardiac arrest induces a 
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brain, we demonstrated that hypothermia for a longer period than 24 hours also is a 
safe therapy.
 Cerebrovascular reactivity to changes in CO2 remains preserved under induced 
mild hypothermic conditions. In our study changes in PaCO2 correlated well with 
changes in SjbO2. Hypocapnia possibly aggravates neurological damage by inducing 
cerebral vasoconstriction, decreasing CBF. Compared with normocapnia, hypocapnia 
is associated with worse clinical outcomes. Thus excessive mechanical ventilation 
should be avoided in (hypothermic) postresuscitation patients. In the present 
ICU-setting monitoring of CO2 levels can be easily performed, at low costs and little 
efforts. If dyscarbia is measured during regular monitoring of arterial blood gas 
values, this should be followed by adjustment of ventilator settings as soon as 
possible.
 In the first hours after cardiac arrest blood viscosity is highest and gradually 
decreasing over the following days. A negative correlation between blood viscosity 
and the MFVMCA was demonstrated, suggesting that CBF in the early phase after 
cardiac arrest may be hampered by a relatively high blood viscosity. So far, the 
optimal goal for Hb in post-cardiac arrest patients has not been defined. A lower 
hematocrit results in lower viscosity, impoving CBF, but also reducing the oxgyen 
carrying capacity of the cerebral blood. In patients with a closed head injury no 
difference in mortality was found when Hb was maintained at 10-12 g/dL in comparison 
with 7-9 g/dL [319]. For the future it is important to determine the optimal viscosity, 
or hematocrit, to optimize cerebral blood flow and to support cerebral recovery after 
cardiac arrest. Hematocrit is easy to measure and can be easily controlled in the ICU. 
This optimum should be determined in coherence with the (disturbed) myocardial 
oxygen consumption and peripheral tissue dissociation.
 The complement activation and the proinflammatory response during rewarming 
after 24 hours of MTH raises new questions about the optimal duration of MTH, and 
could be helpful in titrating the rate and mode (active vs. passive) of rewarming. 
Prolonged application of MTH suppresses complement activation and mitigates the 
possible proinflammatory effect of rewarming. This finding could be useful in 
determining the optimal duration of targeted temperature management in cardiac 
arrest patients in future studies. The mitigated proinflammatory effect of rewarming 
is either a temporal effect or the result of a possible ‘therapeutic’ temperature effect 
of the (prolonged) hypothermia that was applied in the prolonged hypothermia 
study. Although it is not clear whether this effect is directly related to temperature, 
or the application of MTH, versus the moment of time within the post-cardiac arrest 
syndrome the rewarming takes place, we strongly believe that the exact timing of 
careful rewarming seems crucial in avoiding additional ischemia-reperfusion damage.
rolling on the activated endothelial blood vessel walls, neutrophil activation, 
adherence to endothelial cells, and transmigration into the interstitium. Prolonged 
treatment with MTH blunted the increase of ICAM-1 during rewarming, as was seen 
after 24 hours of cooling. Because ICAM-1 expression is enhanced by proinflammato-
ry cytokines, the production of ICAM-1 will be further reduced by the fact that proin-
flammatory stimulation of ICAM-1 is diminished during hypothermia.
 Complement is an important component of the innate immune system and 
strongly temperature dependent in vitro. Hypothermia reduced the concentration of 
activation products, including the terminal component of complement activation. 
Rewarming after 72 hours resulted in a reactivation of the complement system. Based 
on our results, prolonged hypothermia seemed to suppress complement activation 
during the whole hypothermia period. Because the complement system is highly 
temperature dependent, the increased complement activity seen during rewarming 
is most likely caused by the increase in temperature per se.
Conclusions, practical considerations, 
and future perspectives
The optimal mean arterial pressure for post-cardiac arrest patients has not been 
defined by prospective trials [2]. The postanoxic brain needs an adequate perfusion 
pressure to overcome the potential no-reflow phenomenon and cerebral 
microvascular dysfunction. At the same time, relative hypertension should not 
unnecessarily stress the (post-) ischemic myocardium. Heterogenous loss of cerebro-
vascular autoregulation, raised intracranial pressure and many other pathophysiolog-
ical processes occurring in the brain after cardiac arrest on the one hand and possibly 
severe myocardial dysfunction on the other hand lead to the conclusion that the 
optimal MAP after cardiac arrest probably is based on individual features. In the 
future additional research is needed to determine this optimum in relation to the 
individual level of autoregulation.
 In normothermic comatose patients after cardiac arrest the metabolic coupling 
remains intact. It is an important finding that, although mild hypothermia results in 
lower CBF, the cerebral oxygenation is not affected by controlled hypothermia, 
probably due to a lowered brain metabolism, which avoids hypothermia induced 
ischemia (resulting in potential additional secondary brain damage). Thus with regard 
to the metabolic coupling mild therapeutic hypothermia can be considered a safe 
therapy from the brain perspective in the first 24 hours after cardiac arrest. During 
prolonged MTH a reduction in cerebral metabolic activity was observed, contributing 
to a prolonged neuroprotective effect during and after the delayed hypoperfusion 
phase during the post-cardiac arrest syndrome. Again from the perspective of the 
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Ook na een geslaagde reanimatie is de kans op overlijden groot, ondanks de voor- 
uitgang die gedurende de laatste decennia op dit terrein van de geneeskunde is 
geboekt. De in 2002 gepubliceerde trials waarin comateuze patiënten na reanimatie 
gekoeld werden bij opname op de afdeling intensive care tonen een verbeterde 
neurologische uitkomst en overleving in de gekoelde groep patiënten in vergelijking 
met de groep die de standaardbehandeling (niet gecontroleerde normothermie) 
onderging. Vanaf dat moment maakt milde therapeutische hypothermie deel uit van 
de standaardbehandeling van een gereanimeerde en comateuze patiënt op de afdeling 
intensive care.
 De wetenschappelijke aandacht voor therapeutische hypothermie laat in het 
laatste decennium een exponentiële toename zien van het aantal publicaties op dat 
gebied. Ondanks een recente multicenter klinische studie, die na reanimatie geen 
overlevingsvoordeel van milde hypothermie (33˚C) in vergelijking met strikte normo - 
thermie (36˚C) toont, wordt de toepassing van hypothermie gezien als een zinvolle 
therapeutische strategie. Desalniettemin zijn vele fundamentele vragen over de 
veronderstelde werkingsmechanismen van deze therapeutische interventie op de 
(patho-)fysiologie onvoldoende opgehelderd. Daarnaast zijn ook vragen over optimale 
strategie voor inductie en handhaving van hypothermie, duur van de hypothermie, 
evenals de wijze en snelheid van opwarmen nog onbeantwoord. Het traditionele idee 
dat het beschermende effect van milde hypothermie louter gebaseerd is op het 
reduceren van het (cerebrale) metabolisme, hetgeen gepaard gaat met een afgenomen 
zuurstof en glucose behoefte, is inmiddels verlaten.
 In dit proefschrift beschrijven we de effecten van milde hypothermie en opwarmen 
op het cerebrale metabolisme in relatie tot de cerebrale bloeddoorstroming (sectie I) 
en tot de inflammatoire respons (sectie 2), met als achtergrond het verklaren van de 
mogelijk therapeutische effecten van geïnduceerde hypothermie.
Sectie I: cerebraal metabolisme en bloeddoorstroming
Hoofdstuk 2 geeft een overzicht van de cerebrale bloeddoorstroming na circulatiestil-
stand op basis van bestaande wetenschappelijke literatuur. Op de afdeling intensive 
care vormt het creëren van een optimaal milieu voor cerebraal herstel een belangrijk 
uitgangspunt bij de behandeling van gereanimeerde patiënten. Daarbij wordt 
getracht secundaire schade, die optreedt binnen het post-reanimatie syndroom, 
zoveel mogelijk te beperken. De ernst van neurologische schade na een circulatoir 
arrest is in belangrijke mate afhankelijk van het herstel van cerebrale bloeddoorstro-
ming. Onder normale omstandigheden zijn de hersenen goed in staat om de cerebrale 
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 De optimale duur van de toepassing van milde therapeutisch hypothermie is 
onbekend. Dierexperimenteel onderzoek levert tegenstrijdige resultaten op. De 
meeste humane klinische studies en case series die een positief effect van hypothermie 
beschrijven, zijn gebaseerd op 24-48 uur hypothermie. In de TTM trial werden 
patiënten na 28 uur weer langzaam opgewarmd. Studies in asfyctische pasgeborenen 
tonen een verbetering van mortaliteit en morbiditeit na 48 uur en 72 uur hypothermie. 
Onze studie naar de effecten van langdurige hypothermie op de cerebrale door - 
bloeding laat zien dat dit een veilige behandeling is, in ieder geval vanuit het perspectief 
van de hersenen. Aanvullende studies zijn nodig om de optimale toepassingsduur van 
hypothermie te bepalen.
CO2 heeft een sterk vasodilatatoir effect op de bloedvaten van de hersenen. Hypocapnie 
induceert juist een sterke vasocontrictie en vermindert de cerebrale bloeddoorstroming. 
Hypercapnie en hypocapnie verhogen en verlagen de cerebrale bloeddoorstroming 
met respectievelijk 3-5% en 2-3% per mm Hg verandering van PaCO2. Eerder is reeds 
beschreven dat onder normotherme omstandigheden de cerebrovasculaire CO2 
reactiviteit  na reanimatie intact blijft. In hoofdstuk 3 laten wij zien dat dit ook geldt 
onder milde hypotherme omstandigheden. We hebben een gemiddelde verandering 
in stroomsnelheid gemeten van 3.6% per mm Hg. Dit percentage komt overeen met 
de verandering die in andere studies is beschreven bij gezonde proefpersonen en bij 
patiënten met ernstig traumatisch schedel-hersenletsel. 
 Aangezien na reanimatie de cerebrovasculaire CO2 reactiviteit onder hypothermie 
intact blijft, leidt hypocapnie mogelijk tot cerebrale ischemie door vasoconstrictie. In 
onze studie laten we zien dat hypocapnie een lagere bulbus jugularis saturatie 
induceert, hetgeen suggereert dat hypocapnie ook tot cerebrale ischemie kan leiden. 
Hypocapnie is geassocieerd met een slechtere prognose na reanimatie. Vigerende 
richtlijnen met betrekking tot de zorg na een reanimatie bevelen aan om normocapnie 
na te streven. Desalniettemin laten studies zien dat op intensive care afdelingen 
hypo- en hypercapnie frequent voorkomen bij patiënten na reanimatie. 
 Een belangrijke conclusie is dat normocapnie nagestreefd dient te worden, 
teneinde secundaire hersenschade te voorkomen. 
 Van de drie mechanismen die bij post-reanimatie patiënten de cerebrale bloeddoor-
stroming reguleren beschrijven we de metabole koppeling en cerebrovasculaire CO2 
reactiviteit in hoofdstuk 3 en 4. Het derde mechanisme, dat van de druk auto regulatie, 
werd eerder met transcraniële Doppler bestudeerd door Sundgreen et al. tijdens een met 
noradrenaline geïnduceerde bloeddrukstijging in de delayed hypo perfusion fase. Bij een 
meerderheid van de reanimatie patiënten bleek de druk autoregulatie van de cerebrale 
bloeddoorstroming abnormaal of zelfs afwezig. Deze bevinding onderstreept het belang 
van de door ons in hoofdstuk 2 en 3 bestudeerde en intact bevonden mechanismen 
voor de cerebrale bloeddoorstroming tijdens milde hypothermie.
perfusie nauw te reguleren via verschillende mechanismen: 1. druk autoregulatie, 2. 
metabole koppeling en 3. cerebrovasculaire CO2 reactiviteit. 
 Herstel van lichaamscirculatie heeft helaas niet een gelijktijdig herstel van de 
cerebrale circulatie tot gevolg. Vooral in de eerste minuten en uren na het begin van 
het herstel van de cerebrale circulatie is de bloedvoorziening van de hersenen nog 
verlaagd. In deze fase bevindt zich derhalve ook een mogelijk therapeutisch window 
voor interventies. Dit is ook de fase waarin de milde hypothermie wordt toegepast.
In de hoofdstukken 3 en 4 beschrijven we de effecten van 24 uur en 72 uur hypothermie 
op de cerebrale bloeddoorstroming en metabole koppeling na een circulatoir arrest. 
Met transcraniële Doppler hebben we de gemiddelde stroomsnelheid van bloed door 
de arteria cerebri media (ACM) gemeten als parameter van cerebrale bloeddoor-
stroming. Eerdere studies hebben aangetoond dat na reanimatie onder normotherme 
condities de cerebrale bloeddoorstroming initieel laag is en in de eerste 24 uur 
geleidelijk toeneemt. Dit gaat gepaard met een normale cerebrale zuurstofextractie, 
hetgeen impliceert dat de koppeling tussen cerebrale bloeddoorstroming en metabolisme 
intact blijft. Tijdens hypothermie meten we een vergelijkbaar lage cerebrale bloed-
doorstroming, passende bij de low flow state vroeg na de reanimatie. Deze low flow 
state na reanimatie wordt veroorzaakt door pathofysiologische processen in de 
hersenen die resulteren in een verhoogde cerebrovasculaire weerstand. In vergelijking 
met normothermie duurt het tijdens hypothermie langer voordat de cerebrale bloed-
doorstroming is hersteld tot normale waarden. Deze bevinding suggereert dat hypo- 
thermie het herstel tot normale bloeddoorstroming na circulatie arrest vertraagt. 
Desalniettemin blijft de daarbij gemeten bulbus jugularis saturatie (vrijwel) steeds 
boven de ischemische drempelwaarde van 55%. Dit impliceert dat na reanimatie, het 
cerebrale metabolisme tijdens hypothermie verlaagd is en dat de metabole koppeling 
intact blijft.
 De toegepaste hypothermie duur van 24 respectievelijk 72 uur in onze studies 
stelde ons in staat om de cerebrale bloeddoorstroming onder deze twee verschillende 
regimes van therapeutische hypothermie te beschrijven en, voor zover mogelijk, te 
vergelijken. Tijdens geïnduceerde milde hypothermie gedurende 72 uur na reanimatie 
neemt de cerebrale bloeddoorstroming geleidelijk toe tot normale waarden en 
verandert niet specifiek bij het veranderen van de lichaamstemperatuur van de patiënt. 
De regulatie van cerebrale bloeddoorstroming lijkt derhalve niet onder directe invloed van 
de temperatuur te staan. Waarschijnlijker is dat de hypothermie het hersen-
metabolisme verlaagt en secundair daaraan het herstel van cerebrale bloeddoorstro-
ming beïnvloedt. Langdurige behandeling met hypothermie gaat gepaard met een 
lagere cerebrale bloeddoorstroming na 24 en 48 uur in vergelijking met de groep 
patiënten die gedurende 24 uur werd gekoeld, echter dit verschil kan ook veroorzaakt 
zijn door een belangrijk verschil in inclusiecriteria van de twee vergeleken studies.  
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viscositeit, c.q. hematocriet, na te streven in de vroege fase na reanimatie. In de 
complexe intensive care setting na reanimatie geldt het hematocriet als een relatief 
eenvoudig te beïnvloeden parameter via bloedtransfusie of hemodilutie. Het 
hematocriet is een belangrijke determinant van viscositeit, maar daarnaast speelt het 
ook een essentiële rol in de zuurstofafgifte aan de weefsels. Een hoger hemoglobine 
(Hb) gehalte van het bloed ten tijde van presentatie in het ziekenhuis na reanimatie is 
geassocieerd met een betere neurologische uitkomst. Daarentegen leidt een verlaagd 
Hb gehalte tot een verhoging van de NO-productie, hetgeen resulteert in cerebrale 
vasodilatatie, met mogelijk een gunstig effect op de cerebrale bloeddoorstroming. 
Hoofdstuk 5 onderstreept het belang van het bepalen van de optimale viscositeit 
(hematocriet) voor de optimale cerebrale bloeddoorstroming voor neurologisch 
herstel na reanimatie in relatie tot de optimale zuurstofafgifte aan de hersenen.
Conclusie
Na een succesvolle reanimatie is de cerebrale bloeddoorstroming verlaagd, waarschijnlijk 
ten gevolge van een verlaagd cerebraal metabolisme. Hypothermie verlaagt dit 
metabolisme verder, maar is niet de belangrijkste determinant van de cerebrale 
bloeddoorstroming na een circulatiestilstand. Tijdens de behandeling op de afdeling 
intensive care spelen zowel PaCO2 als viscositeit een belangrijke rol in de regulatie 
van cerebrale bloeddoorstroming van gereanimeerde patiënten. 
Sectie II: de inflammatoire respons na reanimatie
Hoofdstuk 6 beschrijft de actuele literatuur met betrekking tot de inflammatoire 
respons tijdens het post-reanimatie syndroom. Een circulatiestilstand leidt tot ischemie/ 
reperfusie schade, hetgeen leidt tot een sterke activatie van de inflammatoire 
cascade door activatie van zowel het aangeboren als het verworven immuunsysteem, 
 endotheelcellen, het complement systeem, celdood mechanismen en stollingscascades. 
Activatie van de ontstekingsreactie is een mechanisme om de verdere beschadiging 
van cellen te voorkomen en om activatie van herstelmechanismen te induceren, maar 
kan op zichzelf ook weer bijdragen aan secundaire (hersen)schade. De systemische 
ontsteking na reanimatie is geassocieerd met verhoogde morbiditeit en mortaliteit 
en verhoogt het risico op multi-orgaanfalen en infecties.
 De systemische activatie van het aangeboren immuunsysteem ten gevolge van 
de ischemie/reperfusie na circulatiestilstand lijkt op het ziektebeeld dat ontstaat bij 
een sepsis, vandaar ook dat de benaming ‘sepsis-like syndrome’ in deze context 
gebruikt wordt. Deze immuun respons wordt beïnvloed door behandelingsstrategieën 
op de afdeling intensive care, bijvoorbeeld door de toepassing van vasopressoren, 
corticosteroïden en milde hypothermie.
 In onze studies wordt een mean arterial pressure (MAP) van 80-100 mm Hg 
nagestreefd. Deze bloeddruk is hoger dan de bloeddruk van ≥ 65 mm Hg die momenteel 
wordt aanbevolen binnen de huidige richtlijnen om een adequate cerebrale perfusie 
te waarborgen. De optimale bloeddruk na reanimatie is waarschijnlijk per individuele 
patiënt verschillend en afhankelijk van de mate van beschadiging van de hersenen en 
autoregulatie, in combinatie met de hoogte van de ‘eigen’, ofwel preëxistente 
bloeddruk.
 Transcraniële Doppler echografie is een non-invasieve en gemakkelijk toepasbare 
methode om stroomsnelheden in de grotere cerebrale arteriën, vaak de arteria 
cerebri media, te meten. De bloeddoorstroming in dit bloedvat wordt bepaald door de 
stroomsnelheid en de diameter van het bloedvat. De veranderingen in stroomsnelheid 
corresponderen met veranderingen in bloeddoorstroming in hetzelfde bloedvat, 
mits de diameter van het gemeten bloedvat gelijk blijft. Bij gezonde proefpersonen 
en (neuro)chirurgische patiënten veranderde de diameter van de arteria cerebri 
media niet tijdens veranderingen in bloeddruk. De gemeten stroomsnelheid in de 
hersenen na een reanimatie is moeilijk te interpreteren, aangezien de stroomsnelheid in 
de arteria cerebri media en bloeddoorstroming niet direct aan elkaar gerelateerd zijn.
 De viscositeit van het bloed is een determinant van macro- en microvasculaire 
weerstand en beïnvloedt de cerebrale bloeddoorstroming. De relatie tussen perfusie- 
druk en bloeddoorstroming wordt deels bepaald door de viscositeit van het bloed. De 
viscositeit neemt af als de shear rate (SR), die bepaald wordt door de stroomsnelheid 
van het bloed en de diameter van het bloedvat, toeneemt. Dit fenomeen is kenmerkend 
voor niet-Newtoniaanse vloeistoffen, zoals bloed. De rheologische eigenschappen 
van bloed zijn afhankelijk van hematocriet en een aantal andere bestanddelen van 
bloedplasma. In hoofdstuk 5 beschrijven we de veranderingen in viscositeit en cerebrale 
bloeddoorstroming bij hypotherme patiënten na reanimatie. De hoogste viscositeit 
hebben we gemeten in de eerste uren na reanimatie. In de daaropvolgende dagen 
daalt de viscositeit geleidelijk. Deze negatieve correlatie tussen bloed viscositeit en 
de cerebrale bloeddoorstroming suggereert dat een lage cerebrale bloeddoorstroming 
in de vroege fase na reanimatie mede het gevolg kan zijn van een hoge viscositeit.
 Verandering van cerebrale bloeddoorstroming door verandering van viscositeit 
leidt tot compensatie via verschillende mechanismen. Verandering van viscositeit 
leidt tot verandering van diameter van de arteriolen, de zogenaamde viscositeit 
autoregulatie. Het is onbekend of dit mechanisme van autoregulatie beschadigd raakt 
onder pathologische omstandigheden, zoals binnen het post-reanimatie syndroom. 
De variatie in het effect van viscositeit op de cerebrale bloeddoorstroming kan het 
gevolg zijn van de mate waarin de viscositeits autoregulatie is aangedaan.
 Onder ischemische omstandigheden vormt de viscositeit van het bloed een 
bepalende determinant van cerebrale bloeddoorstroming. Vanuit dit perspectief is 
het voor een adequate cerebrale bloeddoorstroming belangrijk om de optimale 
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inflammatoir effect van opwarmen na 72 uur niet meer optreedt door het uitdoven 
van de ontstekingsreactie. Verschillende mechanismen spelen hierin een rol, bijvoorbeeld 
een afname van het aantal leukocyten en functie. 
 ICAM-1 is een endotheliaal adhesie molecuul van de immunoglobuline gene 
superfamilie en speelt een rol in de cascade van neutrofiel activatie, adherentie aan 
endotheelcellen en transmigratie naar het interstitium. Langdurige milde hypothermie 
verlaagt de toename van ICAM-1 tijdens opwarmen. Een vergelijkbaar effect zien we 
optreden na 24 uur koelen. De ICAM-1 expressie wordt verder verlaagd door 
verminderd vrijkomen van proinflammatoire cytokines tijdens hypothermie. 
 Het complement systeem is een belangrijke component van het aangeboren 
immuun systeem en is sterk temperatuursafhankelijk. Hypothermie vermindert de 
activatie van het complement systeem. Het opwarmen na 24 en 72 uur leidt tot een 
reactivatie van het complementsysteem. Onze resultaten laten zien dat de activiteit 
van het complementsysteem tijdens hypothermie onderdrukt lijkt te zijn. Aangezien 
deze activiteit van het complement systeem sterk afhankelijk is van de temperatuur, 
is het aannemelijk dat de toegenomen complement activatie tijdens/na opwarmen 
direct gerelateerd is aan deze temperatuursverandering.
Conclusie
Een circulatiestilstand leidt tot ischemie/reperfusie schade. Dit induceert een sterke 
inflammatoire respons tijdens het post-reanimatie syndroom en leidt tot secundaire 
(neurologische) schade. Een matige toename van de temperatuur tijdens de late fase 
van milde therapeutische hypothermie is geassocieerd met een toename van het 
proinflammatoire cytokine IL-6. De verdere opwarming van patiënten is geassocieerd 
met activatie van het complementsysteem na 24 uur en na 72 uur hypothermie. Een 
proinflammatoir effect van opwarmen na langdurige hypothermie treedt niet meer 
op door het uitdoven van de ontstekingsreactie.
Conclusies, aanwijzingen voor de praktijk 
en perspectief voor de toekomst 
De optimale MAP voor een gereanimeerde patiënt is onbekend en niet bestudeerd in 
prospectieve klinische trials. Het postanoxische brein heeft een adequate perfusiedruk 
nodig om het potentiële no-reflow fenomeen en de cerebrale microvasculaire 
disfunctie te overwinnen. Relatieve hypertensie levert echter ook meer stress op 
voor het (post-) ischemische myocard. De heterogene verstoring van autoregulatie, 
verhoogde intracraniële druk en vele andere cerebrale pathofysiologische processen 
enerzijds en anderzijds de belastbaarheid van het hart maken dat de optimale MAP 
na reanimatie waarschijnlijk op individueel niveau bepaald en per patiënt verschillend 
 Naast een gegeneraliseerde immuun respons veroorzaakt een circulatiestilstand 
ook een locale cerebrale ontsteking. Cytokines oefenen direct en indirect effect uit 
op de hersenen na een reanimatie. De cytokines worden in de hersenen hoofdzakelijk 
door microgliale cellen en de astrocyten geproduceerd en dragen bij aan de normale 
autonome, neuro-endocriene en metabole homeostase van de hersenen. Onder 
ischemische omstandigheden neemt de cerebrale cytokine productie toe. Deze 
toename versterkt vervolgens weer de systemische inflammatoire cascade die in 
gang wordt gezet na een circulatiestilstand.
 Tot dusver hebben studies naar de inflammatoire respons conflicterende data 
opgeleverd. In hoofdstuk 7 beschrijven we de inflammatoire balans van gereanimeerde 
patiënten tijdens hypothermie en opwarmen. Milde hypothermie remt de inflammatie 
bij experimentele herseninfarcering. In onze studie is een matige toename van de 
temperatuur tijdens de late fase van milde therapeutische hypothermie geassocieerd 
met een toename van het proinflammatoire cytokine IL-6. De verdere opwarming van 
patiënten is geassocieerd met activatie van het complementsysteem. Ondanks steeds 
sterkere aanwijzingen voor een lokale cerebrale inflammatoire respons vinden we 
geen significant verschil tussen ontstekingseiwitten in bloedmonsters afgenomen uit 
het arteriële vaatsysteem en de bulbus jugularis (veneus bloed uit de hersenen). Een 
mogelijke verklaring hiervoor zou kunnen zijn dat de systemische inflammatoire 
respons zoveel malen sterker is dat de geïsoleerde cerebrale respons te klein is om in 
het bloed uit de bulbus jugularis te meten.
 Patiënten die gedurende 24 uur gekoeld werden laten een activatie van het 
 complementsysteem en een proinflammatoire respons zien tijdens het opwarmen. 
De complexe ontstekingsreactie na reanimatie wordt geïnitieerd door de ischemie/
reperfusie respons, veroorzaakt (secundaire) orgaanschade en bevordert activatie 
van herstelmechanismen. Het exacte verloop van deze processen in de tijd is onbekend, 
maar overschrijdt waarschijnlijk de 24 uurs periode van milde therapeutische 
hypothermie. De opvlamming van inflammatie en complement activatie na deze 24 
uur, toont aan dat de duur van hypothermie gedurende 24 uur arbitrair is. Wellicht 
zou ook een meer gecontroleerde vorm van opwarmen (in plaats van passief 
opwarmen) een dempend effect kunnen hebben op deze opvlamming. Helaas is het 
ten gevolge van de methodologische opzet (afwezigheid van normotherme 
controlegroep) van onze studie niet mogelijk om tijd en temperatuur direct aan elkaar 
te relateren. In hoofdstuk 8 wordt, in tegenstelling tot de studie in hoofstuk 7, het 
effect van hypothermie en passief opwarmen op de inflammatoire respons 
beschreven in een patiëntenpopulatie die gedurende 72 uur wordt gekoeld. Tijdens 
het langdurig koelen wordt de complement activatie onderdrukt. Bovendien daalt 
het proinflammatoire cytokine IL-6 in deze periode waarna de IL-6 concentratie ook 
tijdens het opwarmen laag blijft. Het anti-inflammatoire IL-10 daalt ook tijdens 
langdurige hypothermie en opwarmen. Deze resultaten suggereren dat een pro-
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effect enerzijds direct is toe te schrijven aan de hypothermie of  anderzijds aan de 
fase van het post-reanimatie syndroom waarbinnen het opwarmen plaatsvindt, 
menen wij in sterke mate dat nauwkeurige timing van het opwarmen een cruciale rol 
speelt bij het voorkomen van gesuperponeerde ischemie/reperfusie schade.
is. Toekomstig onderzoek zal moeten uitwijzen of het mogelijk is om het optimum van 
de bloeddruk in relatie tot het individuele autoregulatie-niveau te bepalen en toe te 
passen.
 De metabole koppeling van comateuze gereanimeerde patiënten blijft intact. 
Het is een belangrijke bevinding dat, ondanks een daling van cerebrale bloeddoor-
stroming, de cerebrale oxygenatie niet nadelig wordt beïnvloed door hypothermie, 
waarschijnlijk ten gevolge van een verlaging van het hersenmetabolisme. Dit voorkomt 
door hypothermie geïnduceerde ischemie. Ook tijdens langdurige hypothermie wordt een 
reductie in de cerebrale metabole activiteit waargenomen. Dit draagt naar onze 
mening bij aan een langdurig neuroprotectief effect tijdens en na de delayed 
hypoperfusion fase van het post-reanimatie syndroom. Vanuit het perspectief van de 
hersenen bezien zijn kortdurende en langdurige hypothermie een veilige behandeling. 
 De cerebrovasculaire reactiviteit op veranderingen in PaCO2 blijft intact onder 
milde therapeutische hypothermie. In onze studie is sprake van een sterke correlatie 
tussen veranderingen in PaCO2 en SjbO2. Hypocapnie induceert cerebrale vasocon-
strictie en heeft een afname van cerebrale bloeddoorstroming met mogelijke 
secundaire neurologische beschadiging tot gevolg. In tegenstelling tot normocapnie 
is hypocapnie geassocieerd met een slechtere klinische uitkomst. In de huidige 
intensive care setting vorm het handhaven een geringe inspanning.      
 De viscositeit van het bloed is het hoogst in de eerste uren na een reanimatie en 
neemt daarna geleidelijk af. We tonen een negatieve correlatie aan tussen de 
viscositeit en de bloeddoorstroming in de arteria cerebri media. Deze bevinding 
suggereert dat de cerebrale bloeddoorstroming in de vroege fase na reanimatie 
nadelig beïnvloed kan worden door een relatief hoge viscositeit. Een lager hematocriet 
resulteert in een lagere viscositeit, waardoor verbetering van cerebrale bloeddoor-
stroming optreedt, maar leidt ook juist tot een (ongewenste) verlaging van het 
zuurstof transporterend vermogen van het bloed. In neurotrauma patiënten werd 
eerder geen verschil in mortaliteit gevonden tussen de groep patiënten met een Hb 
van 10-12 g/dL in vergelijking met de patiënten met een Hb van 7-9 g/dL. Het 
vaststellen van de optimale waarde van het hematocriet na reanimatie zou moeten 
geschieden in samenhang met de zuurstofbehoefte van het hart en de perifere zuur-
stofdissociatie. 
 De proinflammatoire respons tijdens opwarmen na hypothermie actualiseert de 
vraag over wat de juiste duur van milde therapeutische hypothermie is en op welke 
wijze een patiënt preferentieel zou moeten worden opgewarmd opgewarmd (actief/
passief). Langdurige hypothermie onderdrukt de proinflammatoire respons tijdens 
opwarmen. Deze bevinding kan van belang zijn bij het vaststellen van de optimale 
duur van hypothermie in toekomstige studies. Het onderdrukte proinflammatoire 
effect van opwarmen is óf een effect in de tijd, óf het resultaat van een mogelijk direct 
therapeutisch effect van de langdurige hypothermie zelf. Hoewel het onduidelijk is of dit 
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